Model name: Babelscape/rebel-large
Test file: data/chemprot/test.jsonl
predictions 	 labels 
{'head': 'platinum-based therapy', 'type': 'facet of', 'tail': 'non-small-cell lung cancer'} 	 {'head': 'gefitinib', 'type': 'Downregulator', 'tail': 'Epidermal growth factor receptor'} 
{'head': 'reversible antagonism', 'type': 'subclass of', 'tail': 'reversible'} 	 {'head': 'Alprenolol', 'type': 'Downregulator', 'tail': 'beta-adrenoceptor'} 
{'head': 'Loperamide', 'type': 'subject has role', 'tail': 'antinociceptive'} 	 {'head': 'loperamide', 'type': 'Part_of', 'tail': 'HSA'} 
{'head': 'domain III', 'type': 'part of', 'tail': 'albumin'} 	 {'head': 'anthranilic acid sulfonamides', 'type': 'Regulator', 'tail': 'MetAP2'} 
{'head': 'enzyme-coupled assay', 'type': 'subclass of', 'tail': 'coupled assay'} 	 {'head': 'adenine', 'type': 'Substrate', 'tail': 'Adenine phosphoribosyltransferase'} 
{'head': "Cholinesterase inhibitors for Alzheimer's disease", 'type': 'facet of', 'tail': "Alzheimer's disease"} 	 {'head': 'donepezil', 'type': 'Downregulator', 'tail': 'cholinesterase'} 
{'head': 'Mitiglinide', 'type': 'subject has role', 'tail': 'anti-diabetic drug'} 	 {'head': 'mitiglinide', 'type': 'Not', 'tail': 'Kir6.2'} 
{'head': 'hypertension', 'type': 'has effect', 'tail': 'heart failure'} 	 {'head': 'telmisartan', 'type': 'Agonist', 'tail': 'peroxisome proliferator-activated receptor-γ'} 
{'head': 'Δ(9)-tetrahydrocannabinol', 'type': 'instance of', 'tail': 'cannabinoid'} 	 {'head': 'Δ(9)-tetrahydrocannabinol', 'type': 'Agonist', 'tail': 'CB1'} 
{'head': 'Indometacin', 'type': 'subject has role', 'tail': 'Nonsteroidal anti-inflammatory drug'} 	 {'head': 'N-[2-(cyclohexyloxyl)-4-nitrophenyl]-methanesulfonamide', 'type': 'Downregulator', 'tail': 'cyclooxygenase-2'} 
{'head': 'MEN1', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'lysine', 'type': 'Part_of', 'tail': 'MEN1'} 
{'head': 'hydroxyl', 'type': 'subclass of', 'tail': 'hydrogen bond'} 	 {'head': 'arginine', 'type': 'Part_of', 'tail': 'bovine beta-1,4-galactosyltransferase I'} 
{'head': 'TMPRSS4', 'type': 'subclass of', 'tail': 'serine protease'} 	 {'head': '2-hydroxydiarylamide', 'type': 'Downregulator', 'tail': 'TMPRSS4'} 
{'head': 'Norepinephrine', 'type': 'instance of', 'tail': 'neurotransmitter'} 	 {'head': 'norepinephrine', 'type': 'Regulator', 'tail': 'beta1AR'} 
{'head': 'retinal degeneration slow', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'INS37217', 'type': 'Agonist', 'tail': 'P2Y(2) receptor'} 
{'head': 'kainate receptor', 'type': 'subclass of', 'tail': 'ion channel'} 	 {'head': 'topiramate', 'type': 'Downregulator', 'tail': 'kainate receptors'} 
{'head': 'Galanthamine', 'type': 'medical condition treated', 'tail': "Alzheimer's disease"} 	 {'head': '(-)-galanthamine', 'type': 'Regulator', 'tail': 'acetylcholinesterase'} 
{'head': 'glycine', 'type': 'subclass of', 'tail': 'amino group'} 	 {'head': 'methyl', 'type': 'Substrate', 'tail': 'glycine N-methyltransferase'} 
{'head': 'testosterone', 'type': 'subclass of', 'tail': 'androgen'} 	 {'head': 'androgen', 'type': 'Modulator', 'tail': 'nuclear receptors'} 
{'head': 'Dasatinib', 'type': 'medical condition treated', 'tail': 'mastocytosis'} 	 {'head': 'Dasatinib', 'type': 'Downregulator', 'tail': 'KIT'} 
{'head': 'pertussis toxin', 'type': 'subject has role', 'tail': 'inhibitor'} 	 {'head': 'prostaglandin E(2)', 'type': 'Substrate', 'tail': 'COX-2'} 
{'head': '7-hydroxy-4-trifluoromethylcoumarin', 'type': 'subject has role', 'tail': 'xenobiotics'} 	 {'head': '7-hydroxy-4-trifluoromethylcoumarin', 'type': 'Substrate', 'tail': 'human UDP-glucuronosyltransferases'} 
{'head': 'ST1283', 'type': 'subject has role', 'tail': 'H3 receptor antagonist'} 	 {'head': 'R-(alpha)-methyl-histamine', 'type': 'Agonist', 'tail': 'H3R'} 
{'head': 'clomipramine', 'type': 'subject has role', 'tail': 'tricyclic antidepressant'} 	 {'head': 'LY 53857', 'type': 'Antagonist', 'tail': '5-HT(2A/2B/2C)-receptor'} 
{'head': 'telomere', 'type': 'part of', 'tail': 'chromosome'} 	 {'head': 'lysine', 'type': 'Part_of', 'tail': 'TRF2'} 
{'head': 'PSS1', 'type': 'subclass of', 'tail': 'phosphatidylserine synthase'} 	 {'head': 'Phosphatidylserine', 'type': 'Substrate', 'tail': 'PtdSer synthases'} 
{'head': 'Euphorbia peplus', 'type': 'has part', 'tail': 'Ingenol 3-angelate'} 	 {'head': 'ingenol 3-angelate', 'type': 'Regulator', 'tail': 'protein kinase C'} 
{'head': 'Tris(1-chloro-2-propyl) and tris(1,3-dichloro-2-propyl) phosphate', 'type': 'subject has role', 'tail': 'flame retardant'} 	 {'head': 'TCPP', 'type': 'Upregulator', 'tail': 'Type I deiodinase'} 
{'head': 'obesity', 'type': 'subclass of', 'tail': 'metabolic diseases'} 	 {'head': 'EtOAc', 'type': 'Agonist', 'tail': 'PPARα/β/γ'} 
{'head': 'remikiren', 'type': 'subject has role', 'tail': 'renin-angiotensin-aldosterone system'} 	 {'head': 'remikiren', 'type': 'Downregulator', 'tail': 'renin'} 
{'head': 'TWIK-1', 'type': 'subclass of', 'tail': 'protein kinase'} 	 {'head': 'amino acid', 'type': 'Part_of', 'tail': 'TWIK-1'} 
{'head': 'Brief Psychiatric Rating Scale', 'type': 'facet of', 'tail': 'psychopathologic'} 	 {'head': 'risperidone', 'type': 'Regulator', 'tail': 'D2 receptor'} 
{'head': 'partial agonist', 'type': 'subclass of', 'tail': 'inotropic'} 	 {'head': 'CGP 12177A', 'type': 'Regulator', 'tail': 'beta(1)-adrenoceptors'} 
{'head': 'antithrombin', 'type': 'subject has role', 'tail': 'Antithrombin binding'} 	 {'head': 'Ca', 'type': 'Downregulator', 'tail': 'factor Xa'} 
{'head': 'short QT syndrome', 'type': 'subclass of', 'tail': 'short QT syndrome'} 	 {'head': 'quinidine', 'type': 'Regulator', 'tail': 'HERG'} 
{'head': 'rofecoxib', 'type': 'subject has role', 'tail': 'analgesic'} 	 {'head': 'PGE2', 'type': 'Substrate', 'tail': 'COX-2'} 
{'head': 'Follicle-stimulating hormone', 'type': 'instance of', 'tail': 'glycoprotein'} 	 {'head': 'steroids', 'type': 'Substrate', 'tail': 'Follicle-stimulating hormone'} 
{'head': 'PDE4 inhibitor', 'type': 'subclass of', 'tail': 'antipsychotic'} 	 {'head': 'rolipram', 'type': 'Regulator', 'tail': 'PDE4B'} 
{'head': 'cat-1', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'amino acids', 'type': 'Substrate', 'tail': 'Cat-1'} 
{'head': 'methyl thiazole tetrazolium', 'type': 'subject has role', 'tail': 'Cytotoxicity'} 	 {'head': 'steroidal glycoalkaloids', 'type': 'Upregulator', 'tail': 'TGF-β receptor I'} 
{'head': 'alpha(2)-adrenoceptor', 'type': 'subclass of', 'tail': 'adrenoceptor'} 	 {'head': 'rilmenidine', 'type': 'Not', 'tail': 'alpha(2A)-adrenoceptors'} 
{'head': 'gonadotropin', 'type': 'subclass of', 'tail': 'mRNA'} 	 {'head': 'Cetrorelix', 'type': 'Downregulator', 'tail': 'GnRH-R'} 
{'head': 'pharmacokinetics', 'type': 'part of', 'tail': 'chemistry'} 	 {'head': 'terfenadine', 'type': 'Antagonist', 'tail': 'histamine H1-receptor'} 
{'head': 'Prunetin', 'type': 'instance of', 'tail': 'isoflavone'} 	 {'head': 'prunetin', 'type': 'Regulator', 'tail': 'IκB kinase'} 
{'head': 'G6PC2', 'type': 'encodes', 'tail': 'Glyphosphatase'} 	 {'head': 'Glucose', 'type': 'Upregulator', 'tail': 'Insulin'} 
{'head': 'PP242', 'type': 'subject has role', 'tail': 'inhibitor'} 	 {'head': 'PP242,', 'type': 'Downregulator', 'tail': 'mTOR'} 
{'head': 'Modafinil', 'type': 'medical condition treated', 'tail': 'attention-deficit/hyperactivity disorder'} 	 {'head': '(+/-)-Modafinil', 'type': 'Regulator', 'tail': 'human dopamine transporter'} 
{'head': 'MARCH1', 'type': 'part of', 'tail': 'ubiquitin-proteasome pathway'} 	 {'head': 'polyphenols', 'type': 'Downregulator', 'tail': 'ovalbumin'} 
{'head': 'macrophages', 'type': 'part of', 'tail': 'cytoplasm'} 	 {'head': 'AOH', 'type': 'Regulator', 'tail': 'Aurora B'} 
{'head': 'prorelaxin', 'type': 'subclass of', 'tail': 'polypeptide hormone'} 	 {'head': 'amino acid', 'type': 'Part_of', 'tail': 'insulin'} 
{'head': 'tinzaparin', 'type': 'subject has role', 'tail': 'antimetastatic'} 	 {'head': 'tinzaparin', 'type': 'Regulator', 'tail': 'VLA-4'} 
{'head': 'GnRH', 'type': 'subclass of', 'tail': 'gonadotropin-releasing hormone'} 	 {'head': 'amino acids', 'type': 'Part_of', 'tail': 'GnRHs'} 
{'head': 'eptastigmine', 'type': 'subclass of', 'tail': 'organophosphorus'} 	 {'head': 'organophosphorus', 'type': 'Downregulator', 'tail': 'acetylcholinesterase'} 
{'head': 'HepaRG', 'type': 'instance of', 'tail': 'cell line'} 	 {'head': 'rifampicin', 'type': 'Upregulator', 'tail': 'CYP3A4'} 
{'head': 'Compound 20', 'type': 'subject has role', 'tail': 'inhibitor'} 	 {'head': 'PF-04859989', 'type': 'Downregulator', 'tail': 'KAT II'} 
{'head': 'antagonist', 'type': 'opposite of', 'tail': 'agonist'} 	 {'head': '[3H]-oxotremorine-M', 'type': 'Regulator', 'tail': 'muscarinic receptors'} 
{'head': 'previous study', 'type': 'main subject', 'tail': 'autism'} 	 {'head': 'pyridoxine', 'type': 'Substrate', 'tail': 'pyridoxal kinase'} 
{'head': 'rifampicin', 'type': 'medical condition treated', 'tail': "Alzheimer's disease"} 	 {'head': "N'-2-(4-benzylpiperidin-/piperazin-1-yl)acylhydrazone", 'type': 'Downregulator', 'tail': 'cholinesterases'} 
{'head': 'Testosterone', 'type': 'subject has role', 'tail': 'anabolic-androgenic steroid'} 	 {'head': 'steroids', 'type': 'Regulator', 'tail': 'hAR'} 
{'head': 'licofelone', 'type': 'subject has role', 'tail': 'anti-inflammatory'} 	 {'head': 'Licofelone', 'type': 'Downregulator', 'tail': 'monocyte chemoattractant protein-1'} 
{'head': 'lumiracoxib', 'type': 'subject has role', 'tail': 'COX-2 selective inhibitor'} 	 {'head': 'lumiracoxib', 'type': 'Downregulator', 'tail': 'COX-2'} 
{'head': 'DNA methyltransferase', 'type': 'subclass of', 'tail': 'proteins'} 	 {'head': 'Alcohol', 'type': 'Regulator', 'tail': 'DNA methyltranferases'} 
{'head': 'Diabetic STZ', 'type': 'has part', 'tail': 'streptozotocin'} 	 {'head': 'Streptozotocin', 'type': 'Regulator', 'tail': 'Clock'} 
{'head': 'monoamine oxidase-A inhibitor', 'type': 'subclass of', 'tail': 'reversible'} 	 {'head': 'moclobemide', 'type': 'Downregulator', 'tail': 'MAO-A'} 
{'head': 'BRN-250', 'type': 'subject has role', 'tail': 'anti-angiogenic'} 	 {'head': 'BRN-103', 'type': 'Downregulator', 'tail': 'VEGF'} 
{'head': 'captopril', 'type': 'subject has role', 'tail': 'inhibitor'} 	 {'head': 'batimastat', 'type': 'Regulator', 'tail': 'metalloproteinase'} 
{'head': 'fracture', 'type': 'has cause', 'tail': 'osteoporosis'} 	 {'head': 'Hcy', 'type': 'Substrate', 'tail': 'MTRR'} 
{'head': 'glutathione', 'type': 'subject has role', 'tail': 'antioxidant'} 	 {'head': 'alcohols', 'type': 'Substrate', 'tail': 'GPxs'} 
{'head': 'pyruvate', 'type': 'subject has role', 'tail': 'glycolytic'} 	 {'head': 'TCDD', 'type': 'Downregulator', 'tail': 'glucose transporter'} 
{'head': 'Vitamin E', 'type': 'subject has role', 'tail': 'antioxidant'} 	 {'head': 'alpha-tocopherol', 'type': 'Substrate', 'tail': 'apolipoprotein A-I'} 
{'head': 'protein phosphatase-1', 'type': 'subclass of', 'tail': 'Ser/Thr protein phosphatase'} 	 {'head': 'motuporin', 'type': 'Regulator', 'tail': 'protein phosphatase-1'} 
{'head': '5HT', 'type': 'subclass of', 'tail': 'monoamine'} 	 {'head': 'cocaine', 'type': 'Regulator', 'tail': 'Drosophila serotonin transporter'} 
{'head': 'dopamine', 'type': 'subclass of', 'tail': 'receptor'} 	 {'head': 'clozapine', 'type': 'Regulator', 'tail': 'D2 receptor'} 
{'head': 'kainic acid', 'type': 'subclass of', 'tail': 'glutamate receptor'} 	 {'head': 'AMPA', 'type': 'Regulator', 'tail': 'glutamate receptors'} 
{'head': 'Pranlukast', 'type': 'subject has role', 'tail': 'leukotriene receptor antagonist'} 	 {'head': 'Pranlukast', 'type': 'Regulator', 'tail': 'CysLTR1'} 
{'head': 'clopidogrel', 'type': 'subject has role', 'tail': 'antithrombotic drug'} 	 {'head': 'ticlopidine', 'type': 'Regulator', 'tail': 'P2Y12'} 
{'head': 'troglitazone', 'type': 'subject has role', 'tail': 'anti-diabetic agent'} 	 {'head': 'thiazolidinediones', 'type': 'Not', 'tail': 'ENT1'} 
{'head': 'SCN1A', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'Phenytoin', 'type': 'Substrate', 'tail': 'CYP2C9'} 
{'head': 'Fisetin', 'type': 'instance of', 'tail': 'flavonol'} 	 {'head': 'Fisetin', 'type': 'Regulator', 'tail': 'mTORC1'} 
{'head': 'Tomudex', 'type': 'subject has role', 'tail': 'antifolate'} 	 {'head': 'Tomudex', 'type': 'Upregulator', 'tail': 'kinase'} 
{'head': 'phosphatidylinositol 3-kinase', 'type': 'subclass of', 'tail': 'protein kinase B'} 	 {'head': 'triglycerides', 'type': 'Regulator', 'tail': 'PTP1B'} 
{'head': 'quinolinic acid', 'type': 'has effect', 'tail': 'neurotoxicity'} 	 {'head': 'tryptophan', 'type': 'Substrate', 'tail': 'IDO'} 
{'head': 'acetylcholine', 'type': 'subject has role', 'tail': 'calcium ionophore'} 	 {'head': 'oxygen', 'type': 'Substrate', 'tail': 'NADPH oxidase'} 
{'head': 'phenanthrene', 'type': 'instance of', 'tail': 'polycyclic aromatic hydrocarbons'} 	 {'head': 'polycyclic aromatic hydrocarbons', 'type': 'Upregulator', 'tail': 'EROD'} 
{'head': 'ApoA-I', 'type': 'instance of', 'tail': 'protein'} 	 {'head': 'manumycin A', 'type': 'Upregulator', 'tail': 'ApoA-I'} 
{'head': 'Exemestane', 'type': 'subject has role', 'tail': 'aromatase inhibitor'} 	 {'head': 'Estrogens', 'type': 'Substrate', 'tail': 'CYP450'} 
{'head': 'melanoma', 'type': 'has cause', 'tail': 'V600E BRAF kinase mutation'} 	 {'head': 'N-(thiophen-2-yl) benzamide', 'type': 'Downregulator', 'tail': 'BRAF'} 
{'head': 'Small interfering RNA', 'type': 'subclass of', 'tail': 'RNA'} 	 {'head': "2'-O-methyl", 'type': 'Regulator', 'tail': 'RISC'} 
{'head': 'Sodium fluoride', 'type': 'medical condition treated', 'tail': 'dental caries'} 	 {'head': 'Sodium fluoride', 'type': 'Regulator', 'tail': 'JNK'} 
{'head': 'pannexin 1', 'type': 'part of', 'tail': 'second gap junction protein family'} 	 {'head': 'carbenoxolone', 'type': 'Downregulator', 'tail': 'Panx1'} 
{'head': 'pyridazinone', 'type': 'subclass of', 'tail': 'dihydropyridazinone'} 	 {'head': '(-)-6-(7-Methoxy-2-(trifluoromethyl)pyrazolo[1,5-a]pyridin-4-yl)-5-methyl-4,5-dihydropyridazin-3(2H)-one', 'type': 'Downregulator', 'tail': 'PDE3/4'} 
{'head': 'biophysical', 'type': 'part of', 'tail': 'biophysically'} 	 {'head': 'phenylalanine', 'type': 'Part_of', 'tail': 'FxxA interaction motif'} 
{'head': 'Fumarate reductase', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'fumarate', 'type': 'Substrate', 'tail': 'FRD'} 
{'head': 'pineal gland', 'type': 'part of', 'tail': 'central nervous system'} 	 {'head': '5-HT', 'type': 'Substrate', 'tail': 'tryptophan hydroxylase'} 
{'head': 'ferritin', 'type': 'has part', 'tail': 'zinc'} 	 {'head': 'zinc', 'type': 'Substrate', 'tail': 'α-CPPs'} 
{'head': 'cyanobacteria', 'type': 'parent taxon', 'tail': 'phytoplankton'} 	 {'head': 'saxitoxin', 'type': 'Regulator', 'tail': 'voltage-gated sodium channel'} 
{'head': 'respiratory failure', 'type': 'subclass of', 'tail': 'cause of death'} 	 {'head': 'paraoxon', 'type': 'Upregulator', 'tail': 'cholinesterase'} 
{'head': 'L6 myotubes', 'type': 'subclass of', 'tail': 'myocytes'} 	 {'head': 'palmatine', 'type': 'Regulator', 'tail': 'insulin dependent glucose transporter-4'} 
{'head': 'anti-Tac', 'type': 'instance of', 'tail': 'monoclonal antibodies'} 	 {'head': '(A) cyclosporine', 'type': 'Regulator', 'tail': 'IL-2 R'} 
{'head': 'Finasteride', 'type': 'subject has role', 'tail': 'alpha-reductase inhibitor'} 	 {'head': 'finasteride', 'type': 'Downregulator', 'tail': '5 alpha-reductase'} 
{'head': 'ondansetron', 'type': 'medical condition treated', 'tail': 'hyperglycemia'} 	 {'head': 'm-CPBG', 'type': 'Regulator', 'tail': '5-HT3'} 
{'head': "3'-R/S-Hydroxyvoacamine", 'type': 'subject has role', 'tail': 'inhibitor'} 	 {'head': "3'-R/S-Hydroxyvoacamine", 'type': 'Downregulator', 'tail': 'acetylcholinesterase'} 
{'head': 'Proliferative diabetic retinopathy', 'type': 'subclass of', 'tail': 'type 2 diabetes mellitus'} 	 {'head': 'tunicamycin', 'type': 'Regulator', 'tail': 'TCF7L2'} 
{'head': 'α-Amino-α´-halomethylketone', 'type': 'subject has role', 'tail': 'inhibitors'} 	 {'head': 'α-Amino-α´-Halomethylketones', 'type': 'Downregulator', 'tail': 'Serine and Cysteine Protease'} 
{'head': 'FLAP', 'type': 'instance of', 'tail': 'protein'} 	 {'head': 'arachidonic acid', 'type': 'Substrate', 'tail': '5-LO'} 
{'head': 'partial', 'type': 'subclass of', 'tail': 'truncation'} 	 {'head': 'N', 'type': 'Part_of', 'tail': 'OATP2B1-FL'} 
{'head': 'memantine', 'type': 'medical condition treated', 'tail': "Alzheimer's disease"} 	 {'head': 'memantine', 'type': 'Not', 'tail': 'cholinesterase'} 
{'head': 'organs', 'type': 'has part', 'tail': 'tissues'} 	 {'head': 'thiazolidinediones', 'type': 'Regulator', 'tail': 'insulin'} 
{'head': 'Rifampicin', 'type': 'medical condition treated', 'tail': 'tuberculosis'} 	 {'head': 'rifampicin', 'type': 'Regulator', 'tail': 'cytochromes P450'} 
{'head': 'PALM cell line', 'type': 'instance of', 'tail': 'cell line'} 	 {'head': '17alpha-methyltestosterone', 'type': 'Regulator', 'tail': 'AR'} 
{'head': 'palinurin', 'type': 'instance of', 'tail': 'sesquiterpene'} 	 {'head': 'palinurin', 'type': 'Downregulator', 'tail': 'GSK-3β'} 
{'head': 'rofecoxib', 'type': 'medical condition treated', 'tail': 'carcinogenesis'} 	 {'head': 'prostanoids', 'type': 'Substrate', 'tail': 'Cyclooxygenase(COX)-2'} 
{'head': 'flumazenil', 'type': 'subject has role', 'tail': 'benzodiazepine receptor antagonist'} 	 {'head': 'Lu AF21934', 'type': 'Modulator', 'tail': 'mGlu₄'} 
{'head': 'PDE5', 'type': 'subclass of', 'tail': 'amino acid'} 	 {'head': 'amino acids', 'type': 'Part_of', 'tail': 'phosphodiesterase-5'} 
{'head': 'complement cascade', 'type': 'part of', 'tail': 'immune response'} 	 {'head': 'amino acid', 'type': 'Part_of', 'tail': 'anaphylatoxins'} 
{'head': 'IL-6', 'type': 'subclass of', 'tail': 'cytokine'} 	 {'head': 'Allicin', 'type': 'Upregulator', 'tail': 'HO-1'} 
{'head': 'aspartame', 'type': 'subject has role', 'tail': 'Artificial sweeteners'} 	 {'head': 'saccharin', 'type': 'Upregulator', 'tail': 'T2R'} 
{'head': 'CXC chemokine receptor 1', 'type': 'subclass of', 'tail': 'G-protein-coupled receptor'} 	 {'head': '2-Arylpropionic', 'type': 'Regulator', 'tail': 'CXC chemokine receptor 1'} 
{'head': 'hepatocytes', 'type': 'part of', 'tail': 'liver'} 	 {'head': 'phenformin', 'type': 'Downregulator', 'tail': 'complex I'} 
{'head': 'DPP-4', 'type': 'subject has role', 'tail': 'inhibitors of dipeptidyl peptidase 4'} 	 {'head': 'xanthine', 'type': 'Downregulator', 'tail': 'dipeptidyl peptidase 4'} 
{'head': 'alpha2A/2C-', 'type': 'subclass of', 'tail': 'receptors'} 	 {'head': 'ergotamine', 'type': 'Regulator', 'tail': 'alpha1-adrenoceptors'} 
{'head': 'apomorphine', 'type': 'subject has role', 'tail': 'dopamine D2 agonist'} 	 {'head': 'apomorphine', 'type': 'Agonist', 'tail': 'dopamine D2'} 
{'head': 'resistance vessel', 'type': 'subclass of', 'tail': 'microvascular arteries'} 	 {'head': 'TES', 'type': 'Regulator', 'tail': 'phosphoinositide 3 (PI3) kinase'} 
{'head': 'racemization', 'type': 'subclass of', 'tail': 'elimination'} 	 {'head': 'L-serine', 'type': 'Substrate', 'tail': 'Mouse brain serine racemase'} 
{'head': 'domains', 'type': 'part of', 'tail': 'protein'} 	 {'head': 'N', 'type': 'Part_of', 'tail': 'Src homology 2 domains'} 
{'head': 'pharmacogenomics', 'type': 'subclass of', 'tail': 'Pharmacogenetic'} 	 {'head': 'Warfarin', 'type': 'Regulator', 'tail': 'CYP2C9'} 
{'head': 'Pseudoephedrine', 'type': 'subject has role', 'tail': 'nasal decongestant'} 	 {'head': 'Pseudoephedrine', 'type': 'Downregulator', 'tail': 'NF-kappaB'} 
{'head': 'indomethacin', 'type': 'medical condition treated', 'tail': 'lymphatic filariasis'} 	 {'head': 'Diethylcarbamazine', 'type': 'Regulator', 'tail': 'cyclooxygenase'} 
{'head': 'Ntp', 'type': 'instance of', 'tail': 'peptide'} 	 {'head': 'N', 'type': 'Part_of', 'tail': 'K(IR)'} 
{'head': 'astrocyte', 'type': 'subclass of', 'tail': 'endothelial cells'} 	 {'head': 'monocarboxylates', 'type': 'Substrate', 'tail': 'Monocarboxylate transporters'} 
{'head': 'mGlu3 receptor', 'type': 'subclass of', 'tail': 'metabotropic glutamate'} 	 {'head': 'LY541850', 'type': 'Regulator', 'tail': 'human mGlu receptors'} 
{'head': 'desoxycorticosterone', 'type': 'subject has role', 'tail': 'glucocorticoid'} 	 {'head': 'corticosterone', 'type': 'Regulator', 'tail': 'CBG'} 
{'head': 'octreotide', 'type': 'subclass of', 'tail': 'somatostatin analogs'} 	 {'head': 'octreotide', 'type': 'Regulator', 'tail': 'SSTR2'} 
{'head': '2,6-dichlorobenzonitrile', 'type': 'instance of', 'tail': 'herbicide'} 	 {'head': '8-methoxypsoralen', 'type': 'Downregulator', 'tail': 'CYP2A'} 
{'head': '1,2,2-trimethyl-propylmethylphosphonofluoridate', 'type': 'instance of', 'tail': 'soman'} 	 {'head': 'soman', 'type': 'Downregulator', 'tail': 'AChE'} 
{'head': "adenosine 5'-(beta,gamma-imino)triphosphate", 'type': 'has part', 'tail': 'ATP'} 	 {'head': 'ATP', 'type': 'Regulator', 'tail': 'TOP2'} 
{'head': 'HbA1c', 'type': 'subclass of', 'tail': 'glycosylated hemoglobin'} 	 {'head': 'ethanol', 'type': 'Upregulator', 'tail': 'ALDH2'} 
{'head': 'quinoline', 'type': 'subject has role', 'tail': 'antimalarial'} 	 {'head': 'quinolines', 'type': 'Downregulator', 'tail': 'QR2'} 
{'head': 'epigenetic silencing', 'type': 'facet of', 'tail': 'epigenetic'} 	 {'head': 'LBH589', 'type': 'Upregulator', 'tail': 'NIS'} 
{'head': '5-MeO-DMT', 'type': 'instance of', 'tail': 'designer drug'} 	 {'head': 'Harmaline', 'type': 'Downregulator', 'tail': 'Monoamine Oxidase A'} 
{'head': 'biosimilars', 'type': 'subclass of', 'tail': 'peptide'} 	 {'head': '(129)I', 'type': 'Part_of', 'tail': 'EPO'} 
{'head': 'levocetirizine', 'type': 'subject has role', 'tail': 'histamine H(1)-receptor antagonist'} 	 {'head': 'cetirizine', 'type': 'Antagonist', 'tail': 'histamine H(1)-receptor'} 
{'head': 'Vegfrecine', 'type': 'subject has role', 'tail': 'inhibitor'} 	 {'head': 'Vegfrecine', 'type': 'Downregulator', 'tail': 'VEGF Receptor Tyrosine Kinases'} 
{'head': 'NaDC-3', 'type': 'subclass of', 'tail': 'cotransporter'} 	 {'head': 'lithium', 'type': 'Downregulator', 'tail': 'hNaDC-3'} 
{'head': 'cornea', 'type': 'part of', 'tail': 'cornea'} 	 {'head': 'amiloride', 'type': 'Downregulator', 'tail': 'u-PA'} 
{'head': 'prednisolone', 'type': 'subject has role', 'tail': 'glucocorticoid'} 	 {'head': 'corticosteroid', 'type': 'Not', 'tail': 'POMC'} 
{'head': 'Myc', 'type': 'subclass of', 'tail': 'oncoprotein'} 	 {'head': '10074-G5', 'type': 'Regulator', 'tail': 'Myc'} 
{'head': 'Miglustat', 'type': 'medical condition treated', 'tail': 'Gaucher disease'} 	 {'head': 'Miglustat', 'type': 'Downregulator', 'tail': 'glucosylceramide synthase'} 
{'head': 'safrole', 'type': 'instance of', 'tail': 'essential oil'} 	 {'head': "Safrole-2',3'-oxide", 'type': 'Regulator', 'tail': 'apolipoprotein E'} 
{'head': "Parkinson's disease", 'type': 'drug used for treatment', 'tail': 'levodopa'} 	 {'head': 'Levodopa', 'type': 'Substrate', 'tail': 'aromatic-L-amino-acid decarboxylase'} 
{'head': 'soy protein isolate', 'type': 'has part', 'tail': 'Soy protein'} 	 {'head': 'nitrogen', 'type': 'Substrate', 'tail': 'casein'} 
{'head': 'aminopeptidase A', 'type': 'subclass of', 'tail': 'aminopeptidase'} 	 {'head': '4-methoxy-2-naphthylamide', 'type': 'Substrate', 'tail': 'aminopeptidase N'} 
{'head': 'active site', 'type': 'part of', 'tail': 'protein'} 	 {'head': 'pSer', 'type': 'Substrate', 'tail': 'peptidyl-prolyl cis/trans-isomerase A1'} 
{'head': 'glutamine synthetase', 'type': 'product or material produced', 'tail': 'glutamine'} 	 {'head': 'ethanol', 'type': 'Regulator', 'tail': 'GS'} 
{'head': 'rufinamide', 'type': 'subject has role', 'tail': 'anticonvulsant'} 	 {'head': 'Rufinamide', 'type': 'Regulator', 'tail': 'voltage-gated sodium channel'} 
{'head': 'apoptosis', 'type': 'subclass of', 'tail': 'cell death'} 	 {'head': 'All-trans retinoic acid', 'type': 'Upregulator', 'tail': 'collagen 8A2'} 
{'head': 'YLR205c', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'H(2)O(2)', 'type': 'Upregulator', 'tail': 'peroxidase'} 
{'head': 'steroidogenic factor-1', 'type': 'subclass of', 'tail': 'iron-sulfur protein'} 	 {'head': 'steroid hormone', 'type': 'Substrate', 'tail': 'FDX1'} 
{'head': 'Flutamide', 'type': 'medical condition treated', 'tail': 'prostatic carcinoma'} 	 {'head': 'Flutamide', 'type': 'Downregulator', 'tail': 'androgen receptor'} 
{'head': 'COX-2', 'type': 'subclass of', 'tail': 'prostaglandin E synthase'} 	 {'head': 'prostaglandin E2', 'type': 'Substrate', 'tail': 'Cycloxygenase-2'} 
{'head': 'Butein', 'type': 'instance of', 'tail': 'polyphenol'} 	 {'head': 'Butein', 'type': 'Regulator', 'tail': 'heme oxygenase-1'} 
{'head': "2'-cytidine monophosphate", 'type': 'subject has role', 'tail': 'inhibitor'} 	 {'head': 'disulfide', 'type': 'Regulator', 'tail': 'bovine pancreatic ribonuclease A'} 
{'head': 'cortisol', 'type': 'subclass of', 'tail': 'prostaglandin'} 	 {'head': 'prostaglandins', 'type': 'Substrate', 'tail': 'PG synthase 2'} 
{'head': 'quipazine', 'type': 'subject has role', 'tail': '5-HT receptor agonist'} 	 {'head': '2-(2-Aminoethyl)-quinoline', 'type': 'Agonist', 'tail': '5-hydroxytryptamine1-like receptors'} 
{'head': 'Bcl-2-associated X protein', 'type': 'subclass of', 'tail': 'Bcl-2'} 	 {'head': 'Vitamin K2', 'type': 'Regulator', 'tail': 'Bak'} 
{'head': 'TCDD', 'type': 'subject has role', 'tail': 'endocrine disruptor'} 	 {'head': 'TCDD', 'type': 'Regulator', 'tail': 'Snrpn'} 
{'head': 'Rasagiline', 'type': 'medical condition treated', 'tail': "Parkinson's disease"} 	 {'head': 'Rasagiline', 'type': 'Regulator', 'tail': 'alpha-synuclein'} 
{'head': 'Tolvaptan', 'type': 'medical condition treated', 'tail': 'hypervolemic hyponatremia'} 	 {'head': 'Tolvaptan', 'type': 'Regulator', 'tail': 'AVP'} 
{'head': 'alpha(1) adrenoceptor', 'type': 'part of', 'tail': 'gonadotrophin-releasing hormone'} 	 {'head': '[(3)H]-prazosin', 'type': 'Regulator', 'tail': 'alpha(1) adrenoceptors'} 
{'head': 'streptozotocin', 'type': 'subject has role', 'tail': 'antidiabetic'} 	 {'head': 'Fisetin', 'type': 'Upregulator', 'tail': 'insulin'} 
{'head': 'tamoxifen', 'type': 'subject has role', 'tail': 'antiestrogen'} 	 {'head': 'LY117018', 'type': 'Regulator', 'tail': 'estrogen receptor'} 
{'head': 'Interluekin-8', 'type': 'part of', 'tail': 'interleukin-8 secretion from keratinocytes'} 	 {'head': 'glucose', 'type': 'Regulator', 'tail': 'extracelluar signal-regulated kinase'} 
{'head': '2-Amino-1-methyl-6-phenylimidazo', 'type': 'instance of', 'tail': 'heterocyclic acid'} 	 {'head': '2-amino-1-methyl-6-phenylimidazo [4, 5-b] pyridine', 'type': 'Regulator', 'tail': 'c-fos'} 
{'head': 'antibodies', 'type': 'has cause', 'tail': 'immunogenicity'} 	 {'head': 'GTX2,3-aldehyde', 'type': 'Regulator', 'tail': 'bovine serum albumin'} 
{'head': 'catalytic mechanism', 'type': 'subclass of', 'tail': 'catalysis'} 	 {'head': '(6R)-5,6,7,8-tetrahydro-L-biopterin', 'type': 'Cofactor', 'tail': 'NOS'} 
{'head': 'prostacyclin', 'type': 'subject has role', 'tail': 'vasodilator'} 	 {'head': 'Prostacyclin', 'type': 'Downregulator', 'tail': 'tissue factor'} 
{'head': 'histones', 'type': 'subclass of', 'tail': 'proteins'} 	 {'head': 'acetyl', 'type': 'Part_of', 'tail': 'histones'} 
{'head': 'papillary thyroid cancer', 'type': 'subclass of', 'tail': 'thyroid cancer'} 	 {'head': 'fluoropyrimidine carbamate', 'type': 'Substrate', 'tail': 'TP'} 
{'head': 'acetazolamide', 'type': 'subject has role', 'tail': 'nonsteroidal anti-inflammatory drug'} 	 {'head': 'prostaglandins', 'type': 'Downregulator', 'tail': 'carbonic anhydrase'} 
{'head': 'nabumetone', 'type': 'subject has role', 'tail': 'nonsteroidal anti-inflammatory drug'} 	 {'head': 'TXB2', 'type': 'Substrate', 'tail': 'COX-1'} 
{'head': 'Nonsteroidal anti-inflammatory drug', 'type': 'subclass of', 'tail': 'anti-inflammatory'} 	 {'head': 'diclofenac', 'type': 'Upregulator', 'tail': 'caspase-3'} 
{'head': 'resistin', 'type': 'subject has role', 'tail': 'antihyperglycemic'} 	 {'head': 'thiazolidinediones', 'type': 'Upregulator', 'tail': 'PPARγ'} 
{'head': 'renal epithelial', 'type': 'subclass of', 'tail': 'cells'} 	 {'head': 'sulforaphane', 'type': 'Regulator', 'tail': 'NRF2'} 
{'head': 'Insulin receptor substrates (IRS) serine phosphorylation', 'type': 'has effect', 'tail': 'insulin resistance'} 	 {'head': 'serine', 'type': 'Part_of', 'tail': 'IRS'} 
{'head': 'angiotensinogen', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'Angiotensin', 'type': 'Cofactor', 'tail': 'human renin'} 
{'head': 'SCN5A', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'mexiletine', 'type': 'Regulator', 'tail': 'M1766L'} 
{'head': 'Oxymatrine', 'type': 'subject has role', 'tail': 'neuroprotective'} 	 {'head': 'OMT', 'type': 'Upregulator', 'tail': 'Bcl-2'} 
{'head': 'sepsis', 'type': 'subclass of', 'tail': 'vascular disease'} 	 {'head': 'Emodin-6-O-β-D-glucoside', 'type': 'Downregulator', 'tail': 'HMGB1'} 
{'head': 'Ramelteon', 'type': 'subject has role', 'tail': 'melatonin MT(1)/MT(2) receptor agonist'} 	 {'head': 'ramelteon', 'type': 'Agonist', 'tail': 'MT(1)'} 
{'head': 'Tamibarotene', 'type': 'instance of', 'tail': 'retinoid'} 	 {'head': 'Am80', 'type': 'Downregulator', 'tail': 'VEGF receptor'} 
{'head': 'Calmodulin-dependent cyclic nucleotide phosphodiesterase', 'type': 'subclass of', 'tail': 'enzyme'} 	 {'head': 'dihydropyridine', 'type': 'Downregulator', 'tail': 'CaMPDE'} 
{'head': 'darapladib', 'type': 'subject has role', 'tail': 'inhibitor'} 	 {'head': 'darapladib', 'type': 'Downregulator', 'tail': 'Lp-PLA(2)'} 
{'head': 'formoterol', 'type': 'subject has role', 'tail': 'beta(2)-adrenoceptor agonist'} 	 {'head': 'formoterol', 'type': 'Agonist', 'tail': 'beta(2)-adrenoceptor'} 
{'head': 'Etoposide', 'type': 'subject has role', 'tail': 'anticancer drug'} 	 {'head': 'VP-16', 'type': 'Downregulator', 'tail': 'topoisomerase II'} 
{'head': 'mitochondria', 'type': 'has part', 'tail': 'mitochondria-associated membrane'} 	 {'head': 'N-ethylmaleimide', 'type': 'Downregulator', 'tail': 'ACS4'} 
{'head': 'ZD1839', 'type': 'subject has role', 'tail': 'tyrosine kinase inhibitor'} 	 {'head': 'tyrosine', 'type': 'Substrate', 'tail': 'tyrosine kinase'} 
{'head': 'gamma-aminobutyric acid', 'type': 'subclass of', 'tail': 'interneurons'} 	 {'head': 'naltrexone', 'type': 'Antagonist', 'tail': 'mu-opioid receptor'} 
{'head': 'dopamine receptor', 'type': 'subclass of', 'tail': 'receptor'} 	 {'head': 'lisuride', 'type': 'Regulator', 'tail': '5-HT(1A)'} 
{'head': 'Bupropion', 'type': 'subject has role', 'tail': 'antidepressant'} 	 {'head': 'Bupropion', 'type': 'Downregulator', 'tail': 'DAT'} 
{'head': 'intrinsic apoptotic pathway', 'type': 'subclass of', 'tail': 'apoptosis'} 	 {'head': 'Nitrogen', 'type': 'Upregulator', 'tail': 'Bim'} 
{'head': 'CASK', 'type': 'subclass of', 'tail': 'calcium/calmodulin-dependent serine protein kinase'} 	 {'head': 'serine', 'type': 'Part_of', 'tail': 'P2X3'} 
{'head': 'Caudal-type homeobox 2', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'chenodeoxycholic acid', 'type': 'Upregulator', 'tail': 'Cdx2'} 
{'head': 'dopamine transporter', 'type': 'product or material produced', 'tail': 'dopamine'} 	 {'head': 'Mazindol', 'type': 'Downregulator', 'tail': 'cocaine binding site'} 
{'head': 'Glyphosate', 'type': 'instance of', 'tail': 'herbicide'} 	 {'head': 'Glyphosate', 'type': 'Downregulator', 'tail': '5-enolpyruvylshikimate-3-phosphate synthase'} 
{'head': 'metformin', 'type': 'medical condition treated', 'tail': 'type 2 diabetes mellitus'} 	 {'head': 'Sitagliptin', 'type': 'Downregulator', 'tail': 'Dipeptidyl Peptidase-4'} 
{'head': 'Cyp1', 'type': 'encodes', 'tail': 'cytochrome P450 1'} 	 {'head': 'vanadium', 'type': 'Regulator', 'tail': 'Cyp1'} 
{'head': 'IL-4', 'type': 'subclass of', 'tail': 'cytokines'} 	 {'head': 'GCS', 'type': 'Not', 'tail': 'IFN-gamma'} 
{'head': 'amprenavir', 'type': 'subject has role', 'tail': 'HIV protease inhibitor'} 	 {'head': 'Amprenavir', 'type': 'Upregulator', 'tail': 'PXR'} 
{'head': 'gentianine', 'type': 'subject has role', 'tail': 'anti-diabetic'} 	 {'head': 'Gentianine', 'type': 'Upregulator', 'tail': 'PPAR-γ'} 
{'head': 'Jaspamide', 'type': 'subclass of', 'tail': 'cyclodepsipeptide'} 	 {'head': 'jaspamide', 'type': 'Regulator', 'tail': 'cardiac ion channel'} 
{'head': 'congestive heart failure', 'type': 'subclass of', 'tail': 'heart failure'} 	 {'head': 'Carvedilol', 'type': 'Regulator', 'tail': 'hypoxia-inducible factor-1alpha'} 
{'head': 'tyrosol', 'type': 'instance of', 'tail': 'phenolic compound'} 	 {'head': 'phenolics', 'type': 'Downregulator', 'tail': 'p66Shc'} 
{'head': 'lysine', 'type': 'subclass of', 'tail': 'amino acid'} 	 {'head': 'amino acid', 'type': 'Part_of', 'tail': 'serine racemases'} 
{'head': '1,3-isobutyl-1-methylxanthine', 'type': 'subject has role', 'tail': 'broad-spectrum phosphodiesterase'} 	 {'head': 'cAMP', 'type': 'Substrate', 'tail': 'phosphodiesterase'} 
{'head': 'endothelin', 'type': 'subclass of', 'tail': 'receptor antagonist'} 	 {'head': 'Ambrisentan', 'type': 'Antagonist', 'tail': 'endothelin type A (ET(A))-selective receptor'} 
{'head': 'red blood cell', 'type': 'part of', 'tail': 'blood'} 	 {'head': 'DMAs(V)', 'type': 'Substrate', 'tail': 'glutathione S-transferase omega 1'} 
{'head': 'Thiazinotrienomycin B', 'type': 'subject has role', 'tail': 'antibiotic'} 	 {'head': 'TT-B', 'type': 'Downregulator', 'tail': 'kinase'} 
{'head': 'Sorafenib', 'type': 'medical condition treated', 'tail': 'renal cell carcinoma'} 	 {'head': 'Sorafenib', 'type': 'Downregulator', 'tail': 'tyrosine kinases'} 
{'head': 'toremifene', 'type': 'subject has role', 'tail': 'selective estrogen receptor modulator'} 	 {'head': 'raloxifene', 'type': 'Regulator', 'tail': 'estrogen receptor'} 
{'head': 'proteasome', 'type': 'has part', 'tail': 'proteasomal gate'} 	 {'head': 'Rapamycin', 'type': 'Downregulator', 'tail': 'proteinase'} 
{'head': 'eumelanin', 'type': 'subclass of', 'tail': 'melanin'} 	 {'head': 'MELANOTAN', 'type': 'Regulator', 'tail': 'MC1 receptor'} 
{'head': 'plasminogen activator', 'type': 'subject has role', 'tail': 'plasmatic thrombolysis'} 	 {'head': 'singlet oxygen', 'type': 'Downregulator', 'tail': 'plasmatic PAI-1'} 
{'head': 'thoracolumbar spinal cord', 'type': 'part of', 'tail': 'sympathetic nervous system'} 	 {'head': 'NE', 'type': 'Regulator', 'tail': 'beta2-adrenergic receptors'} 
{'head': 'thioxanthene', 'type': 'subject has role', 'tail': 'dopaminergic antagonist'} 	 {'head': 'zuclopenthixol', 'type': 'Not', 'tail': 'AChE'} 
{'head': 'Pim family', 'type': 'subclass of', 'tail': 'protein kinase'} 	 {'head': 'ATP', 'type': 'Regulator', 'tail': 'Pim'} 
{'head': 'KCNK1', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'phenobarbital', 'type': 'Upregulator', 'tail': 'KCNK1'} 
{'head': 'dexamethasone', 'type': 'subject has role', 'tail': 'glucorticoid'} 	 {'head': 'Dexamethasone', 'type': 'Regulator', 'tail': 'glucocorticoid receptor'} 
{'head': 'orbitofrontal cortex', 'type': 'part of', 'tail': 'prefrontal cortex'} 	 {'head': 'Methylphenidate', 'type': 'Upregulator', 'tail': 'DAT'} 
{'head': 'diclofenac', 'type': 'subject has role', 'tail': 'COX inhibitor'} 	 {'head': 'meloxicam', 'type': 'Downregulator', 'tail': 'COX-2'} 
{'head': "6,6'-bis(2,3-dimethoxybenzoyl)-a,a-d-trehalose", 'type': 'instance of', 'tail': 'brartemicin'} 	 {'head': 'DMBT', 'type': 'Downregulator', 'tail': 'VEGF'} 
{'head': 'L-type pyruvate kinase', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'carbohydrate', 'type': 'Upregulator', 'tail': 'L-PK'} 
{'head': 'Felbamate', 'type': 'subject has role', 'tail': 'anticonvulsant'} 	 {'head': 'Felbamate', 'type': 'Downregulator', 'tail': 'rat NR1a'} 
{'head': 'Graves disease', 'type': 'subclass of', 'tail': 'hyperthyroidism'} 	 {'head': 'cortisol', 'type': 'Substrate', 'tail': 'ACTH'} 
{'head': 'GRK2', 'type': 'subclass of', 'tail': 'human kappa-opioid receptor'} 	 {'head': 'U50,488H', 'type': 'Not', 'tail': 'rat kappa-opioid receptor'} 
{'head': 'wax apple', 'type': 'parent taxon', 'tail': 'myrtaceae'} 	 {'head': 'vescalagin', 'type': 'Regulator', 'tail': 'insulin'} 
{'head': 'HepG2', 'type': 'instance of', 'tail': 'cell line'} 	 {'head': 'GW4064', 'type': 'Regulator', 'tail': 'FXR'} 
{'head': 'NF-κB', 'type': 'subclass of', 'tail': 'transcription factor'} 	 {'head': 'Ser', 'type': 'Part_of', 'tail': 'p65'} 
{'head': 'chymotrypsin C', 'type': 'part of', 'tail': 'chymotrypsin'} 	 {'head': 'calcium', 'type': 'Not', 'tail': 'D22G'} 
{'head': 'opioid', 'type': 'subclass of', 'tail': 'analgesic'} 	 {'head': 'morphine', 'type': 'Regulator', 'tail': 'Opioid receptors'} 
{'head': 'paclitaxel', 'type': 'medical condition treated', 'tail': 'rheumatism'} 	 {'head': 'aconitine', 'type': 'Not', 'tail': 'cytochrome P450 3A'} 
{'head': 'C-terminal domain', 'type': 'part of', 'tail': 'RNA processing'} 	 {'head': 'Ser', 'type': 'Part_of', 'tail': 'RNA polymerase II'} 
{'head': '4-oxo-5-acetamido-6-phenyl-hex-2-enoic acid', 'type': 'instance of', 'tail': 'peptide'} 	 {'head': '4-oxo-5-acetamido-6-phenyl-hex-2-enoic acid and 4-oxo-5-acetamido-6-(2-thienyl)-hex-2-enoic acid', 'type': 'Downregulator', 'tail': 'PAM'} 
{'head': 'MRP1', 'type': 'subclass of', 'tail': 'Multidrug resistance protein'} 	 {'head': 'Chalcogenopyrylium', 'type': 'Regulator', 'tail': 'MRP1'} 
{'head': 'domains', 'type': 'part of', 'tail': 'protein'} 	 {'head': 'Zinc', 'type': 'Regulator', 'tail': 'prion protein'} 
{'head': 'Interleukin (IL)-22', 'type': 'subclass of', 'tail': 'cytokine'} 	 {'head': 'polyinosinic:polycytidylic acid', 'type': 'Regulator', 'tail': 'IFN'} 
{'head': 'Gemfibrozil', 'type': 'subject has role', 'tail': 'lipid-lowering drug'} 	 {'head': 'Gemfibrozil', 'type': 'Upregulator', 'tail': 'peroxisome proliferator-responsive element'} 
{'head': 'heart rate', 'type': 'part of', 'tail': 'cardiovascular system'} 	 {'head': 'dexmedetomidine', 'type': 'Regulator', 'tail': 'alpha2C'} 
{'head': 'HIF-1alpha', 'type': 'instance of', 'tail': 'transcription factor'} 	 {'head': 'sodium nitroprusside', 'type': 'Not', 'tail': 'soluble guanylyl cyclase'} 
{'head': 'carbonic anhydrase', 'type': 'subclass of', 'tail': 'isozymes'} 	 {'head': 'Indomethacin', 'type': 'Upregulator', 'tail': 'CA'} 
{'head': 'acetylcholinesterase', 'type': 'subject has role', 'tail': 'inhibitors'} 	 {'head': 'pyrano[2,3-b]quinolines', 'type': 'Downregulator', 'tail': 'AChE'} 
{'head': 'Juglone', 'type': 'subject has role', 'tail': 'anti-cancer'} 	 {'head': 'Juglone', 'type': 'Downregulator', 'tail': 'AR'} 
{'head': 'astemizole', 'type': 'medical condition treated', 'tail': 'allergic rhinoconjunctivitis'} 	 {'head': 'Astemizole', 'type': 'Antagonist', 'tail': 'histamine H1-receptor'} 
{'head': "Alzheimer's disease", 'type': 'subclass of', 'tail': 'dementia'} 	 {'head': 'Tacrine', 'type': 'Downregulator', 'tail': 'cholinesterase'} 
{'head': 'NHE1', 'type': 'instance of', 'tail': 'isoforms'} 	 {'head': '5-(N,N-dimethyl)-amiloride', 'type': 'Downregulator', 'tail': 'NHE'} 
{'head': 'EGFR tyrosine kinase inhibitor', 'type': 'medical condition treated', 'tail': 'lung cancer'} 	 {'head': 'crizotinib', 'type': 'Regulator', 'tail': 'anaplastic lymphoma kinase'} 
{'head': 'BRAF', 'type': 'facet of', 'tail': 'melanoma'} 	 {'head': 'dabrafenib', 'type': 'Downregulator', 'tail': 'threonine-protein kinase B-RaF'} 
{'head': 'PXR antagonist', 'type': 'opposite of', 'tail': 'agonist'} 	 {'head': 'azoles', 'type': 'Antagonist', 'tail': 'PXR'} 
{'head': 'L-type channel', 'type': 'subclass of', 'tail': 'calcium channel'} 	 {'head': 'somatostatin-14', 'type': 'Upregulator', 'tail': 'somatostatin receptor subtype 2'} 
{'head': 'Cryptocaryachinensis', 'type': 'parent taxon', 'tail': 'Asclepiadaceae'} 	 {'head': 'Antofine', 'type': 'Regulator', 'tail': 'connexin43'} 
{'head': 'torasemide', 'type': 'medical condition treated', 'tail': 'arterial hypertension'} 	 {'head': 'Torasemide', 'type': 'Downregulator', 'tail': 'angiotensin II'} 
{'head': 'ESI-MS', 'type': 'subclass of', 'tail': 'NMR'} 	 {'head': 'trans-dihydromorin', 'type': 'Downregulator', 'tail': 'tyrosinase'} 
{'head': 'prostaglandin E series', 'type': 'has part', 'tail': 'EP3 receptor'} 	 {'head': 'prostaglandin E', 'type': 'Regulator', 'tail': 'high-voltage-activated (HVA) Ca2+ channels'} 
{'head': 'Mimosine', 'type': 'subject has role', 'tail': 'inhibitor'} 	 {'head': 'mimosine', 'type': 'Regulator', 'tail': 'MCP-1'} 
{'head': 'emergence of new strain of influenza in 2009', 'type': 'point in time', 'tail': '2009'} 	 {'head': 'peramivir', 'type': 'Downregulator', 'tail': 'neuraminidase'} 
{'head': 'CYP2B6', 'type': 'instance of', 'tail': 'CYP2B6 genotype'} 	 {'head': 'bupropion', 'type': 'Substrate', 'tail': 'CYP2B6'} 
{'head': 'alpha-2A adrenoceptor', 'type': 'subclass of', 'tail': 'alpha-2 adrenoceptor subtype'} 	 {'head': 'rauwolscine', 'type': 'Regulator', 'tail': 'alpha-2D adrenoceptor'} 
{'head': 'G protein-coupled receptor', 'type': 'subclass of', 'tail': 'proteins'} 	 {'head': 'succinate', 'type': 'Agonist', 'tail': 'succinate receptor'} 
{'head': 'Neostigmine', 'type': 'medical condition treated', 'tail': 'acute colonic pseudo-obstruction'} 	 {'head': 'Neostigmine', 'type': 'Regulator', 'tail': 'acetylcholinesterase'} 
{'head': 'apoptosis', 'type': 'has cause', 'tail': 'apoptosis initiation'} 	 {'head': 'β-ionone', 'type': 'Regulator', 'tail': 'PI3K'} 
{'head': 'Eprosartan', 'type': 'medical condition treated', 'tail': 'hypertension'} 	 {'head': 'eprosartan', 'type': 'Downregulator', 'tail': 'AII'} 
{'head': '4-aminobiphenyl', 'type': 'instance of', 'tail': 'carcinogen'} 	 {'head': 'arylhydroxylamine', 'type': 'Substrate', 'tail': 'NADH cytochrome b5 reductase'} 
{'head': 'enthalpy', 'type': 'studied by', 'tail': 'thermodynamic'} 	 {'head': 'p-aminobenzamidine', 'type': 'Regulator', 'tail': 'alpha-thrombin'} 
{'head': 'Pranlukast', 'type': 'medical condition treated', 'tail': 'asthma'} 	 {'head': 'pranlukast', 'type': 'Antagonist', 'tail': 'leukotriene receptor'} 
{'head': 'quaternary', 'type': 'subclass of', 'tail': 'basic nitrogen'} 	 {'head': 'clofilium', 'type': 'Regulator', 'tail': 'HERG'} 
{'head': 'parasympatholytic', 'type': 'subclass of', 'tail': 'alkaloid'} 	 {'head': 'Parathion', 'type': 'Downregulator', 'tail': 'cholinesterase'} 
{'head': 'UC1', 'type': 'instance of', 'tail': 'monoclonal antibodies'} 	 {'head': 'mannose 6-phosphate', 'type': 'Substrate', 'tail': 'N-Acetylglucosamine-1-phosphodiester alpha-N-Acetylglucosaminidase'} 
{'head': 'streptozotocin', 'type': 'medical condition treated', 'tail': 'diabetes'} 	 {'head': 'kinsenoside', 'type': 'Regulator', 'tail': 'matrix metalloproteinases'} 
{'head': 'nicardipine', 'type': 'subject has role', 'tail': 'L-type Ca(2+) channel blocker'} 	 {'head': 'Tolbutamide', 'type': 'Upregulator', 'tail': 'insulin'} 
{'head': 'eIF2α', 'type': 'instance of', 'tail': 'ER-stress marker'} 	 {'head': 'Thr', 'type': 'Part_of', 'tail': 'AMPK'} 
{'head': 'adrenocorticotropin', 'type': 'subclass of', 'tail': 'neuropeptide'} 	 {'head': 'Conivaptan', 'type': 'Antagonist', 'tail': 'V1a/V2 AVP receptor'} 
{'head': 'histamine', 'type': 'has effect', 'tail': 'asthma'} 	 {'head': 'Histamine', 'type': 'Regulator', 'tail': 'H1-receptor'} 
{'head': 'PEC41', 'type': 'subclass of', 'tail': 'poly(ethylene carbonate)'} 	 {'head': 'poly(ethylene carbonate)', 'type': 'Substrate', 'tail': 'Cholesterol esterase'} 
{'head': 'glucagon', 'type': 'subject has role', 'tail': 'glucagon receptor antagonist'} 	 {'head': 'glucose', 'type': 'Regulator', 'tail': 'insulin'} 
{'head': "Friedreich's ataxia", 'type': 'subclass of', 'tail': 'neurodegenerative disease'} 	 {'head': 'phosphatidylinositol 4-phosphate', 'type': 'Substrate', 'tail': 'PIP5K1B'} 
{'head': 'regucalcin', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'calcium', 'type': 'Regulator', 'tail': 'Regucalcin'} 
{'head': 'metformin', 'type': 'subject has role', 'tail': 'inhibitor'} 	 {'head': 'metformin', 'type': 'Upregulator', 'tail': 'AMPK'} 
{'head': 'tolmetin', 'type': 'subject has role', 'tail': 'non-steroid anti-inflammatory drug'} 	 {'head': 'celecoxib', 'type': 'Regulator', 'tail': 'COX-2'} 
{'head': 'alcohol', 'type': 'subclass of', 'tail': 'carboxylic acid'} 	 {'head': 'acyl glucuronides', 'type': 'Not', 'tail': 'hCES1'} 
{'head': 'Doxorubicin', 'type': 'subject has role', 'tail': 'anti-cancer drug'} 	 {'head': 'Doxorubicin', 'type': 'Regulator', 'tail': 'NF-κB'} 
{'head': 'Bax', 'type': 'subject has role', 'tail': 'apoptotic proteins'} 	 {'head': 'DZN', 'type': 'Upregulator', 'tail': 'caspase 3'} 
{'head': 'TRPA-1', 'type': 'subclass of', 'tail': 'TRP channel'} 	 {'head': 'calcium', 'type': 'Regulator', 'tail': 'PKC'} 
{'head': '4-(m-chlorophenyl-carbamoyloxy)-2-butynyltrimethylammonium', 'type': 'subject has role', 'tail': 'muscarinic receptor agonist'} 	 {'head': 'fenoterol', 'type': 'Upregulator', 'tail': 'beta(2)-adrenoceptor'} 
{'head': 'Uveitis', 'type': 'subclass of', 'tail': 'inflammation'} 	 {'head': 'Beta-glucogallin', 'type': 'Downregulator', 'tail': 'aldose reductase'} 
{'head': 'annexin A7', 'type': 'instance of', 'tail': 'protein'} 	 {'head': 'amphetamine', 'type': 'Regulator', 'tail': 'pleiotrophin'} 
{'head': 'Rho family', 'type': 'subclass of', 'tail': 'GTPases'} 	 {'head': 'C2-ceramide', 'type': 'Regulator', 'tail': 'Rac'} 
{'head': 'Ramelteon', 'type': 'subject has role', 'tail': 'MT1/MT2 receptor agonist'} 	 {'head': 'ramelteon', 'type': 'Agonist', 'tail': 'MT1/MT2 receptor'} 
{'head': 'serotonin', 'type': 'instance of', 'tail': 'neurotransmitter'} 	 {'head': '5-HT', 'type': 'Regulator', 'tail': 'SERT'} 
{'head': 'SF1126', 'type': 'instance of', 'tail': 'multikinase inhibitor'} 	 {'head': '5-morpholino-7H-thieno[3,2-b]pyran-7-ones', 'type': 'Downregulator', 'tail': 'PI3K'} 
{'head': 'basiliximab', 'type': 'subject has role', 'tail': 'Immunosuppressive drug'} 	 {'head': 'CP-690550', 'type': 'Downregulator', 'tail': 'JAK3'} 
{'head': 'pyridoxal phosphate', 'type': 'has part', 'tail': 'glutamate'} 	 {'head': 'pyridoxal phosphate', 'type': 'Regulator', 'tail': 'GAD'} 
{'head': 'DL-propargylglycine', 'type': 'subject has role', 'tail': 'mediator of inflammation'} 	 {'head': 'Hydrogen sulphide', 'type': 'Substrate', 'tail': 'CSE'} 
{'head': "Alzheimer's disease <subj>rivastigmine", 'type': 'drug used for treatment <triplet>rivastigmine', 'tail': ''} 	 {'head': 'AlCl3', 'type': 'Upregulator', 'tail': 'CRP'} 
{'head': 'glutathione', 'type': 'subject has role', 'tail': 'antioxidant'} 	 {'head': '6-DHSG', 'type': 'Substrate', 'tail': 'glutathione-S-transferase'} 
{'head': 'colitis', 'type': 'drug used for treatment', 'tail': 'intracolonic'} 	 {'head': 'Hydrogen sulfide', 'type': 'Modulator', 'tail': 'ATP-sensitive potassium channels'} 
{'head': 'KCNH2', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'sotalol', 'type': 'Downregulator', 'tail': 'IKr'} 
{'head': 'testosterone', 'type': 'subclass of', 'tail': 'androgen'} 	 {'head': 'RU 23908', 'type': 'Not', 'tail': 'androgen receptor'} 
{'head': 'pH', 'type': 'level', 'tail': '7'} 	 {'head': 'cefadroxil', 'type': 'Substrate', 'tail': 'PEPT2'} 
{'head': 'IB-MECA', 'type': 'medical condition treated', 'tail': 'pancreatitis'} 	 {'head': 'IB-MECA', 'type': 'Downregulator', 'tail': 'α-amylase'} 
{'head': 'pyrrolopyrazine', 'type': 'subject has role', 'tail': 'Syk inhibitor'} 	 {'head': 'Pyrrolopyrazines', 'type': 'Downregulator', 'tail': 'Spleen Tyrosine Kinase'} 
{'head': 'docetaxel', 'type': 'subject has role', 'tail': 'drug resistance'} 	 {'head': 'taxane', 'type': 'Regulator', 'tail': 'microtubules'} 
{'head': 'cardiac function', 'type': 'has part', 'tail': 'heart rate'} 	 {'head': 'Ozone', 'type': 'Upregulator', 'tail': 'CRP'} 
{'head': 'Flavopiridol', 'type': 'instance of', 'tail': 'flavonoid'} 	 {'head': 'Flavopiridol', 'type': 'Downregulator', 'tail': 'cyclin-dependent kinase'} 
{'head': 'acetazolamide', 'type': 'subject has role', 'tail': 'anticonvulsant'} 	 {'head': 'aromatic and heterocyclic sulfonamides', 'type': 'Downregulator', 'tail': 'Carbonic anhydrase'} 
{'head': 'gamma-aminobutyric acid', 'type': 'instance of', 'tail': 'amino acid'} 	 {'head': 'glutamate', 'type': 'Substrate', 'tail': 'Glutamic acid decarboxylase'} 
{'head': 'NF-κB', 'type': 'instance of', 'tail': 'signaling pathways'} 	 {'head': 'nitric oxide', 'type': 'Downregulator', 'tail': 'inducible nitric oxide synthase'} 
{'head': 'tumor necrosis factor alpha', 'type': 'subclass of', 'tail': 'cytokine'} 	 {'head': 'Amrinone', 'type': 'Downregulator', 'tail': 'TNF'} 
{'head': 'Panax ginseng', 'type': 'instance of', 'tail': 'traditional Chinese medicine'} 	 {'head': 'ginsenoside Rg1', 'type': 'Upregulator', 'tail': 'glucocorticoid receptor'} 
{'head': 'candoxatril', 'type': 'subject has role', 'tail': 'inhibitor'} 	 {'head': 'candoxatril', 'type': 'Upregulator', 'tail': 'ANP'} 
{'head': 'HSD11B2', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'cortisol', 'type': 'Substrate', 'tail': 'Type 2 11β-hydroxysteroid dehydrogenase'} 
{'head': 'tamsulosin', 'type': 'medical condition treated', 'tail': 'benign prostatic hyperplasia'} 	 {'head': 'tamsulosin', 'type': 'Antagonist', 'tail': 'alpha(1)-adrenoceptor'} 
{'head': 'renal malondialdehyde', 'type': 'instance of', 'tail': 'cell lines'} 	 {'head': 'pioglitazone', 'type': 'Regulator', 'tail': 'PPAR-γ'} 
{'head': 'cardiac troponin complex', 'type': 'has part', 'tail': 'troponin C'} 	 {'head': 'Ca(2+)', 'type': 'Regulator', 'tail': 'troponin I'} 
{'head': 'Cyp1a1', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'leflunomide', 'type': 'Agonist', 'tail': 'AhR'} 
{'head': 'LRP5', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'serotonin', 'type': 'Regulator', 'tail': 'TPH1'} 
{'head': 'Colorectal cancer', 'type': 'subclass of', 'tail': 'cancer'} 	 {'head': 'Sulindac', 'type': 'Regulator', 'tail': 'cyclic GMP-dependent protein kinase'} 
{'head': 'diphenidol', 'type': 'subject has role', 'tail': 'muscarinic antagonist'} 	 {'head': '2-carbonyl', 'type': 'Antagonist', 'tail': 'muscarinic receptor'} 
{'head': 'apoptosis', 'type': 'subclass of', 'tail': 'signal transduction'} 	 {'head': 'aldosterone', 'type': 'Upregulator', 'tail': 'calpain'} 
{'head': 'Loperamide', 'type': 'subject has role', 'tail': 'opiate'} 	 {'head': 'Loperamide', 'type': 'Regulator', 'tail': 'adrenocorticotropin'} 
{'head': 'double-blind', 'type': 'subclass of', 'tail': 'controlled trial'} 	 {'head': 'R-enantiomer of timolol', 'type': 'Regulator', 'tail': 'extraocular receptors'} 
{'head': 'rosmarinic acid', 'type': 'instance of', 'tail': 'phenolic'} 	 {'head': 'CCl(4)', 'type': 'Upregulator', 'tail': 'nuclear factor-kappaB'} 
{'head': 'Zolmitriptan', 'type': 'medical condition treated', 'tail': 'migraine'} 	 {'head': 'zolmitriptan', 'type': 'Regulator', 'tail': '5HT1B/1D'} 
{'head': 'catechin', 'type': 'subject has role', 'tail': 'anti-glycative'} 	 {'head': 'procyanidins', 'type': 'Upregulator', 'tail': 'insulin'} 
{'head': 'argininosuccinate synthetase', 'type': 'has effect', 'tail': 'Hepatocellular carcinoma'} 	 {'head': 'ornithine', 'type': 'Substrate', 'tail': 'ornithine transcarbamylase'} 
{'head': 'capsaicin', 'type': 'subject has role', 'tail': 'antimigraine'} 	 {'head': 'sumatriptan', 'type': 'Regulator', 'tail': 'c-fos'} 
{'head': 'PGE2', 'type': 'subclass of', 'tail': '17-phenyl trinor'} 	 {'head': 'prostaglandins', 'type': 'Regulator', 'tail': 'EP1'} 
{'head': 'dopamine', 'type': 'instance of', 'tail': 'neurotransmission'} 	 {'head': 'amphetamine', 'type': 'Regulator', 'tail': 'DAT'} 
{'head': 'Sir 2 protein', 'type': 'part of', 'tail': 'SIRT1'} 	 {'head': "N-indolylmethyl spiroindoline-3,2'-quinazolines", 'type': 'Downregulator', 'tail': 'SIRT1'} 
{'head': 'Cyclopentenone prostaglandin', 'type': 'subclass of', 'tail': 'Prostaglandin'} 	 {'head': 'Cyclopentenone prostaglandins', 'type': 'Downregulator', 'tail': 'inducible nitric-oxide synthase'} 
{'head': 'endoscopic injection sclerotherapy', 'type': 'medical condition treated', 'tail': 'oesophageal varices'} 	 {'head': 'EO', 'type': 'Downregulator', 'tail': 'fibrin'} 
{'head': 'celecoxib', 'type': 'subject has role', 'tail': 'nonsteroidal anti-inflammatory drug'} 	 {'head': 'Celecoxib', 'type': 'Downregulator', 'tail': 'cyclo-oxygenase-2'} 
{'head': 'prostatic', 'type': 'subclass of', 'tail': 'blood pressure'} 	 {'head': 'quinazoline', 'type': 'Regulator', 'tail': 'human alpha 1 adrenoceptors'} 
{'head': 'risperidone', 'type': 'subject has role', 'tail': 'antipsychotic'} 	 {'head': 'risperidone', 'type': 'Not', 'tail': 'alpha 1-adrenoceptors'} 
{'head': 'imatinib', 'type': 'medical condition treated', 'tail': 'chronic myelogenous leukemia'} 	 {'head': 'dasatinib', 'type': 'Downregulator', 'tail': 'kinase'} 
{'head': 'fluvoxamine', 'type': 'subject has role', 'tail': 'selective serotonin reuptake inhibitor'} 	 {'head': '5-HT', 'type': 'Substrate', 'tail': 'SERT'} 
{'head': 'p-chloroamphetamine', 'type': 'subject has role', 'tail': 'serotonin'} 	 {'head': '8-hydroxy-2-(di-n-propylamino)tetralin', 'type': 'Agonist', 'tail': '5-HT1A'} 
{'head': 'methionine', 'type': 'subject has role', 'tail': 'antioxidative'} 	 {'head': 'S-adenosylmethionine', 'type': 'Substrate', 'tail': 'MAT'} 
{'head': 'dexmedetomidine', 'type': 'subject has role', 'tail': 'anesthetic'} 	 {'head': 'etomidate', 'type': 'Not', 'tail': 'alpha2A-receptor'} 
{'head': 'cell viability', 'type': 'facet of', 'tail': 'cytotoxicity'} 	 {'head': 'SiO(2)', 'type': 'Upregulator', 'tail': 'caspase-3'} 
{'head': 'CYP2B6*6', 'type': 'instance of', 'tail': 'protein variant'} 	 {'head': 'Ketamine', 'type': 'Substrate', 'tail': 'CYP2B6*6'} 
{'head': 'C-terminal domain', 'type': 'part of', 'tail': 'protein'} 	 {'head': 'C', 'type': 'Part_of', 'tail': 'M6PRΔC'} 
{'head': 'testolactone', 'type': 'subject has role', 'tail': 'aromatase inhibitor'} 	 {'head': 'testolactone', 'type': 'Downregulator', 'tail': 'aromatase'} 
{'head': 'tert-butyl hydroperoxide', 'type': 'subject has role', 'tail': 'oxidant'} 	 {'head': 'benzphetamine', 'type': 'Substrate', 'tail': 'CYP2B4'} 
{'head': 'glutamic acid', 'type': 'has part', 'tail': 'phosphorus'} 	 {'head': 'phenylalkylphosphonamidates', 'type': 'Regulator', 'tail': 'prostate-specific membrane antigen'} 
{'head': 'dexamethasone', 'type': 'subject has role', 'tail': 'anti-inflammatory'} 	 {'head': 'DEX', 'type': 'Regulator', 'tail': 'Bcl-2'} 
{'head': 'IL-2', 'type': 'subclass of', 'tail': 'cytokine'} 	 {'head': 'hydrogen', 'type': 'Part_of', 'tail': 'IL-2'} 
{'head': 'FLT3', 'type': 'subclass of', 'tail': 'tyrosine kinase'} 	 {'head': 'sorafenib', 'type': 'Downregulator', 'tail': 'FLT3'} 
{'head': 'mitochondria', 'type': 'connects with', 'tail': 'cytosol'} 	 {'head': 'DBDCT', 'type': 'Regulator', 'tail': 'cytochrome c'} 
{'head': 'hypertension', 'type': 'has effect', 'tail': 'heart failure'} 	 {'head': 'aliskiren', 'type': 'Downregulator', 'tail': 'human renin'} 
{'head': 'C-terminal', 'type': 'part of', 'tail': 'amino acid'} 	 {'head': 'C', 'type': 'Part_of', 'tail': 'LeuRSs'} 
{'head': 'sunitinib', 'type': 'subject has role', 'tail': 'tyrosine kinase inhibitor'} 	 {'head': 'Everolimus', 'type': 'Downregulator', 'tail': 'mTOR'} 
{'head': 'Sucralfate', 'type': 'subject has role', 'tail': 'ulcer healing'} 	 {'head': 'sucralfate', 'type': 'Regulator', 'tail': 'basic fibroblast growth factor'} 
{'head': 'acyl-CoA:cholesterol acyltransferase 2', 'type': 'subject has role', 'tail': 'inhibitors'} 	 {'head': 'pyripyropene A', 'type': 'Downregulator', 'tail': 'acyl-CoA:cholesterol acyltransferase 2'} 
{'head': 'RINm5F', 'type': 'instance of', 'tail': 'cell line'} 	 {'head': 'Adrenaline', 'type': 'Regulator', 'tail': 'alpha 2-adrenoceptors'} 
{'head': 'fluorescein conjugate', 'type': 'subclass of', 'tail': 'fluorophore'} 	 {'head': 'Ifenprodil', 'type': 'Antagonist', 'tail': 'GluN1'} 
{'head': 'autoimmune diabetes', 'type': 'has cause', 'tail': 'glutamic acid decarboxylase'} 	 {'head': 'C', 'type': 'Part_of', 'tail': 'GAD65'} 
{'head': 'COX-2', 'type': 'subclass of', 'tail': 'cyclooxygenase-2'} 	 {'head': 'lumiracoxib', 'type': 'Not', 'tail': 'Ser-530 to Ala'} 
{'head': 'olanzapine', 'type': 'medical condition treated', 'tail': 'Schizophrenic'} 	 {'head': 'olanzapine', 'type': 'Regulator', 'tail': 'D2-like receptor'} 
{'head': 'methamphetamine', 'type': 'subject has role', 'tail': 'psychostimulant'} 	 {'head': 'methamphetamine', 'type': 'Regulator', 'tail': 'neuronal vesicular monoamine transporter'} 
{'head': 'MEDLINE', 'type': 'language of work or name', 'tail': 'English language'} 	 {'head': 'Cisapride', 'type': 'Regulator', 'tail': 'human ether-a-go-go-related gene (HERG) potassium channel'} 
{'head': 'Betaxolol', 'type': 'subject has role', 'tail': 'beta(1)-adrenoceptor antagonist'} 	 {'head': 'Betaxolol', 'type': 'Regulator', 'tail': 'neurotoxin site 2'} 
{'head': 'amyloid precursor protein', 'type': 'part of', 'tail': 'amyloid-β'} 	 {'head': 'Leukotriene D4', 'type': 'Upregulator', 'tail': 'CysLT₁ R'} 
{'head': 'hypertrophic cardiomyopathy', 'type': 'subclass of', 'tail': 'Cardiac disease'} 	 {'head': 'Ca2+', 'type': 'Regulator', 'tail': 'cardiac troponin C'} 
{'head': 'Escitalopram oxalate', 'type': 'subject has role', 'tail': 'selective serotonin re-uptake inhibitor'} 	 {'head': 'escitalopram', 'type': 'Not', 'tail': 'cytochrome P450'} 
{'head': 'lovastatin', 'type': 'subject has role', 'tail': 'inhibitor'} 	 {'head': 'Statins', 'type': 'Upregulator', 'tail': 'p21'} 
{'head': 'imatinib mesylate', 'type': 'subject has role', 'tail': 'kinase inhibitor'} 	 {'head': 'imatinib mesylate', 'type': 'Downregulator', 'tail': 'tyrosine kinase'} 
{'head': 'lymphocyte function-associated antigen', 'type': 'subclass of', 'tail': 'beta2-integrins'} 	 {'head': 'lovastatin', 'type': 'Regulator', 'tail': 'CD11a I-domain'} 
{'head': 'hypertension', 'type': 'has effect', 'tail': 'pathophysiology of cardiovascular remodeling'} 	 {'head': 'doxycycline', 'type': 'Downregulator', 'tail': 'MMP'} 
{'head': 'dexamethasone 21-phosphate', 'type': 'subject has role', 'tail': 'inducer'} 	 {'head': 'dexamethasone', 'type': 'Upregulator', 'tail': 'cytochrome P450 3A'} 
{'head': 'fluoxetine', 'type': 'subject has role', 'tail': 'serotonin reuptake inhibitor'} 	 {'head': 'd-methamphetamine', 'type': 'Regulator', 'tail': 'Serotonin transporter'} 
{'head': 'lactate dehydrogenase', 'type': 'subclass of', 'tail': 'enzyme'} 	 {'head': 'pyruvate', 'type': 'Substrate', 'tail': 'LDH'} 
{'head': 'Dasatinib', 'type': 'subject has role', 'tail': 'multi-targeted kinase inhibitor'} 	 {'head': 'dasatinib', 'type': 'Downregulator', 'tail': 'kinase'} 
{'head': 'alpha 1D-adrenoceptor', 'type': 'part of', 'tail': 'rat-1 fibroblasts'} 	 {'head': 'noradrenaline', 'type': 'Regulator', 'tail': 'alpha 1D-adrenoceptor'} 
{'head': 'ischemic infarction', 'type': 'subclass of', 'tail': 'ischemia'} 	 {'head': 'ADP', 'type': 'Upregulator', 'tail': 'K(ATP) channels'} 
{'head': 'rofecoxib', 'type': 'medical condition treated', 'tail': 'osteoarthritis'} 	 {'head': 'rofecoxib', 'type': 'Downregulator', 'tail': 'cyclooxygenase 2'} 
{'head': 'Neuroprotective', 'type': 'subclass of', 'tail': 'neuropathologic mechanisms'} 	 {'head': '[-]-Huperzine A', 'type': 'Downregulator', 'tail': 'AChE'} 
{'head': 'cytochrome c', 'type': 'subject has role', 'tail': 'apoptosis'} 	 {'head': 'Vinblastine', 'type': 'Regulator', 'tail': 'Ras homologous A protein'} 
{'head': 'catalytic domain', 'type': 'subclass of', 'tail': 'amino acid'} 	 {'head': 'cAMP', 'type': 'Substrate', 'tail': 'PDE'} 
{'head': 'hydroxyurea', 'type': 'medical condition treated', 'tail': 'sickle cell disease'} 	 {'head': "5-aza-2'-deoxycytidine", 'type': 'Regulator', 'tail': 'fetal hemoglobin'} 
{'head': 'NADPH oxidase Nox4', 'type': 'subclass of', 'tail': 'oxidase'} 	 {'head': 'Quinone', 'type': 'Regulator', 'tail': 'NADPH oxidase'} 
{'head': 'anti-inflammatory', 'type': 'subclass of', 'tail': 'analgesic'} 	 {'head': 'aspirin', 'type': 'Regulator', 'tail': 'cyclooxygenases'} 
{'head': 'Camptothecin', 'type': 'subject has role', 'tail': 'apoptosis'} 	 {'head': 'Camptothecin', 'type': 'Regulator', 'tail': 'topoisomerase (Top) I'} 
{'head': 'felodipine', 'type': 'subject has role', 'tail': 'calcium channel blocker'} 	 {'head': 'felodipine', 'type': 'Regulator', 'tail': 'myosin'} 
{'head': 'Protein Kinase D1', 'type': 'subclass of', 'tail': 'protein kinase'} 	 {'head': 'Aldosterone', 'type': 'Regulator', 'tail': 'protein kinase D1'} 
{'head': 'fluoxetine', 'type': 'subject has role', 'tail': 'serotonin specific reuptake inhibitor'} 	 {'head': 'pindolol', 'type': 'Antagonist', 'tail': '5-HT(1A)'} 
{'head': 'citalopram', 'type': 'subject has role', 'tail': 'Selective serotonin reuptake inhibitor'} 	 {'head': 'RS79948', 'type': 'Antagonist', 'tail': 'α2-adrenoceptor'} 
{'head': 'mRNA', 'type': 'subclass of', 'tail': 'protein'} 	 {'head': 'phenylephrine', 'type': 'Agonist', 'tail': 'alpha(1)-adrenoceptor'} 
{'head': 'benzodiazepine', 'type': 'has part', 'tail': 'GABA(A) receptor'} 	 {'head': 'Benzodiazepines', 'type': 'Modulator', 'tail': 'GABA(A) receptors'} 
{'head': 'p65', 'type': 'subclass of', 'tail': 'nuclear factor-κB'} 	 {'head': "5-Hydroxy-3,6,7,8,3'4'-hexamethoxyflavone", 'type': 'Upregulator', 'tail': 'Nrf-2'} 
{'head': 'MetAP2', 'type': 'has effect', 'tail': 'apoptosis'} 	 {'head': '1,3,4-oxadiazole', 'type': 'Downregulator', 'tail': 'methionine aminopeptidase type II'} 
{'head': 'antagonist', 'type': 'opposite of', 'tail': 'agonist'} 	 {'head': '2,4,6-trisubstituted 1,3,5-triazines', 'type': 'Agonist', 'tail': 'CB2'} 
{'head': 'polyamine', 'type': 'part of', 'tail': 'polyamine catabolism'} 	 {'head': 'spermine', 'type': 'Substrate', 'tail': 'PAOh1'} 
{'head': 'tail flick test', 'type': 'subclass of', 'tail': 'antinociception'} 	 {'head': 'okadaic acid', 'type': 'Not', 'tail': 'protein phosphatases'} 
{'head': 'p-hydroxybenzoic acid', 'type': 'instance of', 'tail': 'phenolic acid'} 	 {'head': 'polyphenols', 'type': 'Downregulator', 'tail': 'mammalian isoforms I-XIV'} 
{'head': 'homodimer', 'type': 'facet of', 'tail': 'structural'} 	 {'head': 'L-serine', 'type': 'Substrate', 'tail': 'L-serine dehydratase'} 
{'head': 'BMS-582949', 'type': 'subject has role', 'tail': 'p38α inhibitor'} 	 {'head': 'carbamoylmethylene', 'type': 'Downregulator', 'tail': 'p38α'} 
{'head': 'phospho-CREB', 'type': 'subclass of', 'tail': 'protein'} 	 {'head': 'ethanol', 'type': 'Not', 'tail': 'CREB'} 
{'head': 'perivascular sympathetic nerves', 'type': 'part of', 'tail': 'sympathetic nervous system'} 	 {'head': 'Adenosine', 'type': 'Regulator', 'tail': 'A1 adenosine receptors'} 
{'head': 'Pasireotide', 'type': 'medical condition treated', 'tail': "Cushing's disease"} 	 {'head': 'Pasireotide', 'type': 'Regulator', 'tail': 'somatostatin receptors'} 
{'head': 'SB365', 'type': 'subject has role', 'tail': 'apoptosis'} 	 {'head': 'SB365', 'type': 'Regulator', 'tail': 'AKT'} 
{'head': 'Megalin', 'type': 'subclass of', 'tail': 'endocytic receptor'} 	 {'head': 'gentamicin C', 'type': 'Downregulator', 'tail': 'SGLT1'} 
{'head': 'histamine', 'type': 'subject has role', 'tail': 'H2-receptor antagonist'} 	 {'head': 'nizatidine', 'type': 'Antagonist', 'tail': 'histamine H2-receptor'} 
{'head': 'quinazoline', 'type': 'subject has role', 'tail': 'inhibitor'} 	 {'head': 'quinazoline', 'type': 'Downregulator', 'tail': 'Aurora A'} 
{'head': 'GABAR', 'type': 'subclass of', 'tail': 'γ amino-butyric acid type A receptor'} 	 {'head': 'UO126', 'type': 'Downregulator', 'tail': 'ERK1/2'} 
{'head': 'lysyl', 'type': 'subclass of', 'tail': 'residues'} 	 {'head': 'lomustine', 'type': 'Regulator', 'tail': 'stathmin'} 
{'head': 'selective serotonin reuptake inhibitor', 'type': 'subclass of', 'tail': 'antidepressant'} 	 {'head': 'Amitriptyline', 'type': 'Regulator', 'tail': 'TrkA'} 
{'head': 'GW572016', 'type': 'subject has role', 'tail': 'EGFR/ErbB2 kinase inhibitor'} 	 {'head': 'GW572016', 'type': 'Regulator', 'tail': 'p95ErbB2'} 
{'head': 'Sulindac sulfide', 'type': 'subject has role', 'tail': 'Nonsteroidal anti-inflammatory drug'} 	 {'head': 'sulindac', 'type': 'Regulator', 'tail': '14-3-3epsilon'} 
{'head': 'pemetrexed', 'type': 'medical condition treated', 'tail': 'non-small-cell lung cancer'} 	 {'head': 'gemcitabine', 'type': 'Regulator', 'tail': 'dCK'} 
{'head': "5' untranslated region", 'type': 'part of', 'tail': 'cDNA'} 	 {'head': 'Kynurenic acid', 'type': 'Antagonist', 'tail': 'glutamate receptor'} 
{'head': 'ATP13A2', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'Mn', 'type': 'Regulator', 'tail': 'DAT'} 
{'head': 'insulin resistance', 'type': 'subclass of', 'tail': 'glucose intolerance'} 	 {'head': 'tyrosine', 'type': 'Part_of', 'tail': 'IRS-1'} 
{'head': 'Viagra', 'type': 'medical condition treated', 'tail': 'erectile dysfunction'} 	 {'head': 'cGMP', 'type': 'Substrate', 'tail': 'PDE5'} 
{'head': 'glycerol', 'type': 'subclass of', 'tail': 'lipid'} 	 {'head': 'thiazolidinedione', 'type': 'Regulator', 'tail': 'Cytosolic aspartate aminotransferase'} 
{'head': 'proapoptotic', 'type': 'subclass of', 'tail': 'apoptotic'} 	 {'head': 'ABT-199', 'type': 'Downregulator', 'tail': 'BCL-2'} 
{'head': 'Cigarette smoke', 'type': 'has effect', 'tail': 'chronic obstructive pulmonary disease'} 	 {'head': 'SB431542', 'type': 'Downregulator', 'tail': 'VEGF'} 
{'head': 'Metabotropic glutamate receptor 5', 'type': 'part of', 'tail': 'metabotropic glutamate receptor 5 positive allosteric modulator'} 	 {'head': 'MPEP', 'type': 'Part_of', 'tail': 'mGlu5'} 
{'head': 'bovine rhodopsin', 'type': 'subclass of', 'tail': 'G protein-coupled receptor'} 	 {'head': 'halothane', 'type': 'Regulator', 'tail': 'bovine rhodopsin'} 
{'head': 'serotonin/noradrenaline reuptake inhibitor', 'type': 'subclass of', 'tail': 'antidepressant'} 	 {'head': 'venlafaxine', 'type': 'Regulator', 'tail': 'alpha-adrenoceptors'} 
{'head': 'GluR5 kainate receptor', 'type': 'subclass of', 'tail': 'ionotropic glutamate receptor'} 	 {'head': 'LY293558', 'type': 'Antagonist', 'tail': 'GluR5'} 
{'head': 'anti-BP-7,8-dihydrodiol-9,10-epoxide', 'type': 'instance of', 'tail': 'carcinogen'} 	 {'head': 'glutathione', 'type': 'Substrate', 'tail': 'glutathione S-transferases'} 
{'head': 'genistein-7-O-gentiobioside', 'type': 'subject has role', 'tail': 'antioxidative'} 	 {'head': 'isoflavone', 'type': 'Upregulator', 'tail': 'heme oxygenase-1'} 
{'head': 'ketorolac tromethamine', 'type': 'subject has role', 'tail': 'nonsteroidal anti-inflammatory drug'} 	 {'head': 'ketorolac tromethamine', 'type': 'Regulator', 'tail': 'cyclooxygenase'} 
{'head': 'EP(1)', 'type': 'subclass of', 'tail': 'prostanoid receptor'} 	 {'head': 'prostaglandin E2', 'type': 'Substrate', 'tail': 'cyclooxygenase-2'} 
{'head': 'Fluticasone propionate', 'type': 'medical condition treated', 'tail': 'asthma'} 	 {'head': 'fluticasone propionate', 'type': 'Regulator', 'tail': 'glucocorticoid receptor'} 
{'head': 'asthma', 'type': 'drug used for treatment', 'tail': 'bronchodilator'} 	 {'head': 'rolipram', 'type': 'Downregulator', 'tail': 'PDE4'} 
{'head': 'alpha', 'type': 'subclass of', 'tail': 'PPAR'} 	 {'head': 'eicosapentaenoic acid', 'type': 'Regulator', 'tail': 'PPARgamma'} 
{'head': 'Flupentixol', 'type': 'subject has role', 'tail': 'neuroleptic'} 	 {'head': 'flupentixol', 'type': 'Regulator', 'tail': 'serotonin (2A) receptors'} 
{'head': 'serotonin', 'type': 'subclass of', 'tail': 'monoamine transporter'} 	 {'head': 'meta-hydroxyephedrine', 'type': 'Downregulator', 'tail': 'monoamine uptake transporters'} 
{'head': 'Rspo2', 'type': 'subclass of', 'tail': 'R-spondin'} 	 {'head': 'TCDD', 'type': 'Not', 'tail': 'Dickkopfs'} 
{'head': 'aortic inflammation', 'type': 'has effect', 'tail': 'abdominal aortic aneurysm'} 	 {'head': 'arachidonic acids', 'type': 'Substrate', 'tail': 'Cytochrome P450 epoxygenase 2J2'} 
{'head': 'organoselenium', 'type': 'subject has role', 'tail': 'antioxidant'} 	 {'head': 'organoselenium', 'type': 'Downregulator', 'tail': 'ADA'} 
{'head': 'Evernia prunastri', 'type': 'instance of', 'tail': 'lichen'} 	 {'head': 'aflatoxin B(1)', 'type': 'Upregulator', 'tail': 'superoxide dismutase'} 
{'head': 'cyp2b9', 'type': 'instance of', 'tail': 'gene expression'} 	 {'head': 'Phenobarbital', 'type': 'Regulator', 'tail': 'HIF'} 
{'head': 'MAT1A', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'S-adenosylmethionine', 'type': 'Downregulator', 'tail': 'methionine adenosyltransferase II alpha2'} 
{'head': 'α1', 'type': 'subclass of', 'tail': 'GABA(A)-R'} 	 {'head': 'alcohol', 'type': 'Regulator', 'tail': 'GABA(A) receptor'} 
{'head': 'arsenic trioxide', 'type': 'instance of', 'tail': 'environmental pollutant'} 	 {'head': 'resveratrol', 'type': 'Regulator', 'tail': 'superoxide dismutase'} 
{'head': 'impaired fasting glucose', 'type': 'subclass of', 'tail': 'diabetes'} 	 {'head': '25-OHD', 'type': 'Regulator', 'tail': 'LDL'} 
{'head': 'CB1', 'type': 'subclass of', 'tail': 'receptor'} 	 {'head': 'SR 141716A', 'type': 'Not', 'tail': 'CB2'} 
{'head': 'GABA', 'type': 'instance of', 'tail': 'ion channel'} 	 {'head': '[3H]EBOB', 'type': 'Regulator', 'tail': 'GABA-gated chloride ion channel'} 
{'head': 'glucocorticoid receptor', 'type': 'subclass of', 'tail': 'receptor'} 	 {'head': 'CDB-2914', 'type': 'Regulator', 'tail': 'rabbit thymic GR'} 
{'head': "5-fluoro-2'-deoxyuridine", 'type': 'subject has role', 'tail': 'antimetabolites'} 	 {'head': '5-Fluorouracil', 'type': 'Downregulator', 'tail': 'thymidylate synthase'} 
{'head': 'RU 486', 'type': 'medical condition treated', 'tail': 'preterm labor'} 	 {'head': 'ritodrine', 'type': 'Downregulator', 'tail': 'beta 2-adrenergic receptor'} 
{'head': 'Antiarrhythmic effects of (-)-epicatechin-3-gallate', 'type': 'instance of', 'tail': 'polyphenol'} 	 {'head': '(-)-epicatechin-3-gallate', 'type': 'Agonist', 'tail': 'sodium channel'} 
{'head': 'Liver choline dehydrogenase', 'type': 'instance of', 'tail': 'enzymes'} 	 {'head': 'methionine', 'type': 'Not', 'tail': 'betaine-homocysteine methyltransferase'} 
{'head': 'Src homology 2', 'type': 'instance of', 'tail': 'domains'} 	 {'head': 'C', 'type': 'Part_of', 'tail': 'C-terminal Src kinase'} 
{'head': 'Bisphenol A', 'type': 'subject has role', 'tail': 'endocrine disruptor'} 	 {'head': 'calcium', 'type': 'Substrate', 'tail': 'PLB'} 
{'head': 'wogonoside', 'type': 'instance of', 'tail': 'flavonoid'} 	 {'head': 'Wogonoside', 'type': 'Regulator', 'tail': 'extracellular signal-regulated kinase'} 
{'head': 'COX20', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'oxygen', 'type': 'Substrate', 'tail': 'mitochondrial respiratory chain complex IV'} 
{'head': 'oxytocin', 'type': 'subclass of', 'tail': 'nonapeptide hormone'} 	 {'head': 'amino acid', 'type': 'Part_of', 'tail': 'bovine oxytocin-neurophysin I (OT-NpI) precursor'} 
{'head': 'pelargonidin', 'type': 'subclass of', 'tail': 'anthocyanidin'} 	 {'head': 'Pelargonidin', 'type': 'Regulator', 'tail': 'CYP1A1'} 
{'head': 'serotonin receptor', 'type': 'subclass of', 'tail': 'receptor'} 	 {'head': 'tricyclic', 'type': 'Regulator', 'tail': 'serotonin receptor'} 
{'head': 'gestational diabetes', 'type': 'subclass of', 'tail': 'diabetes'} 	 {'head': 'glucose', 'type': 'Upregulator', 'tail': 'insulin'} 
{'head': 'alpha-linolenic acid', 'type': 'instance of', 'tail': 'polyunsaturated fatty acid'} 	 {'head': 'PUFA', 'type': 'Substrate', 'tail': 'FADS2'} 
{'head': 'cilazapril', 'type': 'subject has role', 'tail': 'angiotensin-converting enzyme inhibitor'} 	 {'head': 'cilazapril', 'type': 'Regulator', 'tail': 'nitric oxide synthase'} 
{'head': '3,4-methylenedioxymethamphetamine', 'type': 'has part', 'tail': 'N-methyl'} 	 {'head': 'MDA', 'type': 'Regulator', 'tail': '5-HT2A'} 
{'head': 'Stat3', 'type': 'part of', 'tail': 'EGFR'} 	 {'head': 'Cadmium', 'type': 'Upregulator', 'tail': 'NADPH oxidase'} 
{'head': 'anti-IL-2Ralpha', 'type': 'instance of', 'tail': 'monoclonal antibody'} 	 {'head': 'Tyr', 'type': 'Regulator', 'tail': 'IL-2Ralpha'} 
{'head': 'macrophage', 'type': 'opposite of', 'tail': 'brain'} 	 {'head': 'ginseng saponins', 'type': 'Downregulator', 'tail': 'interleukin-6'} 
{'head': 'incretin', 'type': 'subclass of', 'tail': 'glucagon'} 	 {'head': 'Sitagliptin', 'type': 'Upregulator', 'tail': 'incretin hormones'} 
{'head': 'Streptococcus pneumoniae', 'type': 'has effect', 'tail': 'bacterial meningitis'} 	 {'head': 'Z-Val-Ala-Asp-fluoromethylketone', 'type': 'Downregulator', 'tail': 'caspase'} 
{'head': 'morbid obesity', 'type': 'subclass of', 'tail': 'obesity'} 	 {'head': 'Orlistat', 'type': 'Downregulator', 'tail': 'pancreatic lipase'} 
{'head': 'genistin', 'type': 'subclass of', 'tail': 'isoflavone'} 	 {'head': 'Genistin', 'type': 'Downregulator', 'tail': 'myosin light chain kinase'} 
{'head': 'memory', 'type': 'part of', 'tail': 'cognitive'} 	 {'head': 'streptozotocin', 'type': 'Upregulator', 'tail': 'Sim2'} 
{'head': 'D-amphetamine', 'type': 'subject has role', 'tail': 'stimulant'} 	 {'head': 'D-amphetamine', 'type': 'Upregulator', 'tail': 'SLC6A3'} 
{'head': 'acetylcholine', 'type': 'subject has role', 'tail': 'G protein-coupled receptor agonist'} 	 {'head': 'acetylcholine', 'type': 'Agonist', 'tail': 'G protein-coupled receptor'} 
{'head': 'ascorbate peroxidase', 'type': 'subject has role', 'tail': 'antioxidant'} 	 {'head': 'anthocyanin', 'type': 'Substrate', 'tail': 'l-phenylalanine ammonia-lyase'} 
{'head': 'Acetaminophen', 'type': 'subject has role', 'tail': 'COX-2 inhibitor'} 	 {'head': 'Acetaminophen', 'type': 'Downregulator', 'tail': 'COX-2'} 
{'head': 'parasympathomimetic', 'type': 'subclass of', 'tail': 'anticholinesterase'} 	 {'head': 'galantamine', 'type': 'Downregulator', 'tail': 'anticholinesterase'} 
{'head': 'apoptotic', 'type': 'different from', 'tail': 'necrosis'} 	 {'head': 'NaAsO(2)', 'type': 'Not', 'tail': 'heavy subunit of neurofilament'} 
{'head': '3H-D-Ala2-Leu5-enkephalin', 'type': 'subject has role', 'tail': 'opioid'} 	 {'head': 'naloxone-steroid hybrid azine', 'type': 'Antagonist', 'tail': 'delta receptors'} 
{'head': 'atorvastatin', 'type': 'medical condition treated', 'tail': 'type 2 diabetes'} 	 {'head': 'atorvastatin', 'type': 'Downregulator', 'tail': 'porcine DPP-IV'} 
{'head': 'neuroinflammation', 'type': 'subclass of', 'tail': 'inflammation'} 	 {'head': 'Neoechinulin A', 'type': 'Downregulator', 'tail': 'amyloid-β'} 
{'head': 'epirubicin', 'type': 'subclass of', 'tail': 'anthracycline'} 	 {'head': 'Epi', 'type': 'Regulator', 'tail': 'Cav1'} 
{'head': 'HAPI', 'type': 'subclass of', 'tail': 'microglial cells'} 	 {'head': 'TCDD', 'type': 'Upregulator', 'tail': 'IкBα'} 
{'head': 'hypertension', 'type': 'has effect', 'tail': 'heart failure'} 	 {'head': 'eprosartan', 'type': 'Antagonist', 'tail': 'angiotensin II type 1 receptor'} 
{'head': 'chloroethylclonidine', 'type': 'subject has role', 'tail': 'alpha 1L-adrenoceptor antagonist'} 	 {'head': 'noradrenaline', 'type': 'Regulator', 'tail': 'alpha 1A'} 
{'head': 'dimethocaine', 'type': 'subject has role', 'tail': 'local anesthetic'} 	 {'head': 'SCH 39166', 'type': 'Antagonist', 'tail': 'dopamine D1 receptor'} 
{'head': 'digoxin', 'type': 'subject has role', 'tail': 'loop diuretic'} 	 {'head': 'Carvedilol', 'type': 'Downregulator', 'tail': 'N-BNP'} 
{'head': 'clofarabine', 'type': 'subject has role', 'tail': 'anti-cancer'} 	 {'head': 'clofarabine', 'type': 'Downregulator', 'tail': 'Sp1'} 
{'head': 'phillyrin', 'type': 'subject has role', 'tail': 'anti-obesity'} 	 {'head': 'Phillyrin', 'type': 'Regulator', 'tail': 'sterol regulatory element-binding protein-1c'} 
{'head': 'IFNAR2', 'type': 'subclass of', 'tail': 'cell surface receptor'} 	 {'head': 'PEG', 'type': 'Part_of', 'tail': 'IFNalpha(2a)'} 
{'head': 'AKT', 'type': 'instance of', 'tail': 'ortholog'} 	 {'head': 'Ser', 'type': 'Part_of', 'tail': 'AKT-1'} 
{'head': 'Saccharomyces cerevisiae', 'type': 'instance of', 'tail': 'model organism'} 	 {'head': 'Benzenesulfonamides', 'type': 'Downregulator', 'tail': 'Saccharomyces cerevisiae β-carbonic anhydrase'} 
{'head': 'melanogenesis', 'type': 'product or material produced', 'tail': 'melanin'} 	 {'head': 'Artemisinic acid', 'type': 'Downregulator', 'tail': 'HMG-CoA reductase'} 
{'head': 'progesterone', 'type': 'subject has role', 'tail': 'estrogen'} 	 {'head': 'Norethisterone', 'type': 'Regulator', 'tail': 'uteroglobin'} 
{'head': 'autophagy', 'type': 'subclass of', 'tail': 'degradation pathway'} 	 {'head': 'Dioscin', 'type': 'Regulator', 'tail': 'PI3K'} 
{'head': '2-Hydroxy-3-methylanthraquinone', 'type': 'subject has role', 'tail': 'apoptosis'} 	 {'head': '2-Hydroxy-3-methylanthraquinone', 'type': 'Regulator', 'tail': 'MAPK'} 
{'head': '2-chlorodeoxyadenosine', 'type': 'subclass of', 'tail': 'deoxynucleoside analogues'} 	 {'head': 'fludarabine', 'type': 'Regulator', 'tail': 'deoxycytidine kinase'} 
{'head': '5-(p-toluenesulfonylamino)phthalimide', 'type': 'subject has role', 'tail': 'α-glucosidase inhibitor'} 	 {'head': 'N2-substituted-5-(p-toluenesulfonylamino)phthalimide', 'type': 'Downregulator', 'tail': 'α-glucosidase'} 
{'head': 'osteoclast', 'type': 'has part', 'tail': 'lysosomal pH'} 	 {'head': 'chloroquine', 'type': 'Upregulator', 'tail': 'RCAN1'} 
{'head': 'CYP2B6', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'anisomycin', 'type': 'Not', 'tail': 'CYP3A4'} 
{'head': 'fenclozic acid', 'type': 'instance of', 'tail': 'carboxylic acid'} 	 {'head': 'fenclozic acid', 'type': 'Not', 'tail': 'P450'} 
{'head': 'Auranofin', 'type': 'subject has role', 'tail': 'anti-rheumatic drug'} 	 {'head': 'Auranofin', 'type': 'Downregulator', 'tail': 'TLR4'} 
{'head': 'mast cell', 'type': 'subclass of', 'tail': 'epithelial cell'} 	 {'head': 'sulfate', 'type': 'Not', 'tail': 'FGF-7'} 
{'head': 'Vandetanib', 'type': 'subject has role', 'tail': 'tyrosine kinase inhibitor'} 	 {'head': 'Vandetanib', 'type': 'Downregulator', 'tail': 'epidermal growth-factor receptors'} 
{'head': 'lysine mimetic', 'type': 'subclass of', 'tail': 'inhibitors'} 	 {'head': 'tranexamic acid', 'type': 'Downregulator', 'tail': 'plasminogen'} 
{'head': 'epididymal adipose tissue', 'type': 'part of', 'tail': 'adipocyte'} 	 {'head': 'noradrenaline', 'type': 'Downregulator', 'tail': 'IL-6'} 
{'head': 'IL-2', 'type': 'subclass of', 'tail': 'cytokine'} 	 {'head': 'p-bromophenacyl bromide', 'type': 'Regulator', 'tail': 'interleukin-2'} 
{'head': 'imatinib', 'type': 'subject has role', 'tail': 'tyrosine kinase inhibitor'} 	 {'head': 'imatinib', 'type': 'Downregulator', 'tail': 'tyrosine kinase'} 
{'head': 'testosterone', 'type': 'medical condition treated', 'tail': 'diabetes'} 	 {'head': 'TZD', 'type': 'Regulator', 'tail': 'alkaline phosphatase'} 
{'head': 'P2Y1', 'type': 'subclass of', 'tail': 'Gq-coupled seven-transmembrane domain receptor'} 	 {'head': 'clopidogrel', 'type': 'Not', 'tail': 'purinergic receptors'} 
{'head': 'Carnitine acetyltransferase', 'type': 'instance of', 'tail': 'protein engineering'} 	 {'head': 'acetyl-CoA', 'type': 'Substrate', 'tail': 'M564G'} 
{'head': 'dopamine', 'type': 'subclass of', 'tail': 'Catecholamine'} 	 {'head': 'L-noradrenaline', 'type': 'Regulator', 'tail': 'phenylalanine hydroxylase'} 
{'head': 'Kisspeptin', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'amino acid', 'type': 'Part_of', 'tail': 'Kisspeptin'} 
{'head': 'Dexamethasone', 'type': 'subject has role', 'tail': 'glucocorticoid'} 	 {'head': 'betamethasone-esters', 'type': 'Regulator', 'tail': 'glucocorticoid receptor'} 
{'head': 'IGFBP-rP1', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'cysteine', 'type': 'Part_of', 'tail': 'IGFBP-rPs'} 
{'head': 'imatinib mesylate', 'type': 'subject has role', 'tail': 'tyrosine kinase inhibitor'} 	 {'head': 'imatinib mesylate', 'type': 'Regulator', 'tail': 'FIP1L1'} 
{'head': 'quercetin', 'type': 'instance of', 'tail': 'Flavonoid'} 	 {'head': 'epigallocatechin 3-O-gallate', 'type': 'Substrate', 'tail': 'OATP1B1'} 
{'head': 'HL-60', 'type': 'instance of', 'tail': 'cell lines'} 	 {'head': 'N', 'type': 'Part_of', 'tail': 'P-selectin glycoprotein ligand-1'} 
{'head': '123I-iodobenzamide SPECT', 'type': 'subclass of', 'tail': 'in vivo SPECT'} 	 {'head': '123I-iodobenzamide', 'type': 'Regulator', 'tail': 'Dopamine D2-receptor'} 
{'head': 'Reboxetine', 'type': 'medical condition treated', 'tail': 'posttraumatic stress disorder'} 	 {'head': 'Reboxetine', 'type': 'Regulator', 'tail': 'human norepinephrine transporter'} 
{'head': 'LolA', 'type': 'subclass of', 'tail': 'lipoprotein'} 	 {'head': 'thiourea', 'type': 'Regulator', 'tail': 'LolA'} 
{'head': 'alpha1-adrenergic receptor', 'type': 'subclass of', 'tail': 'receptor'} 	 {'head': 'Tamsulosin', 'type': 'Not', 'tail': 'alpha1bAR'} 
{'head': 'Bisphenol A', 'type': 'has effect', 'tail': 'breast cancer'} 	 {'head': 'BPA', 'type': 'Upregulator', 'tail': 'Oct4'} 
{'head': 'demyelinization', 'type': 'location', 'tail': 'central nervous system'} 	 {'head': '7KC', 'type': 'Regulator', 'tail': 'Akt'} 
{'head': 'Ziprasidone', 'type': 'subject has role', 'tail': 'antipsychotic'} 	 {'head': 'Ziprasidone', 'type': 'Regulator', 'tail': '5-HT(2) receptors'} 
{'head': 'Sulindac', 'type': 'subject has role', 'tail': 'Nonsteroidal anti-inflammatory drug'} 	 {'head': 'Sulindac sulfide', 'type': 'Regulator', 'tail': 'extracellular-regulated kinase 1/2'} 
{'head': 'asthma', 'type': 'has cause', 'tail': 'Th2 cytokine'} 	 {'head': 'JNJ 7777120', 'type': 'Antagonist', 'tail': 'H4R'} 
{'head': 'DNA', 'type': 'has part', 'tail': 'nucleotide'} 	 {'head': 'foscarnet', 'type': 'Not', 'tail': 'V715M'} 
{'head': 'Caco-2', 'type': 'instance of', 'tail': 'cell line'} 	 {'head': 'fluoride', 'type': 'Substrate', 'tail': 'F(-)/OH(-) antiporter'} 
{'head': '(-)-1a', 'type': 'subject has role', 'tail': 'γ-secretase inhibitor'} 	 {'head': 'tricyclic bispyran sulfone', 'type': 'Downregulator', 'tail': 'γ-secretase'} 
{'head': 'hepatocytes', 'type': 'part of', 'tail': 'cytoplasm'} 	 {'head': 'griseofulvin', 'type': 'Upregulator', 'tail': 'K18'} 
{'head': 'p-chlorophenylalanine', 'type': 'subject has role', 'tail': 'neurotoxic'} 	 {'head': 'serotonin', 'type': 'Downregulator', 'tail': 'serotonin transporter'} 
{'head': 'Curcumin', 'type': 'subject has role', 'tail': 'anti-inflammatory'} 	 {'head': 'Curcumin', 'type': 'Downregulator', 'tail': 'IL-27'} 
{'head': 'GnRH-II', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'arginine', 'type': 'Part_of', 'tail': 'GnRH-II'} 
{'head': 'KCC1', 'type': 'subclass of', 'tail': 'cotransporter'} 	 {'head': '[(dihydroindenyl)oxy] alkanoic acid', 'type': 'Downregulator', 'tail': 'KCC'} 
{'head': 'gall bladder', 'type': 'connects with', 'tail': 'ileum'} 	 {'head': 'lorglumide', 'type': 'Regulator', 'tail': 'CCK receptors'} 
{'head': 'imidazole', 'type': 'subject has role', 'tail': 'aromatase and sulfatase inhibitors'} 	 {'head': '4-{[(4-Cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate', 'type': 'Downregulator', 'tail': 'Aromatase'} 
{'head': 'pancreatic beta cells', 'type': 'part of', 'tail': 'islet'} 	 {'head': 'dimethyldiguanide', 'type': 'Downregulator', 'tail': 'insulin'} 
{'head': 'norepinephrine', 'type': 'subclass of', 'tail': 'adrenoceptor'} 	 {'head': 'moxonidine', 'type': 'Regulator', 'tail': 'subtype-I2 imidazol(in)e receptor'} 
{'head': 'testosterone', 'type': 'instance of', 'tail': 'steroid hormone'} 	 {'head': 'corticosterone', 'type': 'Regulator', 'tail': 'glucocorticoid receptors'} 
{'head': 'ORF 17583', 'type': 'subject has role', 'tail': 'histamine H2-receptor antagonist'} 	 {'head': 'ORF 17583', 'type': 'Antagonist', 'tail': 'histamine H2-receptor'} 
{'head': 'l-[(14)C]alanine', 'type': 'instance of', 'tail': 'amino acid'} 	 {'head': 'l-[(14)C]alanine', 'type': 'Substrate', 'tail': 'ASCT2'} 
{'head': 'frontal lobe', 'type': 'part of', 'tail': 'brain'} 	 {'head': 'sertindole', 'type': 'Downregulator', 'tail': 'erg3'} 
{'head': 'complement system', 'type': 'part of', 'tail': 'innate immunity'} 	 {'head': 'poly(ethylene glycol)', 'type': 'Regulator', 'tail': 'lectin'} 
{'head': 'PDE5A1', 'type': 'subclass of', 'tail': 'catalytic domain'} 	 {'head': 'vardenafil', 'type': 'Regulator', 'tail': 'PDE5A1 catalytic domain'} 
{'head': 'Rac1', 'type': 'subclass of', 'tail': 'GTPase'} 	 {'head': 'Cucurbitacin I', 'type': 'Not', 'tail': 'P-Rex1'} 
{'head': 'Ig module I', 'type': 'followed by', 'tail': 'Ig module III'} 	 {'head': 'sulfate', 'type': 'Regulator', 'tail': 'Ig module II'} 
{'head': 'NMDA antagonist', 'type': 'subclass of', 'tail': 'anti-allodynic'} 	 {'head': 'CP-101,606', 'type': 'Downregulator', 'tail': 'NR2B'} 
{'head': 'rasagiline', 'type': 'medical condition treated', 'tail': "Parkinson's disease"} 	 {'head': 'Rasagiline', 'type': 'Downregulator', 'tail': 'MAO-B'} 
{'head': 'Omega class', 'type': 'subclass of', 'tail': 'glutathione transferase'} 	 {'head': 'monomethylarsonate', 'type': 'Substrate', 'tail': 'Omega class GSTs'} 
{'head': 'neuron', 'type': 'has part', 'tail': 'white matter'} 	 {'head': 'acetyl', 'type': 'Part_of', 'tail': 'ASPA'} 
{'head': 'tamoxifen', 'type': 'medical condition treated', 'tail': 'breast cancer'} 	 {'head': 'tamoxifen', 'type': 'Downregulator', 'tail': 'BRCA2'} 
{'head': 'troglitazone', 'type': 'subject has role', 'tail': 'anti-diabetic drug'} 	 {'head': 'troglitazone', 'type': 'Regulator', 'tail': 'insulin'} 
{'head': 'retinol binding protein', 'type': 'subclass of', 'tail': 'proteins'} 	 {'head': 'vitamin A', 'type': 'Upregulator', 'tail': 'immunoglobulin A'} 
{'head': 'verapamil', 'type': 'subject has role', 'tail': 'calcium channel blocker'} 	 {'head': 'verapamil', 'type': 'Downregulator', 'tail': 'calcium channel'} 
{'head': 'retinoic acid receptor', 'type': 'subclass of', 'tail': 'protein'} 	 {'head': 'all-trans-13,14-dihydroretinol', 'type': 'Regulator', 'tail': 'Cyp26A1'} 
{'head': '-1639G>A', 'type': 'instance of', 'tail': 'allele'} 	 {'head': 'S-warfarin', 'type': 'Regulator', 'tail': 'CYP2C9'} 
{'head': "Parkinson's disease", 'type': 'has cause', 'tail': 'monoamine oxidase type B'} 	 {'head': 'Rasagiline', 'type': 'Downregulator', 'tail': 'monoamine oxidase type B'} 
{'head': 'GluR3', 'type': 'subclass of', 'tail': 'glutamate receptor'} 	 {'head': 'Lithium', 'type': 'Regulator', 'tail': 'glutamate receptor'} 
{'head': 'aorta', 'type': 'part of', 'tail': 'cardiovascular tissues'} 	 {'head': 'tetrahydrobiopterin', 'type': 'Cofactor', 'tail': 'eNOS'} 
{'head': 'Cisplatin', 'type': 'subject has role', 'tail': 'anti-cancer drug'} 	 {'head': 'cDDP', 'type': 'Substrate', 'tail': 'hCTR1'} 
{'head': '5-HT1A', 'type': 'subclass of', 'tail': 'serotonin'} 	 {'head': 'brexpiprazole', 'type': 'Regulator', 'tail': 'serotonin (5-HT) receptor'} 
{'head': 'perfusion unit', 'type': 'part of', 'tail': 'haemodynamics'} 	 {'head': 'fenofibrate', 'type': 'Not', 'tail': 'AII'} 
{'head': '17864', 'type': 'subject has role', 'tail': 'multikinase inhibitor'} 	 {'head': '17864', 'type': 'Downregulator', 'tail': 'multikinase'} 
{'head': 'dimethylarginine dimethylaminohydrolase', 'type': 'subclass of', 'tail': 'nitric oxide synthase'} 	 {'head': 'arginine', 'type': 'Downregulator', 'tail': 'nitric oxide synthase'} 
{'head': '31', 'type': 'subject has role', 'tail': 'BACE-1 inhibitor'} 	 {'head': 'dihydroisoquinoline', 'type': 'Downregulator', 'tail': 'BACE-1'} 
{'head': 'plasmin', 'type': 'subclass of', 'tail': 'cytokine'} 	 {'head': 'serine', 'type': 'Upregulator', 'tail': 'matrix metalloproteinase-9'} 
{'head': 'chemical synthesis', 'type': 'part of', 'tail': 'chemistry'} 	 {'head': 'CP[c]Ph', 'type': 'Not', 'tail': 'ERα'} 
{'head': 'protein folding', 'type': 'part of', 'tail': 'secretory pathway'} 	 {'head': 'amino acid', 'type': 'Part_of', 'tail': 'BiP binding site'} 
{'head': 'asthma', 'type': 'subclass of', 'tail': 'inflammatory disease'} 	 {'head': 'benzofuran', 'type': 'Downregulator', 'tail': 'leukotriene A(4) hydrolase'} 
{'head': 'Minocycline', 'type': 'subject has role', 'tail': 'neuroprotective'} 	 {'head': 'Minocycline', 'type': 'Regulator', 'tail': 'calpain'} 
{'head': 'dimethocaine', 'type': 'subject has role', 'tail': 'local anesthetic'} 	 {'head': 'cocaine', 'type': 'Regulator', 'tail': 'dopamine transporter'} 
{'head': 'phenelzine', 'type': 'subject has role', 'tail': 'anxiolytic'} 	 {'head': 'phenelzine', 'type': 'Downregulator', 'tail': 'monoamine oxidase'} 
{'head': 'Enalkiren', 'type': 'subject has role', 'tail': 'dipeptide renin inhibitor'} 	 {'head': 'enalkiren', 'type': 'Downregulator', 'tail': 'renin'} 
{'head': 'methamphetamine', 'type': 'subclass of', 'tail': 'amphetamine'} 	 {'head': 'amphetamines', 'type': 'Regulator', 'tail': 'DA transporter'} 
{'head': 'dextromethorphan', 'type': 'subject has role', 'tail': 'anti-inflammatory'} 	 {'head': 'baicalin', 'type': 'Not', 'tail': 'CYP2D'} 
{'head': 'benzimidazole', 'type': 'subject has role', 'tail': 'anti-obesity'} 	 {'head': 'benzimidazole', 'type': 'Antagonist', 'tail': 'NPY Y5 receptor'} 
{'head': 'esmolol', 'type': 'subject has role', 'tail': 'beta 1-adrenergic receptor blocking'} 	 {'head': 'esmolol', 'type': 'Downregulator', 'tail': 'beta 1-adrenergic receptor'} 
{'head': 'gene', 'type': 'encodes', 'tail': 'protein'} 	 {'head': 'N', 'type': 'Part_of', 'tail': 'MetRS'} 
{'head': 'isoprenaline', 'type': 'subject has role', 'tail': 'beta(2)-adrenoceptor'} 	 {'head': 'clenbuterol', 'type': 'Agonist', 'tail': 'beta(2)-AR'} 
{'head': 'pseudogenes', 'type': 'subclass of', 'tail': 'gene'} 	 {'head': 'arachidonic acid', 'type': 'Substrate', 'tail': 'CYP2J'} 
{'head': 'Parkinsonism', 'type': 'subclass of', 'tail': 'neurological disorder'} 	 {'head': 'Mn', 'type': 'Regulator', 'tail': 'DAT'} 
{'head': 'structural model', 'type': 'part of', 'tail': 'three-dimensional'} 	 {'head': 'palmitoyl-CoA', 'type': 'Substrate', 'tail': 'CPT I'} 
{'head': 'breast', 'type': 'subclass of', 'tail': 'cancer cell'} 	 {'head': 'Cholesterol', 'type': 'Substrate', 'tail': 'lipoproteins'} 
{'head': 'α-ketoglutarate', 'type': 'has part', 'tail': 'citrate'} 	 {'head': 'citrate', 'type': 'Regulator', 'tail': 'HIF'} 
{'head': 'rocaglate', 'type': 'instance of', 'tail': 'flavagline'} 	 {'head': 'perviridicin B', 'type': 'Downregulator', 'tail': 'NF-κB'} 
{'head': 'NUGC-3', 'type': 'instance of', 'tail': 'cell lines'} 	 {'head': 'N,N-diethyl-N-(2-(N-methyltetradecanamido)ethyl)prop-2-en-1-aminium bromide', 'type': 'Upregulator', 'tail': 'RhoB'} 
{'head': 'anti-ABCC2 small interfering RNA', 'type': 'subclass of', 'tail': 'RNA interference'} 	 {'head': 'cisplatin', 'type': 'Not', 'tail': 'adenosine triphosphate binding cassette (ABC)-transporter'} 
{'head': 'Epinastine', 'type': 'subject has role', 'tail': 'antihistaminic'} 	 {'head': 'Epinastine', 'type': 'Not', 'tail': 'substance P'} 
{'head': 'Vitamin C', 'type': 'subject has role', 'tail': 'antioxidant'} 	 {'head': 'Vitamin C', 'type': 'Downregulator', 'tail': 'NF-κB'} 
{'head': 'Catalpol', 'type': 'subject has role', 'tail': 'anti-inflammatory'} 	 {'head': 'Catalpol', 'type': 'Downregulator', 'tail': 'NF-κB'} 
{'head': 'VP-16', 'type': 'subject has role', 'tail': 'chemotherapeutic agent'} 	 {'head': 'Etoposide', 'type': 'Downregulator', 'tail': 'topoisomerase-II'} 
{'head': 'TAS-102', 'type': 'subject has role', 'tail': 'anti-cancer drug'} 	 {'head': 'TAS-102', 'type': 'Regulator', 'tail': 'thymidine kinase'} 
{'head': 'Paclitaxel', 'type': 'subject has role', 'tail': 'anti-proliferative'} 	 {'head': 'Furanodiene', 'type': 'Regulator', 'tail': 'Integrin'} 
{'head': 'pharmacokinetic', 'type': 'part of', 'tail': 'pharmacodynamic'} 	 {'head': 'saquinavir', 'type': 'Downregulator', 'tail': 'human immunodeficiency virus protease'} 
{'head': 'guinea-pig', 'type': 'subclass of', 'tail': 'rat'} 	 {'head': 'Labetalol', 'type': 'Antagonist', 'tail': 'beta 1-adrenoceptors'} 
{'head': 'leiomyoma', 'type': 'drug used for treatment', 'tail': 'mifepristone'} 	 {'head': 'mifepristone', 'type': 'Regulator', 'tail': 'progesterone receptor'} 
{'head': 'D,L-propargylglycine', 'type': 'subject has role', 'tail': 'cystathionine gamma-lyase inhibitor'} 	 {'head': 'D,L-propargylglycine', 'type': 'Downregulator', 'tail': 'cystathionine gamma-lyase'} 
{'head': 'caffeine', 'type': 'subject has role', 'tail': 'adenosine receptor antagonist'} 	 {'head': 'flumazenil', 'type': 'Antagonist', 'tail': 'BDZ receptor'} 
{'head': 'ABCA1', 'type': 'instance of', 'tail': 'protein'} 	 {'head': 'cholesterol', 'type': 'Substrate', 'tail': 'ABCA1'} 
{'head': 'ferric nitrilotriacetate', 'type': 'has effect', 'tail': 'hepatotoxicity'} 	 {'head': 'Fe-NTA', 'type': 'Upregulator', 'tail': 'ornithine decarboxylase'} 
{'head': 'o-quinone', 'type': 'subclass of', 'tail': 'polycyclic aromatic hydrocarbons'} 	 {'head': 'polycyclic aromatic hydrocarbons', 'type': 'Substrate', 'tail': 'Aldo-keto reductases'} 
{'head': 'apoptosis', 'type': 'subclass of', 'tail': 'cell death'} 	 {'head': 'β-Lapachone', 'type': 'Regulator', 'tail': 'NAD(P)H:quinone oxidoreductase-1'} 
{'head': 'Lanthanum(III)', 'type': 'instance of', 'tail': 'rare earth element'} 	 {'head': 'La(III)', 'type': 'Downregulator', 'tail': 'nitrate reductase'} 
{'head': 'glucocorticoid', 'type': 'has part', 'tail': 'glucocorticoid receptor'} 	 {'head': 'dexamethasone', 'type': 'Regulator', 'tail': 'human lung glucocorticoid receptors'} 
{'head': 'isatin', 'type': 'subject has role', 'tail': 'monoamine oxidase'} 	 {'head': 'phthalide', 'type': 'Downregulator', 'tail': 'monoamine oxidase'} 
{'head': 'angiotensin II', 'type': 'subclass of', 'tail': 'receptor'} 	 {'head': 'losartan', 'type': 'Agonist', 'tail': 'AT1R'} 
{'head': 'trifluorothymidine', 'type': 'subject has role', 'tail': 'antitumor'} 	 {'head': 'pyrimidine', 'type': 'Substrate', 'tail': 'Thymidine kinase-1'} 
{'head': 'asthma', 'type': 'drug used for treatment', 'tail': 'ketanserin'} 	 {'head': 'ketanserin', 'type': 'Downregulator', 'tail': '5-HT(2A)'} 
{'head': '1-methyl-5-(2,4,6-trimethoxy-phenyl)-1H-pyrazole 6', 'type': 'instance of', 'tail': 'flavone'} 	 {'head': 'keto', 'type': 'Regulator', 'tail': 'COX-2'} 
{'head': 'acetylcholinesterase', 'type': 'subclass of', 'tail': 'enzyme'} 	 {'head': 'n-butanol', 'type': 'Downregulator', 'tail': 'urease'} 
{'head': 'nerve agent', 'type': 'use', 'tail': 'chemical warfare'} 	 {'head': "1,1'-methylenebis{4-hydroxyiminomethyl}pyridinium dimethanesulfonate", 'type': 'Upregulator', 'tail': 'acetylcholinesterase'} 
{'head': 'gene', 'type': 'encodes', 'tail': 'protein'} 	 {'head': 'CpG', 'type': 'Upregulator', 'tail': 'DNA methyl transferase 3a'} 
{'head': 'alpha1-adrenergic receptor', 'type': 'subclass of', 'tail': 'receptor'} 	 {'head': '[3H]CGP12177', 'type': 'Regulator', 'tail': 'beta-adrenergic receptors'} 
{'head': 'acetaminophen', 'type': 'subject has role', 'tail': 'non-steroidal anti-inflammatory drug'} 	 {'head': 'niflumic acid', 'type': 'Downregulator', 'tail': 'UGT1A9'} 
{'head': 'paroxetine', 'type': 'subject has role', 'tail': 'reuptake inhibitor'} 	 {'head': 'paroxetine', 'type': 'Regulator', 'tail': '5-HT transporter'} 
{'head': 'KYNU', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'threonine', 'type': 'Part_of', 'tail': 'kynureninase'} 
{'head': 'methylmalonyl-CoA mutase', 'type': 'subclass of', 'tail': 'enzyme'} 	 {'head': 'Co-C', 'type': 'Part_of', 'tail': 'methylmalonyl-CoA mutase'} 
{'head': 'MDMA', 'type': 'subject has role', 'tail': 'neurotoxic'} 	 {'head': 'MDMA', 'type': 'Regulator', 'tail': 'caspase 3'} 
{'head': 'testosterone', 'type': 'instance of', 'tail': 'carcinogen'} 	 {'head': 'MNU', 'type': 'Upregulator', 'tail': 'MGMT'} 
{'head': 'arsenic', 'type': 'has part', 'tail': 'NaAs'} 	 {'head': 'arsenic', 'type': 'Upregulator', 'tail': 'alanine aminotransferase'} 
{'head': 'ketamine', 'type': 'subject has role', 'tail': 'N-methyl d-aspartate receptor'} 	 {'head': 'ketamine', 'type': 'Regulator', 'tail': 'mammalian target of rapamycin'} 
{'head': '17α-ethynylestradiol', 'type': 'subject has role', 'tail': 'oral contraceptive'} 	 {'head': 'Doxorubicin', 'type': 'Substrate', 'tail': 'P-glycoprotein'} 
{'head': 'glycogen synthase kinase 3 beta', 'type': 'subclass of', 'tail': 'AMP-activated protein kinase'} 	 {'head': 'Ursolic Acid', 'type': 'Upregulator', 'tail': 'AMP-activated Protein Kinase'} 
{'head': 'primary', 'type': 'opposite of', 'tail': 'secondary'} 	 {'head': 'paraoxon', 'type': 'Not', 'tail': 'AChE'} 
{'head': 'dopamine', 'type': 'instance of', 'tail': 'neurotransmitter'} 	 {'head': 'alcohol', 'type': 'Regulator', 'tail': 'opioid receptors'} 
{'head': 'gene', 'type': 'encodes', 'tail': 'protein'} 	 {'head': 'NO', 'type': 'Regulator', 'tail': 'HNS'} 
{'head': 'Esmolol', 'type': 'subject has role', 'tail': 'beta 1-adrenergic receptor blocker'} 	 {'head': 'Esmolol', 'type': 'Downregulator', 'tail': 'beta 1-adrenergic receptor'} 
{'head': 'pro domain', 'type': 'part of', 'tail': 'protein'} 	 {'head': 'Met', 'type': 'Part_of', 'tail': 'metalloproteinase domain'} 
{'head': 'protein', 'type': 'has part', 'tail': 'amino acid'} 	 {'head': 'NH2', 'type': 'Part_of', 'tail': 'carbonic anhydrase (CA) V'} 
{'head': 'catalyzes', 'type': 'subclass of', 'tail': 'catalysis'} 	 {'head': 'Mg2+', 'type': 'Cofactor', 'tail': 'Adenylosuccinate synthetase'} 
{'head': 'Ig kappa enhancer', 'type': 'subclass of', 'tail': 'transcription factor'} 	 {'head': 'sodium salicylate', 'type': 'Downregulator', 'tail': 'NF-kappa B'} 
{'head': 'locus coeruleus', 'type': 'part of', 'tail': 'nucleus accumbens'} 	 {'head': 'morphine', 'type': 'Upregulator', 'tail': 'cyclic AMP regulatory element-binding protein'} 
{'head': 'Na(+)/Ca(2+) exchanger', 'type': 'subclass of', 'tail': 'bidirectional transporter'} 	 {'head': 'Ca(2+)', 'type': 'Substrate', 'tail': 'Na(+)/Ca(2+) exchanger'} 
{'head': 'sitagliptin', 'type': 'subject has role', 'tail': 'dipeptidyl peptidase-4 inhibitor'} 	 {'head': 'sitagliptin', 'type': 'Downregulator', 'tail': 'dipeptidyl peptidase-4'} 
{'head': 'TLR-4', 'type': 'part of', 'tail': 'mRNA'} 	 {'head': 'HSYA', 'type': 'Downregulator', 'tail': 'NF-κB'} 
{'head': 'inhibitor', 'type': 'subclass of', 'tail': 'competitive'} 	 {'head': 'phosphorylated flavonoids', 'type': 'Downregulator', 'tail': 'cholesterol esterase'} 
{'head': 'mesalamine', 'type': 'subject has role', 'tail': 'antinociceptive'} 	 {'head': 'ATB-429', 'type': 'Regulator', 'tail': 'K(ATP) channel'} 
{'head': 'Phenytoin', 'type': 'subject has role', 'tail': 'antiarrhythmic'} 	 {'head': 'sodium', 'type': 'Substrate', 'tail': 'sodium channel'} 
{'head': '5-HT(4) receptor antagonist', 'type': 'subclass of', 'tail': 'prokinetic agent'} 	 {'head': 'serotonin', 'type': 'Regulator', 'tail': 'serotonin 5-HT(4) receptor'} 
{'head': 'inhibitor', 'type': 'subclass of', 'tail': 'drug'} 	 {'head': 'polyamine', 'type': 'Substrate', 'tail': 'SSAT'} 
{'head': 'nuclear factor erythroid 2-related factor 2', 'type': 'subclass of', 'tail': 'transcription factor'} 	 {'head': 'bleomycin', 'type': 'Regulator', 'tail': 'collagen'} 
{'head': 'pharmacokinetic', 'type': 'part of', 'tail': 'pharmacodynamic'} 	 {'head': 'TAK-441', 'type': 'Regulator', 'tail': 'Smo'} 
{'head': 'sulindac sulfide', 'type': 'subject has role', 'tail': 'COX-1'} 	 {'head': 'sulindac sulfide', 'type': 'Downregulator', 'tail': 'COX-1'} 
{'head': 'S100A4', 'type': 'instance of', 'tail': 'protein'} 	 {'head': 'Phenothiazines', 'type': 'Downregulator', 'tail': 'S100A4'} 
{'head': 'ubiquitin', 'type': 'subclass of', 'tail': 'proteins'} 	 {'head': 'N', 'type': 'Part_of', 'tail': 'IAP'} 
{'head': 'N-terminus', 'type': 'part of', 'tail': 'nucleotide sequence'} 	 {'head': 'N', 'type': 'Part_of', 'tail': 'ovine M-CPT 1'} 
{'head': 'BRL35135', 'type': 'subject has role', 'tail': 'beta 3-adrenoceptor agonist'} 	 {'head': 'BRL35135', 'type': 'Agonist', 'tail': 'beta 3-adrenoceptor'} 
{'head': '2,3,7,8-tetrachlorodibenzo-p-dioxin', 'type': 'instance of', 'tail': 'polycyclic aromatic hydrocarbons'} 	 {'head': '2,3,7,8-tetrachlorodibenzo-p-dioxin', 'type': 'Regulator', 'tail': 'AhR'} 
{'head': 'Heterometrus laoticus', 'type': 'endemic to', 'tail': 'Thailand'} 	 {'head': 'nucleotide', 'type': 'Part_of', 'tail': 'HmTx'} 
{'head': 'ERG1', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'terbinafine', 'type': 'Not', 'tail': 'ERG1'} 
{'head': 'nasal allergy', 'type': 'subclass of', 'tail': 'nasal hypersensitivity'} 	 {'head': 'Dexamethasone', 'type': 'Downregulator', 'tail': 'HDC'} 
{'head': 'prehypertension', 'type': 'subclass of', 'tail': 'hypertension'} 	 {'head': 'Carbohydrate', 'type': 'Regulator', 'tail': 'Insulin'} 
{'head': 'Sibutramine', 'type': 'subject has role', 'tail': 'racemic'} 	 {'head': 'clopidogrel', 'type': 'Downregulator', 'tail': 'CYP2B6'} 
{'head': 'cysteinyl leukotriene', 'type': 'subclass of', 'tail': 'receptor'} 	 {'head': 'pranlukast', 'type': 'Regulator', 'tail': 'IL-5'} 
{'head': 'meclofenamic acid', 'type': 'subject has role', 'tail': 'anticonvulsant'} 	 {'head': 'Meclofenamic acid', 'type': 'Regulator', 'tail': 'KCNQ2/Q3'} 
{'head': 'atomoxetine', 'type': 'medical condition treated', 'tail': 'Attention Deficit/Hyperactivity Disorder'} 	 {'head': 'atomoxetine', 'type': 'Regulator', 'tail': 'monoamine transporters'} 
{'head': 'IL-4', 'type': 'subclass of', 'tail': 'cytokine'} 	 {'head': 'PGE2', 'type': 'Downregulator', 'tail': 'IL-13'} 
{'head': 'tabun', 'type': 'subject has role', 'tail': 'nerve agent'} 	 {'head': 'dichlorvos', 'type': 'Downregulator', 'tail': 'AChE'} 
{'head': 'Na+ channel', 'type': 'subclass of', 'tail': 'ion channel'} 	 {'head': 'mibefradil', 'type': 'Regulator', 'tail': 'Nav1.5'} 
{'head': 'docetaxel', 'type': 'instance of', 'tail': 'taxane'} 	 {'head': 'Docetaxel', 'type': 'Downregulator', 'tail': 'bcl-2'} 
{'head': 'CYP2D6', 'type': 'subclass of', 'tail': 'cytochrome P450'} 	 {'head': 'Risperidone', 'type': 'Substrate', 'tail': 'cytochrome P450'} 
{'head': 'Spermine', 'type': 'instance of', 'tail': 'polyamine'} 	 {'head': 'BW-1', 'type': 'Substrate', 'tail': 'PAO'} 
{'head': 'FT-IR', 'type': 'subclass of', 'tail': 'NMR'} 	 {'head': 'N-Aryl pyrido-quinazolines', 'type': 'Downregulator', 'tail': 'EGFR'} 
{'head': 'SPACRCAN', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'amino acids', 'type': 'Part_of', 'tail': 'mucin domain'} 
{'head': 'in vitro', 'type': 'different from', 'tail': 'in vivo'} 	 {'head': 'Cu', 'type': 'Upregulator', 'tail': 'interleukin-8'} 
{'head': 'auranofin', 'type': 'subject has role', 'tail': 'apoptosis'} 	 {'head': 'auranofin', 'type': 'Downregulator', 'tail': 'TrxR'} 
{'head': 'DeltaKPQ', 'type': 'instance of', 'tail': 'amino acid'} 	 {'head': 'sodium', 'type': 'Not', 'tail': 'LQT3 DeltaKPQ mutant'} 
{'head': 'κ-opioid receptor antagonist', 'type': 'studied by', 'tail': 'pharmacodynamic'} 	 {'head': 'naltrindole', 'type': 'Regulator', 'tail': 'κ-opioid receptor'} 
{'head': 'dihydropteridinone', 'type': 'medical condition treated', 'tail': "Parkinson's disease"} 	 {'head': 'dihydropteridinone', 'type': 'Downregulator', 'tail': 'Plk-2'} 
{'head': 'SaOS-2', 'type': 'instance of', 'tail': 'cell lines'} 	 {'head': 'Sphingosine-1-phosphate', 'type': 'Regulator', 'tail': 'β-catenin'} 
{'head': 'Plerixafor', 'type': 'manufacturer', 'tail': 'Genzyme Corporation'} 	 {'head': 'Plerixafor', 'type': 'Downregulator', 'tail': 'stromal cell-derived factor-1'} 
{'head': 'glucagon-like peptide-1', 'type': 'part of', 'tail': 'Wnt signaling pathway'} 	 {'head': 'Thr', 'type': 'Part_of', 'tail': 'Pak1'} 
{'head': 'phosphatidylinositol 3-kinase-serum- and glucocorticoid-dependent kinase 1', 'type': 'subclass of', 'tail': 'protein'} 	 {'head': 'wortmannin', 'type': 'Downregulator', 'tail': 'phosphatidylinositol 3-kinase'} 
{'head': 'olanzapine', 'type': 'subject has role', 'tail': 'antipsychotic'} 	 {'head': 'quinpirole', 'type': 'Regulator', 'tail': 'neurotrophic factor'} 
{'head': 'Fc', 'type': 'subclass of', 'tail': 'glycoprotein'} 	 {'head': 'sulfate', 'type': 'Regulator', 'tail': 'follistatin'} 
{'head': 'Pinosylvin', 'type': 'instance of', 'tail': 'trans-stilbenoid'} 	 {'head': 'pinosylvin', 'type': 'Downregulator', 'tail': 'Src'} 
{'head': 'acetate ester', 'type': 'instance of', 'tail': 'ester'} 	 {'head': 'ammonium', 'type': 'Regulator', 'tail': 'Ehrlich pathway'} 
{'head': 'nitric oxide', 'type': 'subject has role', 'tail': 'analgesic'} 	 {'head': '1,5-diarylpyrrole nitrooxyalkyl ethers', 'type': 'Downregulator', 'tail': 'cyclooxygenase-2'} 
{'head': 'Eprosartan', 'type': 'subject has role', 'tail': 'angiotensin II receptor blocker'} 	 {'head': 'eprosartan', 'type': 'Downregulator', 'tail': 'angiotensin II receptor'} 
{'head': 'paracetamol', 'type': 'has effect', 'tail': 'hepatotoxicity'} 	 {'head': 'CCl4', 'type': 'Upregulator', 'tail': 'ethylmorphine-N-demethylase'} 
{'head': 'kurarinone', 'type': 'instance of', 'tail': 'prenylflavonoid'} 	 {'head': 'prenylflavonoids', 'type': 'Downregulator', 'tail': 'diacylglycerol acyltransferase'} 
{'head': 'T helper 2', 'type': 'subclass of', 'tail': 'cytokine'} 	 {'head': 'Dexamethasone', 'type': 'Downregulator', 'tail': 'CXCL-8'} 
{'head': 'progesterone receptor', 'type': 'subclass of', 'tail': 'nuclear hormone receptor'} 	 {'head': 'progestins', 'type': 'Not', 'tail': 'progesterone receptor'} 
{'head': 'GluN1/GluN2B', 'type': 'subclass of', 'tail': 'receptor'} 	 {'head': 'Ifenprodil', 'type': 'Modulator', 'tail': 'GluN1'} 
{'head': 'Podocyte apoptosis', 'type': 'subclass of', 'tail': 'apoptosis'} 	 {'head': 'rapamycin', 'type': 'Downregulator', 'tail': 'Nox4'} 
{'head': 'formoterol', 'type': 'medical condition treated', 'tail': 'asthma'} 	 {'head': 'formoterol', 'type': 'Regulator', 'tail': 'beta(2)-adrenoceptor'} 
{'head': 'Acarbose', 'type': 'subject has role', 'tail': 'alpha-glucosidase inhibitor'} 	 {'head': 'acarbose', 'type': 'Downregulator', 'tail': 'alpha-glucosidase'} 
{'head': 'hepatic', 'type': 'part of', 'tail': 'blood'} 	 {'head': 'STX', 'type': 'Upregulator', 'tail': 'hemoglobin'} 
{'head': 'Diazepam-binding inhibitor', 'type': 'subclass of', 'tail': 'endozepine'} 	 {'head': 'glucose', 'type': 'Upregulator', 'tail': 'DBI'} 
{'head': 'tetrahydrobiopterin', 'type': 'subclass of', 'tail': 'tetrameric'} 	 {'head': 'tetrahydrobiopterin', 'type': 'Regulator', 'tail': 'Tyrosine hydroxylase'} 
{'head': 'valdecoxib', 'type': 'medical condition treated', 'tail': 'rheumatoid arthritis'} 	 {'head': 'valdecoxib', 'type': 'Downregulator', 'tail': 'cyclooxygenase-2'} 
{'head': 'Silibinin', 'type': 'instance of', 'tail': 'flavonoid'} 	 {'head': 'Silibinin', 'type': 'Upregulator', 'tail': 'p53'} 
{'head': 'epigenetic', 'type': 'studies', 'tail': 'DNA methylation'} 	 {'head': 'Pb', 'type': 'Regulator', 'tail': 'DNMT1'} 
{'head': 'Group I metabotropic glutamate receptor', 'type': 'subclass of', 'tail': 'G protein coupled receptor'} 	 {'head': 'C', 'type': 'Part_of', 'tail': 'mGluR1'} 
{'head': 'glutathione S-transferase', 'type': 'subclass of', 'tail': 'aldehyde metabolizing enzymes'} 	 {'head': '4-Hydroxynonenal', 'type': 'Substrate', 'tail': 'glutathione S-transferase'} 
{'head': 'triglyceride', 'type': 'subclass of', 'tail': 'lipid'} 	 {'head': 'DRF 2655', 'type': 'Upregulator', 'tail': 'carnitine palmitoyltransferase'} 
{'head': 'cyclo-oxygenase', 'type': 'subclass of', 'tail': 'isoenzyme'} 	 {'head': 'arachidonic acid', 'type': 'Substrate', 'tail': 'cyclo-oxygenase'} 
{'head': 'Brain arteriovenous malformations', 'type': 'subclass of', 'tail': 'potentially life-threatening disorder'} 	 {'head': 'Doxycycline', 'type': 'Downregulator', 'tail': 'MMP-9'} 
{'head': 'formate', 'type': 'has part', 'tail': 'C'} 	 {'head': 'glycine', 'type': 'Substrate', 'tail': 'glycine decarboxylase complex'} 
{'head': 'amphetamine', 'type': 'subject has role', 'tail': 'dopamine'} 	 {'head': 'N-(Diphenylmethyl)-2-phenyl-4-quinazolinamine', 'type': 'Regulator', 'tail': 'DAT'} 
{'head': 'EGFP', 'type': 'instance of', 'tail': 'gene'} 	 {'head': '[3H]dihydroalprenolol', 'type': 'Regulator', 'tail': 'beta2AR'} 
{'head': 'Rivastigmine', 'type': 'medical condition treated', 'tail': 'Alzheimer disease'} 	 {'head': 'Rivastigmine', 'type': 'Downregulator', 'tail': 'acetylcholinesterase'} 
{'head': 'allosteric', 'type': 'subclass of', 'tail': 'ligand'} 	 {'head': 'fatty acid', 'type': 'Regulator', 'tail': 'GPCRs'} 
{'head': 'Topotecan', 'type': 'subject has role', 'tail': 'topoisomerase I inhibitor'} 	 {'head': 'Topotecan', 'type': 'Downregulator', 'tail': 'topoisomerase I'} 
{'head': 'Catalytic triad', 'type': 'instance of', 'tail': 'regions'} 	 {'head': 'amiloride', 'type': 'Regulator', 'tail': 'tissue plasminogen activator'} 
{'head': 'basilar arteries', 'type': 'subclass of', 'tail': 'arteries'} 	 {'head': 'RES 701-1', 'type': 'Regulator', 'tail': 'endothelin-1'} 
{'head': 'Metformin and Sulfonylureas in Relation to Cancer Risk in Type II Diabetes Patients', 'type': 'instance of', 'tail': 'Meta-analysis'} 	 {'head': 'metformin', 'type': 'Regulator', 'tail': 'insulin'} 
{'head': 'quinoxaline', 'type': 'medical condition treated', 'tail': 'autoimmune disease'} 	 {'head': 'quinoxalines', 'type': 'Antagonist', 'tail': 'IgG'} 
{'head': 'Clonidine', 'type': 'subject has role', 'tail': 'antihypertensive'} 	 {'head': 'Clonidine', 'type': 'Regulator', 'tail': 'alpha 2-adrenergic and imidazoline receptors'} 
{'head': 'GSK2251052', 'type': 'subject has role', 'tail': 'antibiotic'} 	 {'head': '(S)-3-(Aminomethyl)-7-(3-hydroxypropoxy)-1-hydroxy-1,3-dihydro-2,1-benzoxaborole', 'type': 'Downregulator', 'tail': 'bacterial leucyl tRNA synthetase'} 
{'head': 'serotonin', 'type': 'subject has role', 'tail': 'antidepressant'} 	 {'head': 'serotonin', 'type': 'Substrate', 'tail': 'SERT'} 
{'head': 'gefitinib', 'type': 'subject has role', 'tail': 'inhibitor'} 	 {'head': 'gefitinib', 'type': 'Undefined', 'tail': 'EGFR'} 
{'head': 'DnaJ', 'type': 'instance of', 'tail': 'protein'} 	 {'head': 'pyridoxal phosphate', 'type': 'Cofactor', 'tail': 'NifS'} 
{'head': 'DNA polymerase domain', 'type': 'part of', 'tail': 'protein'} 	 {'head': 'N', 'type': 'Part_of', 'tail': 'N-terminal helicase-like domain'} 
{'head': 'DNA methyl-binding domain', 'type': 'instance of', 'tail': 'protein'} 	 {'head': 'N', 'type': 'Part_of', 'tail': 'MeCP2'} 
{'head': 'prostasin', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'amiloride', 'type': 'Regulator', 'tail': 'amiloride-sensitive epithelial sodium channel'} 
{'head': 'hepatocarcinogenesis', 'type': 'subclass of', 'tail': 'hepatocellular tumor'} 	 {'head': 'methyleugenol', 'type': 'Regulator', 'tail': 'gpt'} 
{'head': 'ethanol-induced hepatic damage', 'type': 'subclass of', 'tail': 'alcoholic liver disease'} 	 {'head': 'alcohol', 'type': 'Upregulator', 'tail': 'nuclear factor (NF)-κB'} 
{'head': 'eicosapentaenoic acid', 'type': 'instance of', 'tail': 'polyunsaturated fatty acid'} 	 {'head': 'EPA', 'type': 'Upregulator', 'tail': 'insulin'} 
{'head': 'cinobufacini', 'type': 'instance of', 'tail': 'steroid'} 	 {'head': 'cinobufagin', 'type': 'Regulator', 'tail': 'nuclear factor-kappa B'} 
{'head': 'metabolic syndrome', 'type': 'subclass of', 'tail': 'cardiovascular disease'} 	 {'head': 'Arsenic', 'type': 'Regulator', 'tail': 'endothelin-1'} 
{'head': 'EPR-1', 'type': 'subclass of', 'tail': 'effector cell protease receptor'} 	 {'head': '5-dimethylaminonaphthalene-1sulfonyl (dansyl) Glu-Gly-Arg-(DEGR)-chloromethylketone', 'type': 'Part_of', 'tail': 'factor Xa'} 
{'head': 'blood pressure', 'type': 'facet of', 'tail': 'cardiovascular disease'} 	 {'head': '[6]-gingerol', 'type': 'Downregulator', 'tail': 'angiotensin II type 1 receptor'} 
{'head': 'HMG-CoA reductase inhibitor', 'type': 'subclass of', 'tail': 'statin'} 	 {'head': 'ezetimibe', 'type': 'Downregulator', 'tail': 'LDL'} 
{'head': 'tetrahydrobiopterin', 'type': 'subject has role', 'tail': 'cofactors'} 	 {'head': 'N5-substituted tetrahydrobiopterin', 'type': 'Regulator', 'tail': 'dihydropteridine reductase'} 
{'head': 'pons', 'type': 'connects with', 'tail': 'medulla oblongata'} 	 {'head': 'reserpine', 'type': 'Downregulator', 'tail': 'VMAT'} 
{'head': 'CLC-5', 'type': 'instance of', 'tail': 'chloride channel'} 	 {'head': 'bumetanide', 'type': 'Regulator', 'tail': 'bumetanide-sensitive sodium-potassium-chloride cotransporter'} 
{'head': 'N(omega)-hydroxy-nor-L-arginine', 'type': 'subject has role', 'tail': 'arginase inhibitor'} 	 {'head': 'nitric-oxide', 'type': 'Substrate', 'tail': 'Mitochondrial arginase II'} 
{'head': 'LQT2', 'type': 'subclass of', 'tail': 'arrhythmias'} 	 {'head': 'RSD1235', 'type': 'Downregulator', 'tail': 'ion channel'} 
{'head': 'apoptosis', 'type': 'subclass of', 'tail': 'cell cycle'} 	 {'head': 'putrescine', 'type': 'Not', 'tail': 'caspase 3'} 
{'head': 'functional class II-III', 'type': 'subclass of', 'tail': 'heart failure'} 	 {'head': 'carvedilol', 'type': 'Regulator', 'tail': 'brain natriuretic peptide'} 
{'head': 'Leflunomide', 'type': 'medical condition treated', 'tail': 'rheumatoid arthritis'} 	 {'head': 'A77 1726', 'type': 'Downregulator', 'tail': 'dihydroorotate dehydrogenase'} 
{'head': 'Asp', 'type': 'instance of', 'tail': 'amino acid'} 	 {'head': 'L-proline', 'type': 'Substrate', 'tail': 'gamma-glutamyl kinase'} 
{'head': 'α', 'type': 'subclass of', 'tail': 'estrogen receptor'} 	 {'head': '2,5-thiophene amides', 'type': 'Downregulator', 'tail': '17β-hydroxysteroid dehydrogenase type 2'} 
{'head': 'theophylline', 'type': 'subject has role', 'tail': 'phosphodiesterase (PDE) inhibitor'} 	 {'head': 'theophylline', 'type': 'Regulator', 'tail': 'phosphodiesterases'} 
{'head': 'Atrazine', 'type': 'instance of', 'tail': 'carcinogen'} 	 {'head': 'atrazine', 'type': 'Regulator', 'tail': 'CYP17A1'} 
{'head': 'Terbutaline', 'type': 'medical condition treated', 'tail': 'asthma'} 	 {'head': 'Terbutaline', 'type': 'Agonist', 'tail': 'beta(2)-adrenoceptor'} 
{'head': 'oxymetazoline', 'type': 'subject has role', 'tail': 'alpha 1A-adrenoceptor antagonist'} 	 {'head': '(+/-)-tamsulosin', 'type': 'Antagonist', 'tail': 'alpha 1A-adrenoceptor'} 
{'head': 'apoptosis', 'type': 'subclass of', 'tail': 'signaling pathway'} 	 {'head': 'Pterostilbene', 'type': 'Downregulator', 'tail': 'JAK2'} 
{'head': 'Sinapic acid', 'type': 'subject has role', 'tail': 'antifibrotic'} 	 {'head': 'sinapic acid', 'type': 'Regulator', 'tail': 'collagen'} 
{'head': 'hypertension', 'type': 'has effect', 'tail': 'chronic heart failure'} 	 {'head': 'candesartan', 'type': 'Regulator', 'tail': 'angiotensin II type 1 receptor'} 
{'head': 'plant', 'type': 'has part', 'tail': 'root'} 	 {'head': 'amino acids', 'type': 'Part_of', 'tail': 'GLR3.2'} 
{'head': 'Vespa affinis', 'type': 'parent taxon', 'tail': 'vespid'} 	 {'head': 'amino acid', 'type': 'Part_of', 'tail': 'Ves a 1s'} 
{'head': 'Thalidomide', 'type': 'subject has role', 'tail': 'antiangiogenic'} 	 {'head': 'Thalidomide', 'type': 'Not', 'tail': 'COX-1'} 
{'head': 'prallethrin 1', 'type': 'instance of', 'tail': 'insecticide'} 	 {'head': 'prallethrin', 'type': 'Upregulator', 'tail': 'hemoglobin'} 
{'head': 'NMDA receptor', 'type': 'subclass of', 'tail': 'ion channel'} 	 {'head': 'CIQ', 'type': 'Not', 'tail': 'NMDA receptor'} 
{'head': 'GIST882', 'type': 'instance of', 'tail': 'cell line'} 	 {'head': 'imatinib', 'type': 'Regulator', 'tail': 'tyrosine kinase'} 
{'head': 'acarbose', 'type': 'subject has role', 'tail': 'alpha-glucosidase inhibitor'} 	 {'head': 'acarbose', 'type': 'Downregulator', 'tail': 'alpha-glucosidase'} 
{'head': 'JAK/ERK/STAT signaling', 'type': 'subclass of', 'tail': 'extracellular signal-regulated kinase'} 	 {'head': 'Nle', 'type': 'Part_of', 'tail': 'α-melanocyte-stimulating hormone'} 
{'head': 'neurodegeneration', 'type': 'subclass of', 'tail': 'neurological disorders'} 	 {'head': 'prostaglandins', 'type': 'Substrate', 'tail': 'COX'} 
{'head': 'nigrostriatal', 'type': 'subclass of', 'tail': 'neurons'} 	 {'head': 'MPTP', 'type': 'Regulator', 'tail': 'cytochrome C'} 
{'head': 'basal insulin', 'type': 'subclass of', 'tail': 'insulin'} 	 {'head': 'sitagliptin', 'type': 'Regulator', 'tail': 'glycated albumin'} 
{'head': 'Selenite cataract', 'type': 'subclass of', 'tail': 'cataract'} 	 {'head': 'sodium selenite', 'type': 'Regulator', 'tail': 'MsrA'} 
{'head': 'MCT2 isoform', 'type': 'subclass of', 'tail': 'monocarboxylate transporters'} 	 {'head': 'pyruvate', 'type': 'Substrate', 'tail': 'monocarboxylate transporters'} 
{'head': 'proteins', 'type': 'has part', 'tail': 'amino acid'} 	 {'head': 'acetaldehyde', 'type': 'Substrate', 'tail': 'Mammalian ALDH1B1'} 
{'head': 'aspirin', 'type': 'subject has role', 'tail': 'non-steroidal anti-inflammatory drug'} 	 {'head': 'Aspirin', 'type': 'Downregulator', 'tail': 'cyclooxygenase'} 
{'head': 'mitogen-activated protein kinase', 'type': 'subclass of', 'tail': 'enzymes'} 	 {'head': 'Minocycline', 'type': 'Downregulator', 'tail': 'cytochrome c'} 
{'head': 'metyrapone', 'type': 'subject has role', 'tail': 'monoacylglycerol lipase inhibitor'} 	 {'head': 'JZL184', 'type': 'Downregulator', 'tail': 'monoacylglycerol lipase'} 
{'head': 'Trichostatin A', 'type': 'medical condition treated', 'tail': 'hepatocarcinogenesis'} 	 {'head': 'Trichostatin A', 'type': 'Downregulator', 'tail': 'histone deacetylase'} 
{'head': 'metastasis', 'type': 'subclass of', 'tail': 'invasion'} 	 {'head': 'mannose 6-phosphate', 'type': 'Part_of', 'tail': 'IGF2R'} 
{'head': 'Orlistat', 'type': 'subject has role', 'tail': 'lipase inhibitor'} 	 {'head': 'Orlistat', 'type': 'Upregulator', 'tail': 'low-density lipoprotein'} 
{'head': "Graves' disease", 'type': 'subclass of', 'tail': 'hyperthyroidism'} 	 {'head': 'cAMP', 'type': 'Upregulator', 'tail': 'TPO'} 
{'head': 'TFIIIC', 'type': 'subclass of', 'tail': 'transcription factor'} 	 {'head': 'N', 'type': 'Part_of', 'tail': 'Saccharomyces cerevisiae τ55'} 
{'head': 'TNF-α', 'type': 'subclass of', 'tail': 'cytokine'} 	 {'head': 'benzo[d]imidazole', 'type': 'Downregulator', 'tail': 'NLRP3'} 
{'head': 'methylphenidate', 'type': 'medical condition treated', 'tail': 'attention deficit/hyperactivity disorder'} 	 {'head': 'MPH', 'type': 'Upregulator', 'tail': 'tyrosine hydroxylase'} 
{'head': 'alpha-estradiol', 'type': 'medical condition treated', 'tail': 'prostate cancer'} 	 {'head': 'Androgen', 'type': 'Antagonist', 'tail': 'androgen receptor'} 
{'head': 'active site', 'type': 'part of', 'tail': 'enzyme'} 	 {'head': 'edrophonium', 'type': 'Downregulator', 'tail': 'Torpedo californica AChE'} 
{'head': 'ascites', 'type': 'subclass of', 'tail': 'cirrhosis'} 	 {'head': 'prostaglandin', 'type': 'Substrate', 'tail': 'cyclooxygenase 2'} 
{'head': 'fluticasone propionate', 'type': 'subject has role', 'tail': 'corticosteroid'} 	 {'head': 'fluticasone propionate', 'type': 'Downregulator', 'tail': 'cPLA2'} 
{'head': 'desipramine', 'type': 'subject has role', 'tail': 'antidepressant'} 	 {'head': 'Desipramine', 'type': 'Downregulator', 'tail': 'norepinephrine transporter'} 
{'head': 'cisapride', 'type': 'subject has role', 'tail': 'prokinetic agent'} 	 {'head': 'cisapride', 'type': 'Downregulator', 'tail': 'human ether-a-go-go-related gene (HERG) potassium channel'} 
{'head': 'clozapine', 'type': 'subject has role', 'tail': 'antipsychotic'} 	 {'head': 'ziprasidone', 'type': 'Regulator', 'tail': '5-HT1A'} 
{'head': 'irreversible', 'type': 'opposite of', 'tail': 'reversible'} 	 {'head': 'phenelzine', 'type': 'Downregulator', 'tail': 'MAO'} 
{'head': 'cytochrome P-450 1A1', 'type': 'instance of', 'tail': 'isoenzyme'} 	 {'head': 'Dicumarol', 'type': 'Downregulator', 'tail': 'quinone oxidoreductase'} 
{'head': 'pyridoxine', 'type': 'medical condition treated', 'tail': 'anemia'} 	 {'head': 'pyridoxine', 'type': 'Regulator', 'tail': 'G663A'} 
{'head': 'Novartis Pharma AG', 'type': 'location of formation', 'tail': 'Basel, Switzerland'} 	 {'head': 'rivastigmine', 'type': 'Downregulator', 'tail': 'acetylcholinesterase'} 
{'head': 'A3 domain', 'type': 'instance of', 'tail': 'domains'} 	 {'head': 'amino acids', 'type': 'Part_of', 'tail': 'factor IX'} 
{'head': 'alpha(2)-adrenergic receptor', 'type': 'subclass of', 'tail': 'monoaminergic receptor'} 	 {'head': 'yohimbine', 'type': 'Regulator', 'tail': 'monoaminergic receptors'} 
{'head': 'codeine', 'type': 'subclass of', 'tail': 'mu-opioid receptor'} 	 {'head': 'SB 227122', 'type': 'Agonist', 'tail': 'opioid receptor'} 
{'head': 'celecoxib', 'type': 'subclass of', 'tail': 'nonsteroidal anti-inflammatory drug'} 	 {'head': 'celecoxib', 'type': 'Downregulator', 'tail': 'cyclooxygenase-2'} 
{'head': 'triazine', 'type': 'subject has role', 'tail': 'antiproliferative'} 	 {'head': 'atovaquone', 'type': 'Downregulator', 'tail': 'human dihydroorotate dehydrogenase'} 
{'head': 'procainamide', 'type': 'subject has role', 'tail': 'Sodium channel blocker'} 	 {'head': 'ajmaline', 'type': 'Regulator', 'tail': 'SCN5A'} 
{'head': 'alpha1A', 'type': 'subclass of', 'tail': 'voltage gated calcium channel'} 	 {'head': 'Mibefradil', 'type': 'Regulator', 'tail': 'Ca2+ channel'} 
{'head': 'tranexamic acid', 'type': 'subject has role', 'tail': 'inhibitor of fibrinolysis'} 	 {'head': 'tranexamic acid', 'type': 'Downregulator', 'tail': 'plasminogen'} 
{'head': 'pentobarbital', 'type': 'subject has role', 'tail': 'Serotonin'} 	 {'head': '+/- propranolol', 'type': 'Agonist', 'tail': '5-HT1'} 
{'head': 'Hsp90', 'type': 'subclass of', 'tail': 'heat shock protein'} 	 {'head': 'geldanamycin', 'type': 'Not', 'tail': 'lysophosphatide acyltransferase'} 
{'head': 'carnitine', 'type': 'has part', 'tail': 'L-carnitine'} 	 {'head': 'carnitine', 'type': 'Substrate', 'tail': 'gamma-Butyrobetaine hydroxylase'} 
{'head': 'Aspirin', 'type': 'subject has role', 'tail': 'antiplatelet'} 	 {'head': 'Aspirin', 'type': 'Modulator', 'tail': 'ETA receptors'} 
{'head': 'Mitomycin C', 'type': 'medical condition treated', 'tail': 'head and neck cancer'} 	 {'head': 'mitomycin C', 'type': 'Substrate', 'tail': 'NQO1'} 
{'head': 'subcutaneous', 'type': 'subclass of', 'tail': 'adipocytes'} 	 {'head': 'Troglitazone', 'type': 'Downregulator', 'tail': 'plasminogen activator inhibitor-1'} 
{'head': 'prazosin', 'type': 'subject has role', 'tail': 'alpha(1)-adrenoceptor antagonist'} 	 {'head': 'JTH-601', 'type': 'Antagonist', 'tail': 'alpha(1)-adrenoceptor'} 
{'head': 'salivary fluid secretory mechanism', 'type': 'use', 'tail': 'salivation'} 	 {'head': 'Cl(-)', 'type': 'Substrate', 'tail': 'NKCC1'} 
{'head': 'striatum', 'type': 'part of', 'tail': 'brain'} 	 {'head': 'scopolamine', 'type': 'Antagonist', 'tail': 'muscarinic acetylcholine (mAch) receptor'} 
{'head': 'mitochondrial', 'type': 'part of', 'tail': 'skeletal muscle'} 	 {'head': 'troglitazone', 'type': 'Regulator', 'tail': 'UCP-3'} 
{'head': 'Retigabine', 'type': 'subject has role', 'tail': 'anticonvulsant'} 	 {'head': 'Retigabine', 'type': 'Upregulator', 'tail': 'potassium channels'} 
{'head': "5'-promoter region serotonin transporter", 'type': 'part of', 'tail': 'Serotonin transporter gene regulatory region'} 	 {'head': '[3H]paroxetine', 'type': 'Regulator', 'tail': '5-HTTLPR'} 
{'head': 'flurbiprofen', 'type': 'subject has role', 'tail': 'nonsteroidal anti-inflammatory drug'} 	 {'head': 'Arachidonic acid', 'type': 'Regulator', 'tail': 'cyclooxygenase-2'} 
{'head': '5-aminosalicylic acid', 'type': 'medical condition treated', 'tail': 'inflammatory bowel disease'} 	 {'head': 'sulfasalazine', 'type': 'Not', 'tail': 'c-Jun-N-terminal kinase (JNK) 1'} 
{'head': 'indomethacin', 'type': 'subject has role', 'tail': 'NSAIDs'} 	 {'head': 'prostaglandins', 'type': 'Substrate', 'tail': 'COX-2'} 
{'head': 'carbidopa', 'type': 'subject has role', 'tail': 'aromatic-L-amino acid decarboxylase inhibitor'} 	 {'head': 'carbidopa', 'type': 'Regulator', 'tail': 'AAAD'} 
{'head': 'physostigmine', 'type': 'subject has role', 'tail': 'acetylcholinesterase inhibitor'} 	 {'head': 'Hexahydrochromeno[4,3-b]pyrrole', 'type': 'Downregulator', 'tail': 'acetylcholinesterase'} 
{'head': 'aminoglutethimide', 'type': 'subject has role', 'tail': 'anti-corticosterone'} 	 {'head': 'aminoglutethimide', 'type': 'Downregulator', 'tail': 'CYP11A1'} 
{'head': 'stop codon', 'type': 'part of', 'tail': 'coding sequence'} 	 {'head': 'cAMP', 'type': 'Not', 'tail': 'NADH-->UQ oxidoreductase'} 
{'head': '5-fluorouracil', 'type': 'subject has role', 'tail': 'antimetabolite'} 	 {'head': 'Gly2', 'type': 'Regulator', 'tail': 'GLP-2 receptor'} 
{'head': 'cocaine', 'type': 'subject has role', 'tail': 'local anesthetic'} 	 {'head': 'DA', 'type': 'Substrate', 'tail': 'dopamine transporter'} 
{'head': 'alpha-intercalated cell', 'type': 'part of', 'tail': 'rat kidney'} 	 {'head': 'Cl-', 'type': 'Substrate', 'tail': 'NKCC1'} 
{'head': 'human mineralocorticoid receptor', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'amino acids', 'type': 'Part_of', 'tail': 'hormone-binding domain'} 
{'head': 'AS-8112', 'type': 'subject has role', 'tail': 'anti-emetic'} 	 {'head': 'AS-8112', 'type': 'Regulator', 'tail': '5-hydroxytryptamine-3 (5-HT3) receptors'} 
{'head': 'catalytic domain', 'type': 'part of', 'tail': 'proteinase'} 	 {'head': 'Arg', 'type': 'Part_of', 'tail': 'chymotrypsin'} 
{'head': 'rofecoxib', 'type': 'medical condition treated', 'tail': 'osteoarthritis'} 	 {'head': 'Rofecoxib', 'type': 'Not', 'tail': 'COX-1'} 
{'head': "Gitelman's variant", 'type': 'subclass of', 'tail': 'inherited hypokalemic alkalosis'} 	 {'head': 'potassium', 'type': 'Regulator', 'tail': 'IGF-I'} 
{'head': 'peroxisome proliferator-activated receptor', 'type': 'subclass of', 'tail': 'receptor'} 	 {'head': 'Fibrates', 'type': 'Regulator', 'tail': 'peroxisome proliferator-activated receptor (PPAR)-alpha'} 
{'head': 'PA inhibitor-1', 'type': 'subject has role', 'tail': 'inhibitors'} 	 {'head': 'N', 'type': 'Part_of', 'tail': 'hemofiltrate CC chemokine 1'} 
{'head': 'procaine', 'type': 'subject has role', 'tail': 'general anesthetic'} 	 {'head': 'Cembranoid', 'type': 'Regulator', 'tail': 'nicotinic acetylcholine receptor'} 
{'head': 'cyst(e)ine', 'type': 'instance of', 'tail': 'amino acid'} 	 {'head': 'Sulfasalazine', 'type': 'Downregulator', 'tail': 'x(c)- transporter'} 
{'head': 'omapatrilat', 'type': 'subject has role', 'tail': 'vasopeptidase inhibitor'} 	 {'head': 'omapatrilat', 'type': 'Upregulator', 'tail': 'atrial and brain natriuretic peptides'} 
{'head': 'Neonatal red blood cell', 'type': 'part of', 'tail': 'umbilical cord blood'} 	 {'head': 'Na+', 'type': 'Substrate', 'tail': 'NHE1'} 
{'head': 'aspirin', 'type': 'subject has role', 'tail': 'anti-inflammatory'} 	 {'head': 'Aspirin', 'type': 'Regulator', 'tail': 'immunoglobulin heavy chain binding protein'} 
{'head': 'left kidney', 'type': 'has part', 'tail': 'proximal convoluted tubules'} 	 {'head': 'ornithine', 'type': 'Substrate', 'tail': 'ornithine aminotransferase'} 
{'head': 'ketorolac', 'type': 'subclass of', 'tail': 'non-steroidal anti-inflammatory drug'} 	 {'head': 'celecoxib', 'type': 'Downregulator', 'tail': 'cyclooxygenase (COX)-2'} 
{'head': 'dofetilide', 'type': 'subject has role', 'tail': 'antiarrhythmic'} 	 {'head': '[3H]dofetilide', 'type': 'Regulator', 'tail': 'HERG'} 
{'head': 'Phenelzine', 'type': 'subject has role', 'tail': 'antidepressant'} 	 {'head': 'PLZ', 'type': 'Downregulator', 'tail': 'GABA transaminase'} 
{'head': 'ketoprofen', 'type': 'subclass of', 'tail': 'Cyclooxygenase-1'} 	 {'head': 'flurbiprofen', 'type': 'Downregulator', 'tail': 'Cyclooxygenase-1'} 
{'head': 'COX-1', 'type': 'subclass of', 'tail': 'cyclooxygenase'} 	 {'head': 'steroidal', 'type': 'Downregulator', 'tail': 'cyclooxygenase'} 
{'head': 'Tamoxifen', 'type': 'medical condition treated', 'tail': 'breast cancer'} 	 {'head': 'ICI 182,780', 'type': 'Regulator', 'tail': 'estrogen receptor'} 
{'head': 'Olopatadine hydrochloride', 'type': 'subject has role', 'tail': 'antiallergic'} 	 {'head': 'Olopatadine hydrochloride', 'type': 'Antagonist', 'tail': 'histamine H1-receptor'} 
{'head': '5HTTLPR', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'cocaine', 'type': 'Regulator', 'tail': '5HTT'} 
{'head': 'theophylline', 'type': 'medical condition treated', 'tail': 'asthma'} 	 {'head': 'theophylline', 'type': 'Upregulator', 'tail': 'histone deacetylase'} 
{'head': 'rifamycin SV', 'type': 'subject has role', 'tail': 'antibiotics'} 	 {'head': 'rifamycin SV', 'type': 'Regulator', 'tail': 'OATP'} 
{'head': 'Metformin', 'type': 'medical condition treated', 'tail': 'type 2 diabetes'} 	 {'head': 'Metformin', 'type': 'Upregulator', 'tail': 'AMPK alpha2'} 
{'head': 'Thalidomide prevents alcoholic liver injury', 'type': 'medical condition treated', 'tail': 'alcoholic liver injury'} 	 {'head': 'Thalidomide', 'type': 'Downregulator', 'tail': 'TNF-alpha'} 
{'head': 'polyamine oxidase', 'type': 'subclass of', 'tail': 'oxidase'} 	 {'head': 'flavin', 'type': 'Part_of', 'tail': 'spermine oxidase'} 
{'head': 'tirofiban', 'type': 'subject has role', 'tail': 'inhibitor'} 	 {'head': 'ADP', 'type': 'Upregulator', 'tail': 'CD62P'} 
{'head': 'alpha-chloroenethiolate', 'type': 'subject has role', 'tail': 'nephrotoxic'} 	 {'head': 'cysteine S-conjugates', 'type': 'Substrate', 'tail': 'beta-lyases'} 
{'head': 'carnitine transporter', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'carnitine', 'type': 'Substrate', 'tail': 'Octn2'} 
{'head': 'organic cation transporter', 'type': 'subclass of', 'tail': 'mRNA'} 	 {'head': 'noradrenaline', 'type': 'Substrate', 'tail': 'noradrenaline transporter'} 
{'head': 'selegiline', 'type': 'medical condition treated', 'tail': "Parkinson's disease"} 	 {'head': '(-)deprenyl', 'type': 'Downregulator', 'tail': 'type B monoamine oxidase'} 
{'head': 'pharmacokinetics', 'type': 'studied by', 'tail': 'pharmacokinetic'} 	 {'head': 'PBZ', 'type': 'Regulator', 'tail': 'cyclo-oxygenase'} 
{'head': 'aprepitant', 'type': 'subject has role', 'tail': 'NK-1 receptor antagonist'} 	 {'head': 'aprepitant', 'type': 'Antagonist', 'tail': 'substance P (SP) receptor'} 
{'head': 'prolactin', 'type': 'part of', 'tail': 'pituitary'} 	 {'head': 'sodium', 'type': 'Regulator', 'tail': 'bFGF'} 
{'head': 'RhBG', 'type': 'subclass of', 'tail': 'ammonium transporter'} 	 {'head': 'thiazide', 'type': 'Regulator', 'tail': 'RhBG'} 
{'head': 'sildenafil', 'type': 'medical condition treated', 'tail': 'erectile dysfunction'} 	 {'head': 'cGMP', 'type': 'Downregulator', 'tail': 'PDE5'} 
{'head': 'beta subunit', 'type': 'part of', 'tail': 'cDNA'} 	 {'head': 'ivermectin', 'type': 'Not', 'tail': 'HG1E'} 
{'head': 'yohimbine', 'type': 'subject has role', 'tail': 'antagonist'} 	 {'head': 'Yohimbine', 'type': 'Regulator', 'tail': 'human alpha 2C-adrenoceptor'} 
{'head': 'IL-3', 'type': 'subclass of', 'tail': 'cytokines'} 	 {'head': 'imiquimod', 'type': 'Regulator', 'tail': 'cytokines'} 
{'head': 'apoptosis', 'type': 'subclass of', 'tail': 'cell death'} 	 {'head': 'sodium arsenite', 'type': 'Upregulator', 'tail': 'heat shock proteins'} 
{'head': 'GW660511X', 'type': 'subject has role', 'tail': 'ACE/NEP inhibitor'} 	 {'head': 'GW660511X', 'type': 'Not', 'tail': 'BrBK4-8'} 
{'head': 'rivastigmine', 'type': 'medical condition treated', 'tail': "Alzheimer's disease"} 	 {'head': 'acetylcholine', 'type': 'Substrate', 'tail': 'AChE'} 
{'head': 'cyclophosphamide', 'type': 'medical condition treated', 'tail': "non-Hodgkin's lymphoma"} 	 {'head': 'eicosapentaenoic acid', 'type': 'Regulator', 'tail': 'cyclin D1'} 
{'head': 'phrenic nerve', 'type': 'part of', 'tail': 'central nervous system'} 	 {'head': 'losartan', 'type': 'Antagonist', 'tail': 'Angiotensin AT1 receptor'} 
{'head': 'azoxymethane', 'type': 'subject has role', 'tail': 'cell growth inhibitor'} 	 {'head': 'azoxymethane', 'type': 'Regulator', 'tail': 'transforming growth factor-beta1'} 
{'head': 'ORL1', 'type': 'subclass of', 'tail': 'opioid receptor'} 	 {'head': 'GTPgammaS', 'type': 'Regulator', 'tail': 'ORL1'} 
{'head': 'arachidonic acid', 'type': 'instance of', 'tail': 'eicosanoid'} 	 {'head': 'LTC4', 'type': 'Substrate', 'tail': 'gIV-PLA2'} 
{'head': 'tazarotenic acid', 'type': 'subclass of', 'tail': 'acetylenic retinoid'} 	 {'head': 'Tazarotene', 'type': 'Regulator', 'tail': 'retinoid receptors'} 
{'head': 'salbutamol', 'type': 'subject has role', 'tail': 'beta 2-adrenoceptor agonist'} 	 {'head': 'clenbuterol', 'type': 'Not', 'tail': 'beta-adrenoceptors'} 
{'head': 'idazoxan', 'type': 'subject has role', 'tail': 'antinociception'} 	 {'head': 'UK 14,304', 'type': 'Agonist', 'tail': 'alpha 2-adrenoceptor'} 
{'head': 'pyruvate', 'type': 'has part', 'tail': 'ammonia'} 	 {'head': "pyridoxal 5'-phosphate", 'type': 'Cofactor', 'tail': 'SDH'} 
{'head': 'Ras', 'type': 'subclass of', 'tail': 'GTPase'} 	 {'head': 'GW572016', 'type': 'Downregulator', 'tail': 'Ras'} 
{'head': 'Isoprenaline', 'type': 'subject has role', 'tail': 'selective beta(1)-adrenoceptor antagonist'} 	 {'head': '(+/-)-[4-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-1,3-dihydro-2H-benzimida zol-2-one] hydrochloride', 'type': 'Agonist', 'tail': 'beta(3)-adrenoceptor'} 
{'head': 'imipramine', 'type': 'subject has role', 'tail': 'inhibitor'} 	 {'head': 'catecholamines', 'type': 'Regulator', 'tail': 'norepinephrine transporter'} 
{'head': 'beta1-receptor antagonist', 'type': 'opposite of', 'tail': 'agonists'} 	 {'head': 'epinephrine', 'type': 'Agonist', 'tail': 'human beta-adrenergic receptors'} 
{'head': 'myocytes', 'type': 'has part', 'tail': 'ventricular'} 	 {'head': 'isoproterenol', 'type': 'Regulator', 'tail': 'beta1AR'} 
{'head': 'flurbiprofen', 'type': 'subject has role', 'tail': 'nonsteroidal anti-inflammatory drug'} 	 {'head': '2-aryl propionic acid', 'type': 'Downregulator', 'tail': 'cyclooxygenase'} 
{'head': 'EGFR', 'type': 'subclass of', 'tail': 'epidermal growth factor receptor'} 	 {'head': 'GW572016', 'type': 'Not', 'tail': 'ERK'} 
{'head': 'Metformin', 'type': 'medical condition treated', 'tail': 'type 2 diabetes'} 	 {'head': 'Metformin', 'type': 'Regulator', 'tail': 'AMP-activated protein kinase'} 
{'head': "Burkitt's lymphoma receptor 1", 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'retinoic acid', 'type': 'Upregulator', 'tail': 'BLR1'} 
{'head': 'nisoxetine', 'type': 'subject has role', 'tail': 'NET inhibitor'} 	 {'head': 'desipramine', 'type': 'Downregulator', 'tail': 'norepinephrine transporter'} 
{'head': 'hydrochlorothiazide', 'type': 'subject has role', 'tail': 'diuretic'} 	 {'head': 'Irbesartan', 'type': 'Regulator', 'tail': 'AT1'} 
{'head': '(-)-isoprenaline', 'type': 'subject has role', 'tail': 'beta-blockers'} 	 {'head': '(-)-[3H]-CGP12177', 'type': 'Regulator', 'tail': 'human beta 1-adrenoceptors'} 
{'head': 'Imiquimod', 'type': 'subject has role', 'tail': 'activator of Toll-like receptor-7'} 	 {'head': 'Imiquimod', 'type': 'Upregulator', 'tail': 'Toll-like receptor-7'} 
{'head': 'mesenteric artery', 'type': 'has part', 'tail': 'c-Jun'} 	 {'head': 'irbesartan', 'type': 'Upregulator', 'tail': 'Ang II'} 
{'head': 'norepinephrine transporter blockade', 'type': 'facet of', 'tail': 'norepinephrine (NE) transporter'} 	 {'head': 'duloxetine', 'type': 'Regulator', 'tail': 'human NET'} 
{'head': 'Auranofin', 'type': 'subject has role', 'tail': 'inhibitor'} 	 {'head': 'Auranofin', 'type': 'Downregulator', 'tail': 'glutathione peroxidase'} 
{'head': 'trivalent', 'type': 'subclass of', 'tail': 'oxidation state'} 	 {'head': 'gallium', 'type': 'Regulator', 'tail': 'transferrin'} 
{'head': 'levetiracetam', 'type': 'subject has role', 'tail': 'antiepileptic'} 	 {'head': 'levetiracetam', 'type': 'Regulator', 'tail': 'synaptic vesicle protein SV2A'} 
{'head': 'GABA receptor', 'type': 'has part', 'tail': 'GABAA'} 	 {'head': 'GABA', 'type': 'Regulator', 'tail': 'GABA binding sites'} 
{'head': 'ROI', 'type': 'part of', 'tail': 'brain'} 	 {'head': '[(11)C]-doxepin', 'type': 'Regulator', 'tail': 'histamine H1 receptor'} 
{'head': 'cetirizine', 'type': 'subject has role', 'tail': 'histamine H1-receptor antagonist'} 	 {'head': 'fexofenadine', 'type': 'Regulator', 'tail': 'histamine H1-receptor'} 
{'head': 'fexofenadine', 'type': 'subject has role', 'tail': 'histamine H1-receptor antagonist'} 	 {'head': 'fexofenadine', 'type': 'Antagonist', 'tail': 'histamine H1-receptor'} 
{'head': 'DNA synthesis', 'type': 'subclass of', 'tail': 'precursors'} 	 {'head': '5-fluorouracil', 'type': 'Regulator', 'tail': 'Thymidylate synthase'} 
{'head': 'Sibutramine', 'type': 'medical condition treated', 'tail': 'hypertension'} 	 {'head': 'Orlistat', 'type': 'Downregulator', 'tail': 'pancreatic lipase'} 
{'head': 'Bsep', 'type': 'instance of', 'tail': 'protein'} 	 {'head': 'Troglitazone', 'type': 'Downregulator', 'tail': 'bile salt export pump'} 
{'head': 'Valdecoxib', 'type': 'subject has role', 'tail': 'COX-2 inhibitor'} 	 {'head': 'Valdecoxib', 'type': 'Regulator', 'tail': 'cyclooxygenase-2'} 
{'head': 'telmisartan', 'type': 'subject has role', 'tail': 'angiotensin II AT1 receptor antagonist'} 	 {'head': 'telmisartan', 'type': 'Upregulator', 'tail': 'GLUT4'} 
{'head': 'asthma', 'type': 'drug used for treatment', 'tail': 'albuterol'} 	 {'head': 'albuterol', 'type': 'Regulator', 'tail': 'beta(2)-adrenergic receptor'} 
{'head': 'kojic acid', 'type': 'subclass of', 'tail': 'tyrosinase'} 	 {'head': 'kojic acid', 'type': 'Downregulator', 'tail': 'tyrosinase'} 
{'head': 'TT-235', 'type': 'subject has role', 'tail': 'Oxytocin antagonist'} 	 {'head': 'TT-235', 'type': 'Regulator', 'tail': 'oxytocin receptor'} 
{'head': 'COX-2', 'type': 'has part', 'tail': 'COX-1'} 	 {'head': 'lumiracoxib', 'type': 'Not', 'tail': 'COX-1'} 
{'head': 'promoter', 'type': 'part of', 'tail': 'protein'} 	 {'head': 'thiamine', 'type': 'Substrate', 'tail': 'PP20'} 
{'head': 'Denufosol tetrasodium', 'type': 'medical condition treated', 'tail': 'cystic fibrosis'} 	 {'head': 'denufosol tetrasodium', 'type': 'Agonist', 'tail': 'P2Y2 receptor'} 
{'head': 'dimemorfan', 'type': 'subject has role', 'tail': 'neuroprotective'} 	 {'head': 'dextromethorphan', 'type': 'Regulator', 'tail': 'sigma1 receptor'} 
{'head': 'V2 vasopressin receptor', 'type': 'instance of', 'tail': 'receptor'} 	 {'head': 'barusiban', 'type': 'Regulator', 'tail': 'vasopressin V2 receptor'} 
{'head': 'DNA methyltransferase 1', 'type': 'subject has role', 'tail': 'transcription'} 	 {'head': "5'-azacytidine", 'type': 'Downregulator', 'tail': 'DNMT1'} 
{'head': "5-iodo-2'-deoxyuridine", 'type': 'instance of', 'tail': 'analogue'} 	 {'head': 'fluoropyrimidine', 'type': 'Downregulator', 'tail': 'thymidylate synthase'} 
{'head': 'cetuximab', 'type': 'medical condition treated', 'tail': 'sarcoma'} 	 {'head': 'imatinib mesylate', 'type': 'Regulator', 'tail': 'heparin-binding EGF-like growth factor'} 
{'head': 'PDGFRA', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'STI 571', 'type': 'Regulator', 'tail': 'PDGFRA'} 
{'head': 'beta 2', 'type': 'subclass of', 'tail': 'polypeptide'} 	 {'head': 'ethanol', 'type': 'Substrate', 'tail': 'ADH2'} 
{'head': 'interleukin (IL)-18', 'type': 'part of', 'tail': 'cytokine cascade'} 	 {'head': 'Simvastatin', 'type': 'Upregulator', 'tail': 'interleukin-18'} 
{'head': 'meloxicam', 'type': 'subject has role', 'tail': 'NSAIDs'} 	 {'head': 'phenylbutazone', 'type': 'Downregulator', 'tail': 'cyclooxygenases'} 
{'head': 'Carvedilol', 'type': 'subject has role', 'tail': 'beta-blockers'} 	 {'head': 'Carvedilol', 'type': 'Downregulator', 'tail': 'hypoxia-inducible factor-1alpha'} 
{'head': 'Imatinib', 'type': 'medical condition treated', 'tail': 'chronic myelogenous leukemia'} 	 {'head': 'Imatinib', 'type': 'Downregulator', 'tail': 'KIT'} 
{'head': 'mast cell', 'type': 'subclass of', 'tail': 'leukocytes'} 	 {'head': '4-methylhistamine', 'type': 'Regulator', 'tail': 'H(4)R'} 
{'head': 'Irinotecan', 'type': 'medical condition treated', 'tail': 'carcinoma'} 	 {'head': 'Irinotecan', 'type': 'Downregulator', 'tail': 'DNA topoisomerase I'} 
{'head': 'pyridoxamine', 'type': 'instance of', 'tail': 'pyridoxal'} 	 {'head': 'roscovitine', 'type': 'Regulator', 'tail': 'pyridoxal kinase'} 
{'head': 'isoproterenol', 'type': 'subject has role', 'tail': 'beta-adrenergic agonist'} 	 {'head': 'PD153035', 'type': 'Downregulator', 'tail': 'mucin'} 
{'head': 'Losartan', 'type': 'medical condition treated', 'tail': 'heart failure'} 	 {'head': 'Losartan', 'type': 'Regulator', 'tail': 'AT(1) receptor'} 
{'head': 'macrophage', 'type': 'has part', 'tail': 'macrophage cell lines'} 	 {'head': 'amrinone', 'type': 'Upregulator', 'tail': 'TNF'} 
{'head': 'stratum pyramidale', 'type': 'part of', 'tail': 'gerbil hippocampus'} 	 {'head': "pyridoxal 5'-phosphate", 'type': 'Substrate', 'tail': 'PLK'} 
{'head': 'p-trifluoromethoxyphenylhydrazone', 'type': 'subject has role', 'tail': 'protonophore'} 	 {'head': 'alpha-cyano-4-hydroxycinnamic acid', 'type': 'Downregulator', 'tail': 'monocarboxylate transporter'} 
{'head': 'olmesartan medoxomil', 'type': 'subject has role', 'tail': 'angiotensin receptor blocker'} 	 {'head': 'olmesartan medoxomil', 'type': 'Regulator', 'tail': 'AT1'} 
{'head': 'ONO-5046', 'type': 'subject has role', 'tail': 'neutrophil elastase inhibitor'} 	 {'head': 'ONO-5046', 'type': 'Downregulator', 'tail': 'neutrophil elastase'} 
{'head': 'Miglustat', 'type': 'medical condition treated', 'tail': 'lysosomal storage disorder'} 	 {'head': 'Miglustat', 'type': 'Downregulator', 'tail': 'glucosylceramide synthase'} 
{'head': 'galantamine', 'type': 'subject has role', 'tail': 'nicotinic receptor'} 	 {'head': 'galantamine', 'type': 'Not', 'tail': 'nicotinic receptors'} 
{'head': 'RAR-alpha', 'type': 'subclass of', 'tail': 'nuclear receptor'} 	 {'head': 'retinoic acid', 'type': 'Regulator', 'tail': 'RAR-alpha'} 
{'head': 'phorbol 12-myristate 13-acetate', 'type': 'subclass of', 'tail': 'Protein kinase C'} 	 {'head': 'fenoterol', 'type': 'Downregulator', 'tail': 'beta(2)-adrenoceptor'} 
{'head': 'Cetuximab', 'type': 'medical condition treated', 'tail': 'colorectal cancer'} 	 {'head': 'quinazoline', 'type': 'Downregulator', 'tail': 'EGFR'} 
{'head': 'alpha-(methylamino)isobutyric acid', 'type': 'instance of', 'tail': 'amino acid'} 	 {'head': 'amino acids', 'type': 'Part_of', 'tail': 'human PAT1'} 
{'head': 'interferon-gamma', 'type': 'subclass of', 'tail': 'cytokine'} 	 {'head': 'reboxetine', 'type': 'Regulator', 'tail': 'IL-10'} 
{'head': 'Cyproheptadine', 'type': 'subject has role', 'tail': 'antihistamine'} 	 {'head': 'amino acid', 'type': 'Part_of', 'tail': 'Leptin'} 
{'head': 'Captopril', 'type': 'subject has role', 'tail': 'ACE inhibitor'} 	 {'head': 'captopril', 'type': 'Downregulator', 'tail': 'ACE'} 
{'head': 'sorafenib', 'type': 'subject has role', 'tail': 'multikinase inhibitor'} 	 {'head': 'Sorafenib', 'type': 'Downregulator', 'tail': 'Raf-1'} 
{'head': 'lung metastasis', 'type': 'subclass of', 'tail': 'metastasis'} 	 {'head': 'bexarotene', 'type': 'Regulator', 'tail': 'vascular endothelial growth factor'} 
{'head': 'dysmenorrhea', 'type': 'drug used for treatment', 'tail': 'vasopressin'} 	 {'head': 'atosiban', 'type': 'Downregulator', 'tail': 'vasopressin'} 
{'head': '5-fluorouracil', 'type': 'medical condition treated', 'tail': 'pancreatic cancer'} 	 {'head': '5-fluorouracil', 'type': 'Regulator', 'tail': 'Thymidylate synthase'} 
{'head': 'proline', 'type': 'subclass of', 'tail': 'residues'} 	 {'head': "pyridoxal 5'-phosphate", 'type': 'Cofactor', 'tail': 'SDH'} 
{'head': 'acetylcholinesterase inhibitor', 'type': 'subclass of', 'tail': 'inhibitors'} 	 {'head': 'histamine', 'type': 'Substrate', 'tail': 'N-methyltransferase'} 
{'head': 'Combination chemotherapy', 'type': 'subclass of', 'tail': 'chemotherapy'} 	 {'head': 'sorafenib', 'type': 'Downregulator', 'tail': 'BRAF'} 
{'head': 'Drs2', 'type': 'instance of', 'tail': 'protein'} 	 {'head': 'PS', 'type': 'Upregulator', 'tail': 'ATPase'} 
{'head': 'N-methyl-D-asparate', 'type': 'subclass of', 'tail': 'Glutamate receptor'} 	 {'head': 'Memantine', 'type': 'Regulator', 'tail': 'NMDA receptor'} 
{'head': 'Sorafenib', 'type': 'subject has role', 'tail': 'small-molecule inhibitor'} 	 {'head': 'Sorafenib', 'type': 'Downregulator', 'tail': 'tyrosine kinases'} 
{'head': 'Hydrogen sulfide', 'type': 'subject has role', 'tail': 'vasodilator'} 	 {'head': 'Hydrogen sulfide', 'type': 'Regulator', 'tail': 'heme oxygenase-1'} 
{'head': 'urea', 'type': 'has part', 'tail': 'urea'} 	 {'head': 'L-arg', 'type': 'Substrate', 'tail': 'argininosuccinate synthetase'} 
{'head': 'vasopressin', 'type': 'subject has role', 'tail': 'antidiuretic'} 	 {'head': 'VPA-985', 'type': 'Antagonist', 'tail': 'vasopressin receptor'} 
{'head': 'dimethindene', 'type': 'subclass of', 'tail': 'histamine'} 	 {'head': 'chlorpheniramine', 'type': 'Antagonist', 'tail': 'histamine H1-receptor'} 
{'head': 'DNA polymerase beta inhibitor', 'type': 'subject has role', 'tail': 'inhibitor of DNA polymerase'} 	 {'head': 'cytosine arabinoside-3-phosphate', 'type': 'Downregulator', 'tail': 'DNA polymerase beta'} 
{'head': 'chlorpromazine', 'type': 'subject has role', 'tail': 'antipsychotic'} 	 {'head': 'nucleotide', 'type': 'Part_of', 'tail': 'Ser311Cys'} 
{'head': 'calpain', 'type': 'subclass of', 'tail': 'cysteine protease'} 	 {'head': 'N', 'type': 'Part_of', 'tail': 'GAD65(Delta1-69)'} 
{'head': 'sorafenib', 'type': 'medical condition treated', 'tail': 'melanoma'} 	 {'head': 'sorafenib', 'type': 'Regulator', 'tail': 'BRAF'} 
{'head': 'candesartan', 'type': 'subject has role', 'tail': 'AT1-receptor blocker'} 	 {'head': 'candesartan', 'type': 'Downregulator', 'tail': 'AT(1)'} 
{'head': 'phosphatidic acid', 'type': 'has part', 'tail': 'Diacylglycerol'} 	 {'head': 'Diacylglycerol', 'type': 'Modulator', 'tail': 'protein kinase C'} 
{'head': 'Monoclonal antibody 25B1', 'type': 'instance of', 'tail': 'monoclonal antibody'} 	 {'head': 'diisopropyl phosphorofluoridate', 'type': 'Downregulator', 'tail': 'bovine serum acetylcholinesterase'} 
{'head': 'methyl groups', 'type': 'use', 'tail': 'DNA methylation'} 	 {'head': 'folate', 'type': 'Regulator', 'tail': 'C677T'} 
{'head': 'amphotericin B', 'type': 'subject has role', 'tail': 'antifungal drug'} 	 {'head': 'azole', 'type': 'Regulator', 'tail': 'cytochrome P-450'} 
{'head': 'D-myo-inositol', 'type': 'has part', 'tail': 'phosphate'} 	 {'head': 'D-myo-inositol 1-phosphate', 'type': 'Regulator', 'tail': 'G protein-coupled receptor'} 
{'head': 'Glyoxylate', 'type': 'instance of', 'tail': 'glycose'} 	 {'head': 'glycine', 'type': 'Substrate', 'tail': 'alanine-glyoxylate aminotransferase'} 
{'head': 'Cortisol metabolism in hypertension', 'type': 'has effect', 'tail': 'hypertension'} 	 {'head': 'cortisone', 'type': 'Regulator', 'tail': 'glucocorticoid receptor'} 
{'head': 'retinol', 'type': 'part of', 'tail': 'retinoic acid synthesis'} 	 {'head': 'retinoic acid', 'type': 'Upregulator', 'tail': 'CD1d'} 
{'head': 'Ramelteon', 'type': 'medical condition treated', 'tail': 'insomnia'} 	 {'head': 'Ramelteon', 'type': 'Agonist', 'tail': 'MT1'} 
{'head': 'quercetin', 'type': 'subject has role', 'tail': 'antioxidant'} 	 {'head': 'resveratrol', 'type': 'Downregulator', 'tail': 'VGSC'} 
{'head': 'amrubicin', 'type': 'subject has role', 'tail': 'topoisomerase II inhibitor'} 	 {'head': 'amrubicin', 'type': 'Downregulator', 'tail': 'topoisomerase II'} 
{'head': 'peptic ulcer disease', 'type': 'has cause', 'tail': 'Helicobacter pylori'} 	 {'head': 'aspirin', 'type': 'Not', 'tail': 'COX-1'} 
{'head': 'pemetrexed', 'type': 'subject has role', 'tail': 'antifolate'} 	 {'head': 'adenine', 'type': 'Substrate', 'tail': 'Methylthioadenosine phosphorylase'} 
{'head': 'thiazolidinediones', 'type': 'medical condition treated', 'tail': 'type 2 diabetes'} 	 {'head': 'Sulfonylureas', 'type': 'Regulator', 'tail': 'peroxisome proliferator-activated receptor gamma'} 
{'head': 'PDE4B', 'type': 'subclass of', 'tail': 'phosphodiesterase'} 	 {'head': 'cyclic adenosine monophosphate', 'type': 'Regulator', 'tail': 'protein kinase A'} 
{'head': 'Her-2/neu', 'type': 'instance of', 'tail': 'oncogene'} 	 {'head': 'doxorubicin', 'type': 'Upregulator', 'tail': 'FAS promoter'} 
{'head': 'alpha', 'type': 'subclass of', 'tail': 'estrogen receptor'} 	 {'head': 'Mifepristone', 'type': 'Regulator', 'tail': 'steroid receptors'} 
{'head': 'polyprimidine tract-binding protein', 'type': 'instance of', 'tail': 'protein'} 	 {'head': 'glucose', 'type': 'Upregulator', 'tail': 'insulin'} 
{'head': 'neurons', 'type': 'part of', 'tail': 'brain'} 	 {'head': 'N-methyl-D-aspartate', 'type': 'Regulator', 'tail': 'Cysteinyl leukotriene receptor 1'} 
{'head': 'paclitaxel', 'type': 'medical condition treated', 'tail': 'breast cancer'} 	 {'head': 'serine', 'type': 'Part_of', 'tail': 'Fas-associated death domain-containing protein'} 
{'head': 'carvedilol', 'type': 'subject has role', 'tail': 'antihypertensive'} 	 {'head': 'racemic carvedilol', 'type': 'Antagonist', 'tail': 'beta adrenoceptor'} 
{'head': 'inflammation', 'type': 'subclass of', 'tail': 'symptoms'} 	 {'head': 'alosetron', 'type': 'Antagonist', 'tail': '5-HT3 receptor'} 
{'head': 'SH3 domain', 'type': 'part of', 'tail': 'receptor'} 	 {'head': 'progesterone', 'type': 'Regulator', 'tail': 'progesterone receptor'} 
{'head': 'picrotoxin', 'type': 'subject has role', 'tail': 'gamma-aminobutyric acid receptor antagonist'} 	 {'head': 'picrotoxin', 'type': 'Antagonist', 'tail': 'gamma-aminobutyric acid receptor'} 
{'head': 'positron emission tomography', 'type': 'subclass of', 'tail': 'in vivo imaging'} 	 {'head': "carbon-11 labeled 2beta-carbomethoxy-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes", 'type': 'Regulator', 'tail': 'serotonin transporter'} 
{'head': 'hydrochlorothiazide', 'type': 'subject has role', 'tail': 'diuretic'} 	 {'head': 'olmesartan medoxomil', 'type': 'Antagonist', 'tail': 'AT1 receptor'} 
{'head': 'S100P', 'type': 'instance of', 'tail': 'protein family'} 	 {'head': 'gemcitabine', 'type': 'Regulator', 'tail': 'S100P'} 
{'head': 'protein', 'type': 'has part', 'tail': 'amino acid'} 	 {'head': 'pyridoxal phosphate', 'type': 'Cofactor', 'tail': 'mammalian Sec synthase'} 
{'head': 'Triflusal', 'type': 'subclass of', 'tail': 'cyclooxygenase-2'} 	 {'head': 'Triflusal', 'type': 'Not', 'tail': 'GFAP'} 
{'head': 'GRIP1', 'type': 'instance of', 'tail': 'protein'} 	 {'head': 'Glutamate', 'type': 'Regulator', 'tail': 'GluR2'} 
{'head': 'asthma', 'type': 'subclass of', 'tail': 'inflammatory airway disorders'} 	 {'head': 'leukotriene D4', 'type': 'Upregulator', 'tail': 'mucin'} 
{'head': 'crossover design', 'type': 'subclass of', 'tail': 'clinical trial'} 	 {'head': 'isoflavone', 'type': 'Not', 'tail': 'ABCA1'} 
{'head': 'Sorafenib', 'type': 'medical condition treated', 'tail': 'renal cell carcinoma'} 	 {'head': 'sorafenib', 'type': 'Not', 'tail': 'KIT'} 
{'head': 'cortisol', 'type': 'subject has role', 'tail': 'glucocorticoid'} 	 {'head': 'mifepristone', 'type': 'Antagonist', 'tail': 'glucocorticoid receptor'} 
{'head': 'aspirin', 'type': 'subject has role', 'tail': 'anti-inflammatory drug'} 	 {'head': 'aspirin', 'type': 'Downregulator', 'tail': 'NF-kappaB'} 
{'head': 'nephron', 'type': 'part of', 'tail': 'rat kidney'} 	 {'head': 'nicotinamide-adenine dinucleotide phosphate', 'type': 'Regulator', 'tail': '11 beta hydroxysteroid dehydrogenase'} 
{'head': 'Fluoxetine', 'type': 'subject has role', 'tail': 'selective serotonin reuptake inhibitor'} 	 {'head': 'Fluoxetine', 'type': 'Not', 'tail': 'hSERT'} 
{'head': 'Anti-CD11a', 'type': 'instance of', 'tail': 'monoclonal antibody'} 	 {'head': 'acetylcholine', 'type': 'Substrate', 'tail': 'choline acetyltransferase'} 
{'head': 'breast cancer', 'type': 'subclass of', 'tail': 'carcinogen'} 	 {'head': 'Medroxyprogesterone acetate', 'type': 'Upregulator', 'tail': 'PR'} 
{'head': 'gene expression', 'type': 'part of', 'tail': 'gene'} 	 {'head': 'estrogen', 'type': 'Upregulator', 'tail': 'X-inactive-specific transcript'} 
{'head': 'macrophage', 'type': 'subclass of', 'tail': 'monocytes'} 	 {'head': 'Monosodium urate', 'type': 'Regulator', 'tail': 'NALP3'} 
{'head': 'active site', 'type': 'part of', 'tail': 'structural'} 	 {'head': 'suramin', 'type': 'Regulator', 'tail': 'human SIRT5'} 
{'head': 'Hyperhomocyst(e)inemia', 'type': 'subclass of', 'tail': 'hypomorph'} 	 {'head': 'methyltetrahydrofolate', 'type': 'Substrate', 'tail': 'methionine synthase'} 
{'head': 'Metformin', 'type': 'instance of', 'tail': 'biguanide'} 	 {'head': 'Metformin', 'type': 'Upregulator', 'tail': 'AMPK'} 
{'head': '5-hydroxytryptamine', 'type': 'subclass of', 'tail': 'serotonin'} 	 {'head': '[125I]iodocyanopindolol', 'type': 'Regulator', 'tail': '5-hydroxytryptamine1B'} 
{'head': 'clozapine', 'type': 'subject has role', 'tail': 'antipsychotic'} 	 {'head': 'clozapine', 'type': 'Regulator', 'tail': 'H(1)'} 
{'head': 'phosphatidylcholine', 'type': 'subclass of', 'tail': 'phospholipid'} 	 {'head': 'ethanol', 'type': 'Not', 'tail': 'PtdSer synthase 1'} 
{'head': 'alanine', 'type': 'instance of', 'tail': 'amino acid'} 	 {'head': 'amino acid', 'type': 'Substrate', 'tail': 'alanine aminotransferase'} 
{'head': 'p42/44', 'type': 'subclass of', 'tail': 'mitogen-activated protein kinases'} 	 {'head': 'D-glucose', 'type': 'Regulator', 'tail': 'type II TGF-beta receptors'} 
{'head': 'HaCaT', 'type': 'subclass of', 'tail': 'keratinocyte'} 	 {'head': 'n-3 and n-6 polyunsaturated fatty acids', 'type': 'Upregulator', 'tail': 'PPARgamma'} 
{'head': 'arformoterol tartrate', 'type': 'subject has role', 'tail': 'beta(2)-adrenergic agonist'} 	 {'head': 'arformoterol tartrate', 'type': 'Agonist', 'tail': 'beta(2)-adrenergic'} 
{'head': 'mitochondria', 'type': 'subclass of', 'tail': 'cell'} 	 {'head': 'fatty acid', 'type': 'Substrate', 'tail': 'ACC1'} 
{'head': 'retinoic acid', 'type': 'subclass of', 'tail': 'vitamin A'} 	 {'head': 'RA', 'type': 'Substrate', 'tail': 'Cyp26A1'} 
{'head': 'glucagon-like peptide-1', 'type': 'subject has role', 'tail': 'glucoregulatory'} 	 {'head': 'glucose', 'type': 'Regulator', 'tail': 'glucagon'} 
{'head': 'Aripiprazole', 'type': 'medical condition treated', 'tail': 'schizophrenia'} 	 {'head': 'aripiprazole', 'type': 'Not', 'tail': '5-HT receptors'} 
{'head': 'Mitotane', 'type': 'subject has role', 'tail': 'steroidogenesis inhibitor'} 	 {'head': "Mifepriston'e", 'type': 'Downregulator', 'tail': 'glucocorticoid receptor'} 
{'head': 'paraventricular nucleus', 'type': 'part of', 'tail': 'hypothalamus'} 	 {'head': 'N-(piperidin-1-yl)-5-(4-chlorophenyl)-4-methyl-1H-pyrazole-3-carboxyamide', 'type': 'Antagonist', 'tail': 'cannabinoid CB1 receptor'} 
{'head': 'amyloid', 'type': 'subclass of', 'tail': 'protein'} 	 {'head': 'SB203580', 'type': 'Downregulator', 'tail': 'p38'} 
{'head': 'RDH12', 'type': 'subclass of', 'tail': 'retinol dehydrogenase'} 	 {'head': 'androstanediol', 'type': 'Substrate', 'tail': 'human type 12 RDH'} 
{'head': 'sibutramine', 'type': 'subject has role', 'tail': 'serotonin'} 	 {'head': 'sibutramine', 'type': 'Regulator', 'tail': 'SLC6A4'} 
{'head': 'N-terminal', 'type': 'part of', 'tail': 'mRNA'} 	 {'head': 'N', 'type': 'Part_of', 'tail': 'rat brain calpastatin'} 
{'head': 'histamine H3 receptor antagonist', 'type': 'subclass of', 'tail': 'chiral drug'} 	 {'head': 'GT-2331', 'type': 'Regulator', 'tail': 'histamine H3 receptor'} 
{'head': 'vecuronium', 'type': 'subject has role', 'tail': 'neuromuscular blocker'} 	 {'head': 'vecuronium', 'type': 'Downregulator', 'tail': 'human muscarinic M2 receptors'} 
{'head': 'melanocyte', 'type': 'part of', 'tail': 'epidermal'} 	 {'head': 'Hydrogen peroxide', 'type': 'Regulator', 'tail': 'calmodulin'} 
{'head': 'catalyzes', 'type': 'subclass of', 'tail': 'enzyme'} 	 {'head': 'nitrosyl', 'type': 'Regulator', 'tail': 'mouse cysteine dioxygenase'} 
{'head': 'PPARalpha1', 'type': 'subclass of', 'tail': 'peroxisome proliferator-activated receptor'} 	 {'head': 'Wy-14643', 'type': 'Regulator', 'tail': 'PPARalpha2'} 
{'head': 'human African trypanosomiasis', 'type': 'drug used for treatment', 'tail': 'melarsoprol'} 	 {'head': 'aprepitant', 'type': 'Antagonist', 'tail': 'substance P receptor'} 
{'head': 'promoter', 'type': 'part of', 'tail': 'protein'} 	 {'head': 'amino acids', 'type': 'Part_of', 'tail': '36-kDa water-soluble protein'} 
{'head': 'nitric oxide', 'type': 'has part', 'tail': 'phosphate'} 	 {'head': 'dimethylarginine', 'type': 'Substrate', 'tail': 'DDAH'} 
{'head': 'trastuzumab', 'type': 'instance of', 'tail': 'humanized antibody'} 	 {'head': 'doxorubicin', 'type': 'Regulator', 'tail': 'HER2'} 
{'head': 'NMDA receptor', 'type': 'has part', 'tail': 'N-methyl-d-aspartate'} 	 {'head': '(5S,10R)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,b]cyclohepten-5,10-imine', 'type': 'Antagonist', 'tail': 'NMDA receptor'} 
{'head': 'Desvenlafaxine succinate', 'type': 'medical condition treated', 'tail': 'major depressive disorder'} 	 {'head': 'Desvenlafaxine succinate', 'type': 'Antagonist', 'tail': 'hNET'} 
{'head': 'Lp(a) lipoprotein', 'type': 'instance of', 'tail': 'lipoprotein'} 	 {'head': 'Arg', 'type': 'Part_of', 'tail': 'Lp(a)'} 
{'head': 'sorafenib', 'type': 'medical condition treated', 'tail': 'renal cell carcinoma'} 	 {'head': 'Sorafenib', 'type': 'Downregulator', 'tail': 'VEGFR-2'} 
{'head': 'Oral administration of acitretin', 'type': 'subclass of', 'tail': 'topical use'} 	 {'head': 'retinoids', 'type': 'Regulator', 'tail': 'retinoic acid receptors'} 
{'head': 'Rasagiline', 'type': 'medical condition treated', 'tail': "Parkinson's disease"} 	 {'head': 'rasagiline', 'type': 'Not', 'tail': 'MAO-B'} 
{'head': 'camptothecin', 'type': 'subject has role', 'tail': 'anti-cancer drug'} 	 {'head': 'camptothecin', 'type': 'Regulator', 'tail': 'Top1p'} 
{'head': 'prostacyclin synthase', 'type': 'product or material produced', 'tail': 'prostacyclin'} 	 {'head': 'prostaglandin H2', 'type': 'Regulator', 'tail': 'prostacyclin (PGI2) synthase'} 
{'head': 'idraparinux', 'type': 'subject has role', 'tail': 'anticoagulant'} 	 {'head': 'rivaroxaban', 'type': 'Downregulator', 'tail': 'factor Xa'} 
{'head': 'Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD', 'type': 'instance of', 'tail': 'randomized controlled trial'} 	 {'head': 'cilazapril', 'type': 'Downregulator', 'tail': 'ACE'} 
{'head': 'TLR7', 'type': 'subclass of', 'tail': 'Toll-like receptor'} 	 {'head': 'imiquimod', 'type': 'Not', 'tail': 'TLR8'} 
{'head': '4-chloropropofol', 'type': 'instance of', 'tail': 'halogenated'} 	 {'head': 'halogenated propofol', 'type': 'Downregulator', 'tail': 'voltage-operated skeletal muscle and neuronal sodium channels'} 
{'head': 'Irbesartan', 'type': 'medical condition treated', 'tail': 'hypertension'} 	 {'head': 'Irbesartan', 'type': 'Antagonist', 'tail': 'angiotensin II receptor type 1'} 
{'head': 'raltitrexed', 'type': 'subject has role', 'tail': 'inhibitors of thymidylate synthase'} 	 {'head': 'thymidylate', 'type': 'Substrate', 'tail': 'thymidylate synthase'} 
{'head': 'Nicotinic acid', 'type': 'subject has role', 'tail': 'inhibitor'} 	 {'head': 'nicotinamide', 'type': 'Substrate', 'tail': 'Nicotinamide N-methyltransferase'} 
{'head': 'LTCC', 'type': 'subclass of', 'tail': 'L-type calcium channel'} 	 {'head': '1,4-dihydropyridine', 'type': 'Regulator', 'tail': 'LTCC'} 
{'head': 'bosutinib', 'type': 'subject has role', 'tail': 'kinase inhibitor'} 	 {'head': 'bosutinib', 'type': 'Not', 'tail': 'ABL'} 
{'head': 'microtubule-associated protein', 'type': 'subclass of', 'tail': 'domains'} 	 {'head': 'estramustine phosphate', 'type': 'Regulator', 'tail': 'MAPs'} 
{'head': 'diphosphopyridine nucleotide', 'type': 'instance of', 'tail': 'coenzyme'} 	 {'head': "5'-[p-(fluorosulfonyl)benzoyl]adenosine", 'type': 'Regulator', 'tail': 'human placental 3 beta-hydroxy-5-ene-steroid dehydrogenase'} 
{'head': 'Imatinib', 'type': 'medical condition treated', 'tail': 'chronic myelogenous leukemia'} 	 {'head': 'Imatinib', 'type': 'Downregulator', 'tail': 'kinase'} 
{'head': 'phenelzine', 'type': 'subject has role', 'tail': 'MAO inhibitor'} 	 {'head': 'phenelzine', 'type': 'Downregulator', 'tail': 'MAO'} 
{'head': 'Atomoxetine', 'type': 'medical condition treated', 'tail': 'attention-deficit hyperactivity disorder'} 	 {'head': 'Atomoxetine', 'type': 'Not', 'tail': 'neurotransmitter receptors'} 
{'head': 'hyperinsulinemia', 'type': 'subclass of', 'tail': 'hyperammonemia disorder'} 	 {'head': 'l-glutamate', 'type': 'Substrate', 'tail': 'Mammalian glutamate dehydrogenase'} 
{'head': 'peripheral inflammation', 'type': 'subclass of', 'tail': 'inflammation'} 	 {'head': 'prostaglandin E2', 'type': 'Substrate', 'tail': 'COX-2'} 
{'head': 'chlorethylclonidine', 'type': 'subject has role', 'tail': 'alpha 1-adrenoceptor antagonist'} 	 {'head': 'chlorethylclonidine', 'type': 'Antagonist', 'tail': 'alpha 1-adrenoceptor'} 
{'head': 'Ambrisentan', 'type': 'medical condition treated', 'tail': 'pulmonary arterial hypertension'} 	 {'head': 'Ambrisentan', 'type': 'Antagonist', 'tail': 'endothelin receptor'} 
{'head': 'oxaprozin', 'type': 'subject has role', 'tail': 'nonsteroidal anti-inflammatory drug'} 	 {'head': 'oxaprozin', 'type': 'Regulator', 'tail': 'cyclooxygenase-2'} 
{'head': 'dydrogesterone', 'type': 'subject has role', 'tail': 'progestogen'} 	 {'head': 'progestogens', 'type': 'Downregulator', 'tail': 'sulfatase'} 
{'head': 'Mitiglinide', 'type': 'subject has role', 'tail': 'sulfonylurea receptor'} 	 {'head': 'Mitiglinide', 'type': 'Regulator', 'tail': 'sulfonylurea receptor'} 
{'head': 'muscarinic receptor', 'type': 'subclass of', 'tail': 'G protein-coupled receptor'} 	 {'head': 'C', 'type': 'Part_of', 'tail': 'M(2) muscarinic receptor'} 
{'head': 'Ibuprofen', 'type': 'subject has role', 'tail': 'nonsteroidal anti-inflammatory drug'} 	 {'head': 'ibuprofen', 'type': 'Regulator', 'tail': 'peroxisome proliferator-activated receptor gamma'} 
{'head': 'apixaban', 'type': 'subject has role', 'tail': 'factor Xa inhibitor'} 	 {'head': 'dabigatran', 'type': 'Downregulator', 'tail': 'thrombin'} 
{'head': 'Captopril', 'type': 'subject has role', 'tail': 'angiotensin-converting enzyme'} 	 {'head': 'Captopril', 'type': 'Downregulator', 'tail': 'MMP-2'} 
{'head': 'Phenformin', 'type': 'medical condition treated', 'tail': 'diabetes mellitus'} 	 {'head': 'Phenformin', 'type': 'Downregulator', 'tail': 'Kir6.1'} 
{'head': 'parathyroid hormone', 'type': 'subclass of', 'tail': 'PTH'} 	 {'head': 'Ca', 'type': 'Regulator', 'tail': 'Ca-sensing receptor'} 
{'head': 'thalidomide', 'type': 'medical condition treated', 'tail': 'leprosy'} 	 {'head': 'Thalidomide', 'type': 'Regulator', 'tail': 'CRBN'} 
{'head': 'telmisartan', 'type': 'subject has role', 'tail': 'angiotensin II receptor blocker'} 	 {'head': 'Telmisartan', 'type': 'Downregulator', 'tail': 'angiotensin II receptor'} 
{'head': 'tamoxifen', 'type': 'subject has role', 'tail': 'breast cancer therapy'} 	 {'head': 'tamoxifen', 'type': 'Agonist', 'tail': 'ER'} 
{'head': 'agonist', 'type': 'has part', 'tail': 'ligand'} 	 {'head': 'salmeterol', 'type': 'Agonist', 'tail': 'beta(2)-adrenoceptor'} 
{'head': 'L-Dopa', 'type': 'subject has role', 'tail': 'monoamine oxidase-B inhibitor'} 	 {'head': 'Rasagiline', 'type': 'Downregulator', 'tail': 'monoamine oxidase-B'} 
{'head': 'lingual thyroid', 'type': 'subclass of', 'tail': 'thyroid gland'} 	 {'head': 'levothyroxine', 'type': 'Not', 'tail': 'TSH'} 
{'head': 'celecoxib', 'type': 'subclass of', 'tail': 'non-steroidal anti-inflammatory drug'} 	 {'head': 'steroidal', 'type': 'Downregulator', 'tail': 'cyclooxygenase-2'} 
{'head': 'MK-329', 'type': 'subject has role', 'tail': 'peripheral CCK (CCK-A) receptor antagonist'} 	 {'head': 'SMS 201-995', 'type': 'Regulator', 'tail': 'CCK-A receptor'} 
{'head': 'cleft palate', 'type': 'subclass of', 'tail': 'palate development'} 	 {'head': 'chlorcyclizine', 'type': 'Regulator', 'tail': 'Bmp2'} 
{'head': 'R(+)etomidate', 'type': 'subject has role', 'tail': 'general anesthesia'} 	 {'head': 'amino acid', 'type': 'Part_of', 'tail': 'GABA(A)-R'} 
{'head': 'chlorpromazine', 'type': 'has part', 'tail': 'calcium'} 	 {'head': 'calcium', 'type': 'Regulator', 'tail': 'prolactin'} 
{'head': 'putrescine', 'type': 'instance of', 'tail': 'polyamine'} 	 {'head': 'spermine', 'type': 'Substrate', 'tail': 'SMS'} 
{'head': 'Cabozantinib', 'type': 'subject has role', 'tail': 'small-molecule kinase inhibitor'} 	 {'head': 'Cabozantinib', 'type': 'Downregulator', 'tail': 'kinase'} 
{'head': 'metastasize', 'type': 'has cause', 'tail': 'cancer'} 	 {'head': 'Thiocolchicoside', 'type': 'Regulator', 'tail': 'RANKL'} 
{'head': 'sildenafil', 'type': 'medical condition treated', 'tail': 'erectile dysfunction'} 	 {'head': 'sildenafil', 'type': 'Regulator', 'tail': 'eNOS'} 
{'head': 'NF-κB', 'type': 'subclass of', 'tail': 'transcription factor'} 	 {'head': 'Mercury', 'type': 'Upregulator', 'tail': 'cyclooxygenase-2'} 
{'head': 'cholinergic', 'type': 'subclass of', 'tail': 'neurons'} 	 {'head': 'CHPG', 'type': 'Agonist', 'tail': 'mGluR(5)'} 
{'head': 'apoptotic', 'type': 'subclass of', 'tail': 'mitosis'} 	 {'head': 'AR323', 'type': 'Downregulator', 'tail': 'Chk1'} 
{'head': 'S6 kinase 1', 'type': 'part of', 'tail': 'ribosomal protein'} 	 {'head': 'Aspirin', 'type': 'Upregulator', 'tail': 'AMPK'} 
{'head': 'mitochondrial complex I', 'type': 'part of', 'tail': 'mitochondrial'} 	 {'head': 'forskolin', 'type': 'Regulator', 'tail': 'K-ras'} 
{'head': 'α-SMA', 'type': 'subclass of', 'tail': 'mRNA'} 	 {'head': 'Berberine', 'type': 'Regulator', 'tail': 'p38'} 
{'head': 'pomalidomide', 'type': 'subject has role', 'tail': 'immunomodulatory'} 	 {'head': 'lenalidomide', 'type': 'Regulator', 'tail': 'CRBN'} 
{'head': 'guava leaf polyphenol', 'type': 'instance of', 'tail': 'polyphenols'} 	 {'head': 'polyphenols', 'type': 'Downregulator', 'tail': 'CYPs'} 
{'head': 'Crizotinib', 'type': 'medical condition treated', 'tail': 'non-small-cell lung cancer'} 	 {'head': 'Crizotinib', 'type': 'Regulator', 'tail': 'ALK'} 
{'head': 'Enprofylline', 'type': 'subject has role', 'tail': 'inhibitor of cyclic AMP phosphodiesterase'} 	 {'head': 'ethanol', 'type': 'Regulator', 'tail': 'adenosine'} 
{'head': 'NF-κB', 'type': 'subclass of', 'tail': 'transcription factor'} 	 {'head': 'Celastrol', 'type': 'Regulator', 'tail': 'TGF-β'} 
{'head': 'nor-binaltorphimine', 'type': 'subject has role', 'tail': 'Tricyclic antidepressant'} 	 {'head': 'mianserin', 'type': 'Regulator', 'tail': 'kappa-opioid'} 
{'head': 'hypertension', 'type': 'has effect', 'tail': 'cardiovascular morbidity'} 	 {'head': 'propranolol', 'type': 'Antagonist', 'tail': 'β-receptor'} 
{'head': 'isoflavonoid', 'type': 'subclass of', 'tail': 'flavonoid'} 	 {'head': 'chalcones', 'type': 'Regulator', 'tail': 'heme oxygenase 1'} 
{'head': 'endosomes', 'type': 'instance of', 'tail': 'cell organelles'} 	 {'head': 'oxysterols', 'type': 'Upregulator', 'tail': 'LXRs'} 
{'head': 'somatostatin', 'type': 'part of', 'tail': 'somatostatinergic receptor-effector system'} 	 {'head': 'α-tocopherol', 'type': 'Upregulator', 'tail': 'cyclic adenosine monophosphate response element binding protein'} 
{'head': 'SU5416', 'type': 'subject has role', 'tail': 'vascular endothelial cell growth factor receptor inhibitor'} 	 {'head': 'SU5416', 'type': 'Not', 'tail': 'PARP-1'} 
{'head': 'codeine', 'type': 'subject has role', 'tail': 'opioid'} 	 {'head': 'Galantamine', 'type': 'Regulator', 'tail': 'nicotinic acetylcholine receptors'} 
{'head': 'anovulation', 'type': 'subclass of', 'tail': 'Abnormal uterine bleeding'} 	 {'head': 'Danazol', 'type': 'Regulator', 'tail': 'GnRH'} 
{'head': 'supraoptic', 'type': 'subclass of', 'tail': 'nuclei'} 	 {'head': 'nitric oxide', 'type': 'Substrate', 'tail': 'NADPH-diaphorase'} 
{'head': 'VX', 'type': 'instance of', 'tail': 'nerve agent'} 	 {'head': 'oxime', 'type': 'Regulator', 'tail': 'huBuChE'} 
{'head': 'eukaryotic', 'type': 'has part', 'tail': 'endoplasmic reticulum'} 	 {'head': 'Verrucarin A', 'type': 'Regulator', 'tail': 'TRAIL'} 
{'head': 'actin', 'type': 'subclass of', 'tail': 'cytoskeletons'} 	 {'head': 'glucose', 'type': 'Substrate', 'tail': 'glucose transporter isoform 4'} 
{'head': 'SPR assay', 'type': 'uses', 'tail': 'sensor chip'} 	 {'head': 'Androstanol', 'type': 'Regulator', 'tail': 'CARs'} 
{'head': 'NMDA receptor blockade', 'type': 'different from', 'tail': 'NMDA receptor antagonist'} 	 {'head': 'AP7', 'type': 'Downregulator', 'tail': 'NMDA receptor'} 
{'head': 'Triethylenetetramine', 'type': 'medical condition treated', 'tail': "Wilson's disease"} 	 {'head': 'triethylenetetramine', 'type': 'Substrate', 'tail': 'thialysine acetyltransferase'} 
{'head': 'elzasonan', 'type': 'subject has role', 'tail': '5-hydroxytryptamine1B receptor antagonist'} 	 {'head': 'elzasonan', 'type': 'Antagonist', 'tail': '5-hydroxytryptamine1B'} 
{'head': 'IgG', 'type': 'subclass of', 'tail': 'antibody'} 	 {'head': 'amino acid', 'type': 'Part_of', 'tail': 'AglycoT-Fc1004'} 
{'head': 'valproic acid', 'type': 'subject has role', 'tail': 'histone deacetylase'} 	 {'head': 'valproic acid', 'type': 'Downregulator', 'tail': 'histone deacetylase'} 
{'head': 'Amiodarone', 'type': 'subject has role', 'tail': 'antiarrhythmic drug'} 	 {'head': 'α-TOCO', 'type': 'Downregulator', 'tail': 'pancaspase'} 
{'head': 'HuBChE', 'type': 'subject has role', 'tail': 'bioscavenger'} 	 {'head': 'Amino acid', 'type': 'Part_of', 'tail': 'human butyrylcholinesterase'} 
{'head': 'cisplatin', 'type': 'has part', 'tail': 'platinum'} 	 {'head': 'cisplatin', 'type': 'Regulator', 'tail': 'CTR1'} 
{'head': 'mRNA', 'type': 'encodes', 'tail': 'protein'} 	 {'head': 'bisphenol A', 'type': 'Downregulator', 'tail': 'Ugt1a6'} 
{'head': 'dimethylfumarate', 'type': 'medical condition treated', 'tail': 'renal fibrosis'} 	 {'head': 'Dimethylfumarate', 'type': 'Regulator', 'tail': 'NF-E2-related factor 2'} 
{'head': 'osteoclast', 'type': 'followed by', 'tail': 'osteoblasts'} 	 {'head': 'Met', 'type': 'Upregulator', 'tail': 'osteocalcin'} 
{'head': 'tachycardia', 'type': 'has cause', 'tail': 'heart'} 	 {'head': 'quinolizidine alkaloids', 'type': 'Downregulator', 'tail': 'hERG'} 
{'head': 'inflammation', 'type': 'has cause', 'tail': 'immune response'} 	 {'head': 'polyphenols', 'type': 'Regulator', 'tail': 'chemokine'} 
{'head': 'metastatic', 'type': 'subclass of', 'tail': 'cancer'} 	 {'head': 'naphtho[1,2-b]furan-4,5-dione', 'type': 'Downregulator', 'tail': 'EGF'} 
{'head': 'cAMP', 'type': 'subclass of', 'tail': 'second messenger'} 	 {'head': '3-(5-tert-butyl-isoxazol-3-yl)-2-[(3-chloro-phenyl)-hydrazono]-3-oxo-propionitrile', 'type': 'Downregulator', 'tail': 'insulin'} 
{'head': 'Metformin', 'type': 'subject has role', 'tail': 'antidiabetic drug'} 	 {'head': 'Metformin', 'type': 'Regulator', 'tail': 'AMPK'} 
{'head': 'prochloraz', 'type': 'instance of', 'tail': 'fungicide'} 	 {'head': 'prochloraz', 'type': 'Regulator', 'tail': 'ABCG2'} 
{'head': 'hepatocyte', 'type': 'part of', 'tail': 'liver'} 	 {'head': 'Ag', 'type': 'Regulator', 'tail': 'lactate dehydrogenase'} 
{'head': 'prostaglandin E(2)', 'type': 'subclass of', 'tail': 'E-prostanoid 3'} 	 {'head': 'GTP', 'type': 'Not', 'tail': 'ECII'} 
{'head': 'hypertension', 'type': 'subclass of', 'tail': 'cardiovascular complications'} 	 {'head': 'OSU-03012', 'type': 'Downregulator', 'tail': 'PDK-1'} 
{'head': 'spermatogenesis', 'type': 'part of', 'tail': 'seminiferous epithelial cycle'} 	 {'head': 'CdCl₂', 'type': 'Regulator', 'tail': 'ICAM2'} 
{'head': '5-methoxytryptamine', 'type': 'subclass of', 'tail': 'serotonin'} 	 {'head': 'serotonin', 'type': 'Substrate', 'tail': 'CYP2D'} 
{'head': 'aromatase inhibitor', 'type': 'subclass of', 'tail': 'inhibitors'} 	 {'head': 'estradiol', 'type': 'Regulator', 'tail': 'ERα'} 
{'head': 'apoptosis', 'type': 'part of', 'tail': 'cell cycle'} 	 {'head': 'Toosendanin', 'type': 'Downregulator', 'tail': 'JNK'} 
{'head': 'C57BL6', 'type': 'instance of', 'tail': 'model'} 	 {'head': 'nicotine', 'type': 'Upregulator', 'tail': 'tumor necrosis factor-α'} 
{'head': 'SQSTM1', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'hydrogen', 'type': 'Part_of', 'tail': 'KIR'} 
{'head': 'neurotrophin', 'type': 'subclass of', 'tail': 'neuropeptide'} 	 {'head': 'glucose', 'type': 'Regulator', 'tail': 'Orexin-A'} 
{'head': 'Mesalamine', 'type': 'medical condition treated', 'tail': 'ulcerative colitis'} 	 {'head': 'Mesalamine', 'type': 'Downregulator', 'tail': 'p-21 activated kinase-1'} 
{'head': 'Mrp2', 'type': 'encodes', 'tail': 'multidrug resistance-associated protein 2'} 	 {'head': 'EGCG', 'type': 'Upregulator', 'tail': 'Cyp7a1'} 
{'head': 'serotonin', 'type': 'subclass of', 'tail': 'catecholamines'} 	 {'head': 'C', 'type': 'Part_of', 'tail': '5-HT6'} 
{'head': 'ColQ-1', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'cAMP', 'type': 'Regulator', 'tail': 'ColQ-1a'} 
{'head': 'COX-2', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'Catalpol', 'type': 'Downregulator', 'tail': 'IFN-γ'} 
{'head': 'non-insulin-dependent diabetes mellitus', 'type': 'subclass of', 'tail': 'diabetes'} 	 {'head': 'dammarane', 'type': 'Downregulator', 'tail': 'Protein tyrosine phosphatase 1B'} 
{'head': 'neuron', 'type': 'has part', 'tail': 'neurofilament'} 	 {'head': '(PhTe)(2)', 'type': 'Not', 'tail': 'phospho-GSK-3-β'} 
{'head': 'naphthalimide', 'type': 'instance of', 'tail': 'dye'} 	 {'head': 'quinone', 'type': 'Substrate', 'tail': 'human NAD(P)H:quinone oxidoreductase isozyme 1'} 
{'head': 'lipopolysaccharide', 'type': 'subclass of', 'tail': 'amino acid'} 	 {'head': 'glycyrrhizin', 'type': 'Downregulator', 'tail': 'high-mobility group box-1'} 
{'head': 'orthosteric', 'type': 'subclass of', 'tail': 'ligand'} 	 {'head': 'TPBP', 'type': 'Antagonist', 'tail': 'mAChR'} 
{'head': 'interactions', 'type': 'studied by', 'tail': 'pharmacokinetics'} 	 {'head': 'risperidone', 'type': 'Substrate', 'tail': 'P-gp'} 
{'head': 'arginine vasopressin', 'type': 'subject has role', 'tail': 'antioxytocic'} 	 {'head': 'N', 'type': 'Part_of', 'tail': 'arginine vasopressin'} 
{'head': 'Liver X Receptor', 'type': 'subclass of', 'tail': 'nuclear receptor'} 	 {'head': 'oxysterols', 'type': 'Upregulator', 'tail': 'Liver X Receptor (LXR) α'} 
{'head': 'LHβ', 'type': 'subclass of', 'tail': 'gonadotropin'} 	 {'head': 'GnRH', 'type': 'Regulator', 'tail': 'β-catenin'} 
{'head': 'paraquat', 'type': 'instance of', 'tail': 'herbicide'} 	 {'head': 'paraquat', 'type': 'Substrate', 'tail': 'P-gp'} 
{'head': 'fludarabine', 'type': 'medical condition treated', 'tail': 'chronic lymphocytic leukemia'} 	 {'head': 'P505-15', 'type': 'Downregulator', 'tail': 'B-cell receptor'} 
{'head': 'RNA synthesis', 'type': 'product or material produced', 'tail': 'RNA'} 	 {'head': '6-azauracil', 'type': 'Regulator', 'tail': 'RPB1'} 
{'head': '17-Allylamino-17-demethoxygeldanamycin', 'type': 'medical condition treated', 'tail': 'lung adenocarcinoma'} 	 {'head': '17-Allylamino-17-demethoxygeldanamycin', 'type': 'Regulator', 'tail': 'Aryl hydrocarbon receptor'} 
{'head': "2',2'-difluorodeoxycytidine", 'type': 'instance of', 'tail': 'Gemcitabine'} 	 {'head': 'Gemcitabine', 'type': 'Substrate', 'tail': 'DCK'} 
{'head': 'TCF4', 'type': 'part of', 'tail': 'transcription'} 	 {'head': '4-phenyl-2-phenylaminopyridine', 'type': 'Downregulator', 'tail': 'Traf2- and Nck-interacting kinase'} 
{'head': 'Ras cycle', 'type': 'has part', 'tail': 'Ras protein'} 	 {'head': 'Boron', 'type': 'Downregulator', 'tail': 'acyl protein thioesterases 1 and 2'} 
{'head': 'genistein', 'type': 'subclass of', 'tail': 'phytoestrogen'} 	 {'head': 'genistein', 'type': 'Regulator', 'tail': 'RhoA'} 
{'head': 'simvastatin', 'type': 'subject has role', 'tail': 'HMG-coA reductase inhibitor'} 	 {'head': 'GSK1292263', 'type': 'Not', 'tail': 'OATP1B1'} 
{'head': 'fungal infection', 'type': 'has cause', 'tail': 'fungi'} 	 {'head': 'steroid', 'type': 'Not', 'tail': 'Aus1'} 
{'head': 'MSH2', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'MMS', 'type': 'Regulator', 'tail': 'MSH2'} 
{'head': 'icariin', 'type': 'instance of', 'tail': 'flavonoid'} 	 {'head': 'flavonoid', 'type': 'Downregulator', 'tail': 'STAT1'} 
{'head': 'MTORC1', 'type': 'part of', 'tail': 'signaling network'} 	 {'head': 'rapamycin', 'type': 'Downregulator', 'tail': 'insulin'} 
{'head': 'gene', 'type': 'encodes', 'tail': 'protein'} 	 {'head': 'N', 'type': 'Part_of', 'tail': 'AF10'} 
{'head': '2', 'type': 'subject has role', 'tail': 'Toll-like receptor 7 agonist'} 	 {'head': '8-oxoadenine', 'type': 'Agonist', 'tail': 'Toll-like receptor 7'} 
{'head': 'piperidine', 'type': 'has part', 'tail': 'nitrogen'} 	 {'head': 'benzo-fused spirocyclic oxazepine', 'type': 'Downregulator', 'tail': 'SCD1'} 
{'head': 'CMV', 'type': 'subclass of', 'tail': 'reporter'} 	 {'head': 'ETB', 'type': 'Downregulator', 'tail': 'human Hsp60'} 
{'head': 'APO', 'type': 'subject has role', 'tail': 'calcium influx inhibitor'} 	 {'head': 'Apocynin', 'type': 'Regulator', 'tail': 'StAR'} 
{'head': 'Transcription factor p63', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'Arsenic', 'type': 'Regulator', 'tail': 'ΔNp63'} 
{'head': 'Jaceosidin', 'type': 'instance of', 'tail': 'flavonoid'} 	 {'head': 'Jaceosidin', 'type': 'Regulator', 'tail': 'cyclin B'} 
{'head': 'primary myotube', 'type': 'part of', 'tail': 'skeletal muscle'} 	 {'head': 'ATP', 'type': 'Regulator', 'tail': 'GLUT4'} 
{'head': 'interferon regulatory factor 5', 'type': 'subclass of', 'tail': 'transcription factor'} 	 {'head': 'carboxyl', 'type': 'Part_of', 'tail': 'IRF5'} 
{'head': 'hTERT', 'type': 'subject has role', 'tail': 'telomerase inhibitor'} 	 {'head': 'anthra[1,2-d]imidazole-6,11-dione', 'type': 'Regulator', 'tail': 'hTERT'} 
{'head': 'sulforaphane', 'type': 'subject has role', 'tail': 'NF-E2-related factor 2-antioxidant response element'} 	 {'head': 'Trichostatin A', 'type': 'Upregulator', 'tail': 'NF-E2-related factor 2'} 
{'head': 'rimonabant', 'type': 'subject has role', 'tail': 'inverse agonist'} 	 {'head': 'rimonabant', 'type': 'Regulator', 'tail': 'CB(1) receptor'} 
{'head': 'late-onset GDM', 'type': 'subclass of', 'tail': 'gestational diabetes mellitus'} 	 {'head': 'glucose', 'type': 'Regulator', 'tail': 'insulin'} 
{'head': 'rivaroxaban', 'type': 'subject has role', 'tail': 'inhibitors of prothrom'} 	 {'head': 'rivaroxaban', 'type': 'Downregulator', 'tail': 'FXa'} 
{'head': 'catalyzes', 'type': 'subclass of', 'tail': 'catalysis'} 	 {'head': 'NADH', 'type': 'Regulator', 'tail': 'ALDH1'} 
{'head': 'Acrolein', 'type': 'has effect', 'tail': "Alzheimer's disease"} 	 {'head': 'Acrolein', 'type': 'Regulator', 'tail': 'APP'} 
{'head': 'immortalized', 'type': 'subclass of', 'tail': 'cell line'} 	 {'head': 'estradiol', 'type': 'Upregulator', 'tail': 'estrogen receptors'} 
{'head': 'Coffee', 'type': 'has part', 'tail': 'caffeine'} 	 {'head': 'eicosanoyl-5-hydroxytryptamide', 'type': 'Regulator', 'tail': 'α-synuclein'} 
{'head': 'Klotho', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'H(2)S', 'type': 'Regulator', 'tail': 'Klotho'} 
{'head': 'HO-1', 'type': 'encodes', 'tail': 'heme oxygenase-1'} 	 {'head': 'ethanol', 'type': 'Upregulator', 'tail': 'HO-1'} 
{'head': 'FMO1', 'type': 'subclass of', 'tail': 'flavin mono-oxygenase'} 	 {'head': 'trimethylamine', 'type': 'Substrate', 'tail': 'flavin mono-oxygenase'} 
{'head': 'estrogen', 'type': 'subclass of', 'tail': 'steroid'} 	 {'head': 'steroids', 'type': 'Regulator', 'tail': 'estrogen receptor-α'} 
{'head': "Alzheimer's disease", 'type': 'subclass of', 'tail': 'neurodegenerative disorder'} 	 {'head': 'quinoline', 'type': 'Downregulator', 'tail': 'phosphodiesterase 5'} 
{'head': 'N-benzyl-5-(4-isopropylthiophenol)-2-hydroxynicotinamide', 'type': 'subject has role', 'tail': 'inhibitor'} 	 {'head': 'N-substituted-5-(4-isopropylthiophenol)-2-hydroxynicotinamide', 'type': 'Downregulator', 'tail': 'Mcl-1'} 
{'head': 'Peginesatide', 'type': 'subject has role', 'tail': 'erythropoietic'} 	 {'head': 'Peginesatide', 'type': 'Upregulator', 'tail': 'erythropoietin receptor'} 
{'head': 'myosin', 'type': 'subclass of', 'tail': 'regulatory light chain'} 	 {'head': 'nucleotide', 'type': 'Regulator', 'tail': 'ATPase'} 
{'head': 'peritoneal fibrosis', 'type': 'subclass of', 'tail': 'fibrosis'} 	 {'head': 'lysophosphatidic acid', 'type': 'Regulator', 'tail': 'LPA1'} 
{'head': 'Styrene oxide', 'type': 'has part', 'tail': 'Styrene'} 	 {'head': 'styrene', 'type': 'Regulator', 'tail': 'CYP2E1'} 
{'head': 'cholestatic liver disease', 'type': 'subclass of', 'tail': 'nonalcoholic fatty liver disease'} 	 {'head': 'Bile acids', 'type': 'Upregulator', 'tail': 'constitutive androstane receptor'} 
{'head': 'osteoprotegerin', 'type': 'has part', 'tail': 'receptor activator of NF-κB ligand'} 	 {'head': 'YR-11', 'type': 'Regulator', 'tail': 'RANK'} 
{'head': 'THP-1 macrophages', 'type': 'subclass of', 'tail': 'macrophages'} 	 {'head': 'silica', 'type': 'Regulator', 'tail': 'actin'} 
{'head': 'L5178', 'type': 'instance of', 'tail': 'cell line'} 	 {'head': 'lathyrane diterpene', 'type': 'Regulator', 'tail': 'P-gp'} 
{'head': 'Chk1', 'type': 'subclass of', 'tail': 'checkpoint kinase'} 	 {'head': 'arsenic trioxide', 'type': 'Upregulator', 'tail': 'ATM'} 
{'head': 'lignan', 'type': 'subclass of', 'tail': 'Phytoestrogen'} 	 {'head': 'isoflavonoid', 'type': 'Upregulator', 'tail': 'PPARγ'} 
{'head': 'T-helper cell', 'type': 'subclass of', 'tail': 'monocyte'} 	 {'head': 'fatty acids', 'type': 'Not', 'tail': 'CD69'} 
{'head': 'Radix Angelicae Dahuricae', 'type': 'instance of', 'tail': 'traditional Chinese medicine'} 	 {'head': 'imperatorin', 'type': 'Substrate', 'tail': 'P-gp'} 
{'head': 'transmethylation', 'type': 'instance of', 'tail': 'reaction'} 	 {'head': 'adenosine dialdehyde', 'type': 'Regulator', 'tail': 'Src'} 
{'head': 'MMP-1 inhibitor', 'type': 'facet of', 'tail': 'matrix metalloproteinase-1'} 	 {'head': 'methyl rosmarinate', 'type': 'Downregulator', 'tail': 'MMP-1'} 
{'head': 'RAW 264', 'type': 'instance of', 'tail': 'cell line'} 	 {'head': 'prostaglandin E2', 'type': 'Substrate', 'tail': 'cyclooxygenase-2'} 
{'head': 'Nocellara del Belice', 'type': 'country of origin', 'tail': 'Italy'} 	 {'head': 'oleocanthal', 'type': 'Regulator', 'tail': 'COX1'} 
{'head': 'cisplatin', 'type': 'subclass of', 'tail': 'platinum'} 	 {'head': 'iodido', 'type': 'Regulator', 'tail': 'p53'} 
{'head': 'TRPML1', 'type': 'subclass of', 'tail': 'transporters'} 	 {'head': 'zinc', 'type': 'Substrate', 'tail': 'TRPML1'} 
{'head': 'α-santalol', 'type': 'subject has role', 'tail': 'anti-hyperglycemic'} 	 {'head': 'α-santalol', 'type': 'Regulator', 'tail': 'catalase'} 
{'head': 'ritodrine', 'type': 'subject has role', 'tail': 'tocolytic'} 	 {'head': 'ritodrine', 'type': 'Regulator', 'tail': 'β2-adrenoceptor'} 
{'head': 'Ceftazidime-avibactam', 'type': 'instance of', 'tail': 'cephalosporin/β-lactamase inhibitor combination'} 	 {'head': 'Ceftazidime', 'type': 'Downregulator', 'tail': 'β-lactamase'} 
{'head': 'obesity', 'type': 'has effect', 'tail': 'hypertension'} 	 {'head': 'celecoxib', 'type': 'Downregulator', 'tail': 'cyclooxygenase-2'} 
{'head': 'Upamostat', 'type': 'subject has role', 'tail': 'anti-cancer agent'} 	 {'head': 'Upamostat', 'type': 'Downregulator', 'tail': 'serine protease'} 
{'head': 'ubiquitin-specific protease 22', 'type': 'subclass of', 'tail': 'deubiquitinating enzyme'} 	 {'head': 'lysine', 'type': 'Part_of', 'tail': 'USP22'} 
{'head': 'selenocysteine', 'type': 'instance of', 'tail': 'amino acid'} 	 {'head': 'selenium', 'type': 'Regulator', 'tail': 'GPx1'} 
{'head': "Parkinson's disease", 'type': 'has cause', 'tail': 'Mn'} 	 {'head': 'Mn', 'type': 'Upregulator', 'tail': 'p38'} 
{'head': 'nitric oxide', 'type': 'subject has role', 'tail': 'pro-inflammatory factor'} 	 {'head': 'Nocapyrone H', 'type': 'Downregulator', 'tail': 'interleukin-1β'} 
{'head': 'apixaban', 'type': 'subject has role', 'tail': 'factor Xa inhibitor'} 	 {'head': 'apixaban', 'type': 'Downregulator', 'tail': 'factor Xa'} 
{'head': 'Trypanosoma cruzi', 'type': 'has effect', 'tail': 'Chagas disease'} 	 {'head': 'Sulfonamide', 'type': 'Downregulator', 'tail': 'α-Carbonic Anhydrase'} 
{'head': 'interstitium', 'type': 'part of', 'tail': 'rat testis'} 	 {'head': 'DEHP', 'type': 'Not', 'tail': 'Insl3'} 
{'head': 'LβT2', 'type': 'instance of', 'tail': 'cell line'} 	 {'head': 'GnRH', 'type': 'Regulator', 'tail': 'FSH'} 
{'head': 'sophocarpine', 'type': 'medical condition treated', 'tail': 'non-alcoholic steatohepatitis'} 	 {'head': 'Sophocarpine', 'type': 'Regulator', 'tail': 'adipocytokine'} 
{'head': 'small intestine', 'type': 'has part', 'tail': 'jejunum'} 	 {'head': 'darunavir', 'type': 'Substrate', 'tail': 'P-gp'} 
{'head': 'Codium fragile', 'type': 'parent taxon', 'tail': 'Codiales'} 	 {'head': 'buthanol', 'type': 'Downregulator', 'tail': 'cyclooxygenase-2'} 
{'head': 'hepatocyte', 'type': 'subclass of', 'tail': 'tissues'} 	 {'head': 'flavonolignans', 'type': 'Regulator', 'tail': 'organic anion-transporting polypeptides'} 
{'head': 'lysozyme', 'type': 'subclass of', 'tail': 'protein'} 	 {'head': 'ω-tertiary amine', 'type': 'Regulator', 'tail': 'lysozyme'} 
{'head': 'apoptosis', 'type': 'location', 'tail': 'mitochondrial'} 	 {'head': 'H2O2', 'type': 'Upregulator', 'tail': 'Bax'} 
{'head': 'glucagon-like peptide-1', 'type': 'subject has role', 'tail': 'beta cell secretagogue'} 	 {'head': 'glucose', 'type': 'Upregulator', 'tail': 'insulin'} 
{'head': 'VEGF', 'type': 'subclass of', 'tail': 'glycoprotein'} 	 {'head': 'C', 'type': 'Part_of', 'tail': 'VEGF-D'} 
{'head': 'paroxetine', 'type': 'subject has role', 'tail': '5-HT reuptake inhibitor'} 	 {'head': 'SSR125543', 'type': 'Antagonist', 'tail': 'CRF(1) (corticotropin releasing factor type 1) receptor'} 
{'head': '5-chlorothiophene-2-sulfonamide', 'type': 'instance of', 'tail': 'indazole arylsulfonamide'} 	 {'head': 'indazole arylsulfonamides', 'type': 'Antagonist', 'tail': 'human CCR4'} 
{'head': 'JZL184', 'type': 'subject has role', 'tail': 'monoacylglycerol lipase (MAGL) inhibitor'} 	 {'head': 'JZL184', 'type': 'Regulator', 'tail': 'CB(1)'} 
{'head': 'pyrimidinone', 'type': 'instance of', 'tail': 'amide'} 	 {'head': 'bicyclic pyrazinone and pyrimidinone amides', 'type': 'Downregulator', 'tail': 'TF'} 
{'head': 'Streptavidin', 'type': 'subject has role', 'tail': 'peptide inhibitor'} 	 {'head': 'proline', 'type': 'Part_of', 'tail': 'HIF-1α'} 
{'head': 'inhibitor', 'type': 'subclass of', 'tail': 'cancer therapy'} 	 {'head': 'HJC0123', 'type': 'Upregulator', 'tail': 'caspase-3'} 
{'head': 'DNA', 'type': 'part of', 'tail': 'chromosome'} 	 {'head': 'biotinylated trimethylpsoralen', 'type': 'Regulator', 'tail': 'supercoiling domains'} 
{'head': 'PDE5-I vardenafil', 'type': 'subject has role', 'tail': 'phosphodiesterase type 5 inhibitor'} 	 {'head': 'vardenafil', 'type': 'Downregulator', 'tail': 'PDE5'} 
{'head': 'coronary artery disease', 'type': 'drug used for treatment', 'tail': 'statin'} 	 {'head': 'cholesterol', 'type': 'Substrate', 'tail': '3-hydroxy-3-methylglutaryl coenzyme A reductase'} 
{'head': 'mitochondrial impairment', 'type': 'has cause', 'tail': 'Hyperthyroidism'} 	 {'head': 'bezafibrate', 'type': 'Agonist', 'tail': 'peroxisome proliferator-activated receptor alpha'} 
{'head': 'REV-ERBα', 'type': 'instance of', 'tail': 'orphan receptor'} 	 {'head': 'dexamethasone', 'type': 'Regulator', 'tail': 'DRD3'} 
{'head': 'IKM-159', 'type': 'instance of', 'tail': 'heterotricyclic'} 	 {'head': 'IKM-159', 'type': 'Antagonist', 'tail': '(AMPA) receptor'} 
{'head': 'biphenyl', 'type': 'instance of', 'tail': 'flavone'} 	 {'head': 'benzo[c]phenanthrene', 'type': 'Regulator', 'tail': 'P450 2A13'} 
{'head': 'partial agonist', 'type': 'subclass of', 'tail': 'agonist'} 	 {'head': 'Rosiglitazone', 'type': 'Agonist', 'tail': 'peroxisome proliferator-activated receptor (PPAR)γ'} 
{'head': 'α-helical domain', 'type': 'part of', 'tail': 'GPCR'} 	 {'head': 'C', 'type': 'Part_of', 'tail': 'EL2'} 
{'head': 'omeprazole', 'type': 'subclass of', 'tail': 'cytochrome P450'} 	 {'head': '(R)-omeprazole', 'type': 'Substrate', 'tail': 'CYP2C19'} 
{'head': 'pregnane X receptor', 'type': 'subclass of', 'tail': 'xenobiotic receptor'} 	 {'head': 'oxycodone', 'type': 'Not', 'tail': 'PXR'} 
{'head': 'retinol', 'type': 'subclass of', 'tail': 'vitamin'} 	 {'head': 'all-trans retinoic acid', 'type': 'Upregulator', 'tail': 'nuclear receptors'} 
{'head': 'kidney', 'type': 'has part', 'tail': 'renal tubular cells'} 	 {'head': 'creatine', 'type': 'Upregulator', 'tail': 'miR-21'} 
{'head': 'diamide', 'type': 'instance of', 'tail': 'thiol'} 	 {'head': 'Disulfide', 'type': 'Part_of', 'tail': 'Human Hydroxysteroid Sulfotransferase hSULT2A1'} 
{'head': 'ICI-182,780', 'type': 'subject has role', 'tail': 'estrogen receptor antagonist'} 	 {'head': 'ICI-182,780', 'type': 'Regulator', 'tail': 'ER'} 
{'head': 'transforming growth factor-β', 'type': 'subclass of', 'tail': 'receptor'} 	 {'head': '7-methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1H-imidazol-5-yl]-1,3-benzothiazole', 'type': 'Downregulator', 'tail': 'transforming growth factor-β type I receptor'} 
{'head': 'androgen response region', 'type': 'subclass of', 'tail': 'Androgen receptor'} 	 {'head': 'androgen', 'type': 'Not', 'tail': 'AR'} 
{'head': 'IL-1β', 'type': 'instance of', 'tail': 'inflammation markers'} 	 {'head': '7-ketosterol', 'type': 'Regulator', 'tail': 'holesterol transport-related proteins'} 
{'head': 'platelet', 'type': 'has part', 'tail': 'lymphocyte'} 	 {'head': 'caffeic acid', 'type': 'Upregulator', 'tail': 'ADA'} 
{'head': 'Mcl-1', 'type': 'subclass of', 'tail': 'transcription factor'} 	 {'head': 'serine', 'type': 'Part_of', 'tail': 'STAT3'} 
{'head': 'imidacloprid', 'type': 'instance of', 'tail': 'insecticide'} 	 {'head': 'neonicotinoids', 'type': 'Substrate', 'tail': 'AOX'} 
{'head': 'Non-front-fanged colubroid snake', 'type': 'instance of', 'tail': 'taxa'} 	 {'head': 'neostigmine', 'type': 'Downregulator', 'tail': 'acetylcholinesterase'} 
{'head': 'troglitazone', 'type': 'subject has role', 'tail': 'Anti-adipogenic'} 	 {'head': 'platyphyllonol-5-O-β-d-xylopyranoside', 'type': 'Downregulator', 'tail': 'CCAAT/enhancer binding protein α'} 
{'head': 'CXCR4', 'type': 'subclass of', 'tail': 'chemokine receptor'} 	 {'head': 'Benzenesulfonamides', 'type': 'Downregulator', 'tail': 'chemokine receptor type 4'} 
{'head': 'LC-MS', 'type': 'subclass of', 'tail': 'mass spectrometry'} 	 {'head': '3β-Hydroxy-Δ(5)-bile Acids', 'type': 'Substrate', 'tail': 'Bile Salt Export Pump'} 
{'head': 'Intracellular Domain Fragment of the p75 Neurotrophin Receptor', 'type': 'instance of', 'tail': 'intracellular domain'} 	 {'head': 'amino acid', 'type': 'Part_of', 'tail': 'p75(NTR)'} 
{'head': 'cyclisation reaction', 'type': 'part of', 'tail': 'in vitro'} 	 {'head': '3-(benzylthio)-5-(1H-indol-3-yl)-1,2,4-triazol-4-amines', 'type': 'Downregulator', 'tail': 'Bcl-2'} 
{'head': 'arsenic', 'type': 'has effect', 'tail': 'arsenic toxicity'} 	 {'head': 'arsenic', 'type': 'Not', 'tail': 'Glutathione-S-transferase'} 
{'head': 'fadrozole', 'type': 'subject has role', 'tail': 'aromatase inhibitor'} 	 {'head': 'fadrozole', 'type': 'Downregulator', 'tail': 'aromatase'} 
{'head': 'TRPA1', 'type': 'subclass of', 'tail': 'nonselective cation channel'} 	 {'head': 'Benzoquinone', 'type': 'Regulator', 'tail': 'TRPA1'} 
{'head': 'celocoxib', 'type': 'subject has role', 'tail': 'cyclooxygenase inhibitor'} 	 {'head': 'diaryltriazole', 'type': 'Downregulator', 'tail': 'cyclooxygenase'} 
{'head': 'hydrogen peroxide', 'type': 'has parts of the class', 'tail': 'oxygen'} 	 {'head': 'NO', 'type': 'Regulator', 'tail': 'Prx1'} 
{'head': 'dimethylnitrosamine', 'type': 'has effect', 'tail': 'fibrosis'} 	 {'head': 'DMN', 'type': 'Regulator', 'tail': 'collagen'} 
{'head': 'intrinsic apoptosis', 'type': 'subclass of', 'tail': 'apoptosis'} 	 {'head': 'CdTe', 'type': 'Regulator', 'tail': 'caspase-3'} 
{'head': 'ischemic-reperfused', 'type': 'has effect', 'tail': 'myocardial infarction'} 	 {'head': 'polyethyleneimine', 'type': 'Regulator', 'tail': 'SHP-1'} 
{'head': 'Puerarin', 'type': 'subject has role', 'tail': 'neuroprotective'} 	 {'head': 'Puerarin', 'type': 'Upregulator', 'tail': 'PI3K'} 
{'head': 'Py3MeO-TBPo', 'type': 'subject has role', 'tail': 'photosensitizer'} 	 {'head': 'Py3MeO-TBPo', 'type': 'Regulator', 'tail': 'Bax'} 
{'head': 'C34', 'type': 'subclass of', 'tail': 'amino acid'} 	 {'head': 'N', 'type': 'Part_of', 'tail': 'gp41'} 
{'head': 'Piper gaudichaudianum Kunth', 'type': 'instance of', 'tail': 'essential oil'} 	 {'head': 'nerolidol', 'type': 'Regulator', 'tail': 'ntg1'} 
{'head': 'Radiochromatogram', 'type': 'subclass of', 'tail': 'mass spectrometry'} 	 {'head': '(3)H', 'type': 'Regulator', 'tail': 'MRP4'} 
{'head': 'cell-cycle', 'type': 'subclass of', 'tail': 'cell cycle'} 	 {'head': '1NMPP1', 'type': 'Regulator', 'tail': 'Cdk1'} 
{'head': 'Compound 19a', 'type': 'has part', 'tail': 'dihydroxypropyl'} 	 {'head': 'N', 'type': 'Regulator', 'tail': 'vesicular monoamine transporter'} 
{'head': 'IPI-926', 'type': 'subject has role', 'tail': 'inhibitor'} 	 {'head': 'IPI-926', 'type': 'Regulator', 'tail': 'human α-1-acid glycoprotein'} 
{'head': 'Lorcaserin', 'type': 'subject has role', 'tail': 'selective serotonin 5-HT2C receptor agonist'} 	 {'head': 'lorcaserin', 'type': 'Agonist', 'tail': '5-HT2C'} 
{'head': '11h', 'type': 'subject has role', 'tail': 'dipeptidyl peptidase 4'} 	 {'head': '(S)-Phenylalanine', 'type': 'Downregulator', 'tail': 'Dipeptidyl Peptidase 4'} 
{'head': 'MDR1', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'pregnenolone-16α-carbonitrile', 'type': 'Regulator', 'tail': 'PXR'} 
{'head': 'anti-allergic inflammatory', 'type': 'facet of', 'tail': 'allergic inflammatory disease'} 	 {'head': 'Galangin', 'type': 'Downregulator', 'tail': 'cytokines'} 
{'head': 'p21(Cip1)', 'type': 'subclass of', 'tail': 'checkpoint protein'} 	 {'head': 'BHA', 'type': 'Regulator', 'tail': 'HP1α'} 
{'head': 'Hepatocyte growth factor', 'type': 'subclass of', 'tail': 'receptor'} 	 {'head': 'Nobiletin', 'type': 'Downregulator', 'tail': 'ERK'} 
{'head': 'HLA-B*57:01', 'type': 'instance of', 'tail': 'allele'} 	 {'head': 'abacavir', 'type': 'Not', 'tail': 'MHC'} 
{'head': 'brain atrophy', 'type': 'subclass of', 'tail': 'neurodegenerative'} 	 {'head': 'Cholesterol', 'type': 'Downregulator', 'tail': 'Amyloid β'} 
{'head': 'CaMKII', 'type': 'subclass of', 'tail': 'calcium/calmodulin-dependent protein kinase II'} 	 {'head': 'glutamate', 'type': 'Substrate', 'tail': 'CaMKII'} 
{'head': '3-Hydroxypyridin-2-thione', 'type': 'subject has role', 'tail': 'histone deacetylase inhibitor'} 	 {'head': '3-Hydroxypyridin-2-thione', 'type': 'Downregulator', 'tail': 'Histone Deacetylase'} 
{'head': 'lixisenatide', 'type': 'medical condition treated', 'tail': 'type 2 diabetes mellitus'} 	 {'head': 'glucose', 'type': 'Regulator', 'tail': 'insulin'} 
{'head': 'maqui berry', 'type': 'instance of', 'tail': 'anthocyanin'} 	 {'head': 'delphinidin glycoside', 'type': 'Upregulator', 'tail': 'photoreceptor'} 
{'head': 'turmeric', 'type': 'has part', 'tail': 'Curcumin'} 	 {'head': 'curcumin', 'type': 'Downregulator', 'tail': 'matrix metalloproteinase-9'} 
{'head': 'apoptosis', 'type': 'part of', 'tail': 'cell cycle'} 	 {'head': 'EVn-50', 'type': 'Upregulator', 'tail': 'Histone 3'} 
{'head': 'acetic acid', 'type': 'subject has role', 'tail': 'antinociceptive'} 	 {'head': 'CAT', 'type': 'Regulator', 'tail': 'PKC'} 
{'head': 'breast cancer', 'type': 'has effect', 'tail': 'metastasis'} 	 {'head': 'Xanthohumol', 'type': 'Downregulator', 'tail': 'Bcl-2'} 
{'head': 'd-serine', 'type': 'instance of', 'tail': 'd-amino acid'} 	 {'head': '4-Hydroxypyridazin-3(2H)-one', 'type': 'Downregulator', 'tail': 'd-Amino Acid Oxidase'} 
{'head': 'heptylparaben', 'type': 'instance of', 'tail': 'parabens'} 	 {'head': 'parabens', 'type': 'Not', 'tail': 'AR'} 
{'head': 'pentahydroxy-pregn-14-ol,20-one-β-d-thevetopyranoside', 'type': 'subject has role', 'tail': 'anti-inflammatory'} 	 {'head': 'steroidal glycoside', 'type': 'Downregulator', 'tail': 'COX-2'} 
{'head': 'E-cadherin', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'calcium', 'type': 'Regulator', 'tail': 'E-cadherin'} 
{'head': 'ethanol', 'type': 'has parts of the class', 'tail': 'CO'} 	 {'head': 'Quercetin', 'type': 'Upregulator', 'tail': 'HO-1'} 
{'head': 'galanthamine', 'type': 'subject has role', 'tail': 'acetylcholinesterase inhibitor'} 	 {'head': 'tetrahydrocurcuminoid dihydropyrimidinone', 'type': 'Downregulator', 'tail': 'acetylcholinesterase'} 
{'head': 'proestrus', 'type': 'followed by', 'tail': 'estrous cycle'} 	 {'head': 'ICI 182 780', 'type': 'Upregulator', 'tail': 'AKT'} 
{'head': '2,3-oxidosqualen', 'type': 'subject has role', 'tail': 'oxidosqualene cyclase inhibitor'} 	 {'head': 'Aminopropylindenes', 'type': 'Downregulator', 'tail': 'oxidosqualene cyclase'} 
{'head': 'pannexin1', 'type': 'subclass of', 'tail': 'hemichannels'} 	 {'head': 'ATP', 'type': 'Not', 'tail': 'P2X receptors'} 
{'head': 'tBHQ', 'type': 'subject has role', 'tail': 'antioxidant'} 	 {'head': 'tBHQ', 'type': 'Upregulator', 'tail': 'ACOX1'} 
{'head': 'PDGF', 'type': 'subclass of', 'tail': 'angiogenic growth factor'} 	 {'head': 'PLGA', 'type': 'Upregulator', 'tail': 'VEGF'} 
{'head': 'CHK1', 'type': 'subject has role', 'tail': 'kinase inhibitor'} 	 {'head': 'imidazo[1,2-a]pyrazine', 'type': 'Downregulator', 'tail': 'MK2'} 
{'head': 'Fer tyrosine kinase', 'type': 'subclass of', 'tail': 'tyrosine kinase'} 	 {'head': 'Tyr', 'type': 'Part_of', 'tail': 'PDGFbeta receptor'} 
{'head': 'aryl ureas', 'type': 'subclass of', 'tail': 'aryl amide'} 	 {'head': 'aryl ureas', 'type': 'Antagonist', 'tail': 'histamine H3 receptor'} 
{'head': 'BIRD kinetics', 'type': 'studied by', 'tail': 'thermochemistry'} 	 {'head': 'halogen', 'type': 'Regulator', 'tail': 'tridentate receptor'} 
{'head': 'sciatic nerve injury', 'type': 'subclass of', 'tail': 'neuropathic pain'} 	 {'head': 'anandamide', 'type': 'Substrate', 'tail': 'FAAH'} 
{'head': 'LXR', 'type': 'subclass of', 'tail': 'receptor'} 	 {'head': '24(S)-hydroxycholesterol', 'type': 'Substrate', 'tail': '24-hydroxylase'} 
{'head': 'NMR', 'type': 'subclass of', 'tail': 'spectroscopic'} 	 {'head': 'amino acid', 'type': 'Part_of', 'tail': 'Human Serum Albumin'} 
{'head': 'striatonigral terminals', 'type': 'part of', 'tail': 'rat brain'} 	 {'head': 'Ca(2+)', 'type': 'Regulator', 'tail': 'CaMKIIα'} 
{'head': 'hyperglycemia', 'type': 'has cause', 'tail': 'mitochondrial dysfunction'} 	 {'head': 'glucose', 'type': 'Upregulator', 'tail': 'HO'} 
{'head': 'polyketide synthase', 'type': 'subclass of', 'tail': 'nonribosomal peptide synthetase'} 	 {'head': 'benzopyranopyrrole', 'type': 'Substrate', 'tail': 'nonribosomal peptide synthetases'} 
{'head': 'Synaptotagmin-1', 'type': 'instance of', 'tail': 'protein'} 	 {'head': 'Ca(2+)', 'type': 'Regulator', 'tail': 'synaptotagmin-1'} 
{'head': 'Estradiol', 'type': 'subject has role', 'tail': 'Psychostimulant'} 	 {'head': 'cocaine', 'type': 'Regulator', 'tail': 'estrogen receptor alpha'} 
{'head': 'coronary artery', 'type': 'has part', 'tail': 'vascular smooth muscle cell'} 	 {'head': 'Calcium', 'type': 'Substrate', 'tail': 'Intermediate-conductance Calcium-activated Potassium Channel KCa3.1'} 
{'head': 'inverse agonist', 'type': 'subclass of', 'tail': 'bioactivation'} 	 {'head': 'Imidazo- and 2-Methylimidazo[2,1-b]thiazole', 'type': 'Agonist', 'tail': 'Ghrelin Receptor'} 
{'head': 'vancomycin', 'type': 'subject has role', 'tail': 'antimicrobial'} 	 {'head': 'vancomycin', 'type': 'Regulator', 'tail': 'VanB'} 
{'head': 'linoleic acid', 'type': 'instance of', 'tail': 'fatty acid'} 	 {'head': 'DEHP', 'type': 'Regulator', 'tail': 'mPPARα'} 
{'head': 'interleukin (IL)-1β', 'type': 'part of', 'tail': 'innate immune system'} 	 {'head': 'polysialic acid', 'type': 'Regulator', 'tail': 'neural cell adhesion molecule'} 
{'head': 'euglycemic', 'type': 'subclass of', 'tail': 'glycemic control'} 	 {'head': 'Vildagliptin', 'type': 'Regulator', 'tail': 'glucagon'} 
{'head': 'Tamoxifen', 'type': 'medical condition treated', 'tail': 'estrogen-sensitive breast cancer'} 	 {'head': '4-Hydroxytamoxifen', 'type': 'Not', 'tail': 'cyclin E'} 
{'head': 'domains', 'type': 'part of', 'tail': 'protein'} 	 {'head': 'Cu(I)', 'type': 'Regulator', 'tail': 'hSOD1'} 
{'head': 'aminoalkylindole', 'type': 'subclass of', 'tail': 'ligand'} 	 {'head': 'Aminoalkylindole', 'type': 'Regulator', 'tail': 'Cannabinoid Receptor'} 
{'head': 'Glycyrrhizic acid', 'type': 'subject has role', 'tail': 'anti-asthmatic'} 	 {'head': 'Glycyrrhizic acid', 'type': 'Regulator', 'tail': 'ovalbumin'} 
{'head': 'high-fat diet', 'type': 'has effect', 'tail': 'obesity'} 	 {'head': 'vildagliptin', 'type': 'Downregulator', 'tail': 'DPP4'} 
{'head': 'palmitate', 'type': 'instance of', 'tail': 'free fatty acids'} 	 {'head': 'glucose', 'type': 'Substrate', 'tail': 'glucose transporter'} 
{'head': 'Puerarin', 'type': 'instance of', 'tail': 'isoflavone'} 	 {'head': 'Puerarin', 'type': 'Regulator', 'tail': 'ER'} 
{'head': 'phosphatidylinositol 3-kinase', 'type': 'subject has role', 'tail': 'apoptosis'} 	 {'head': 'free fatty acid', 'type': 'Regulator', 'tail': 'phosphatidylinositol 3-kinase'} 
{'head': 'oxyfluorfen', 'type': 'instance of', 'tail': 'herbicide'} 	 {'head': 'oxyfluorfen', 'type': 'Regulator', 'tail': 'CAT'} 
{'head': 'dopamine', 'type': 'subclass of', 'tail': 'receptor'} 	 {'head': 'SCH23390', 'type': 'Antagonist', 'tail': 'D1'} 
{'head': 'haloperidol', 'type': 'subject has role', 'tail': 'antipsychotic'} 	 {'head': 'Haloperidol', 'type': 'Regulator', 'tail': 'mTORC1'} 
{'head': 'rivaroxaban', 'type': 'subject has role', 'tail': 'anticoagulant'} 	 {'head': 'rivaroxaban', 'type': 'Downregulator', 'tail': 'factor Xa'} 
{'head': 'cadmium chloride', 'type': 'has part', 'tail': 'cadmium'} 	 {'head': 'Cd', 'type': 'Upregulator', 'tail': 'caspase-3'} 
{'head': 'oestrogen receptor alpha', 'type': 'subclass of', 'tail': 'oestrogen receptor'} 	 {'head': '17beta-oestradiol', 'type': 'Downregulator', 'tail': 'sodium iodide symporter'} 
{'head': 'ndhB-149', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'lincomycin', 'type': 'Regulator', 'tail': 'RNA polymerase'} 
{'head': 'atorvastatin', 'type': 'subject has role', 'tail': 'statin'} 	 {'head': 'simvastatin', 'type': 'Substrate', 'tail': 'cytochrome P450 (CYP) 3A'} 
{'head': 'phase 1', 'type': 'facet of', 'tail': 'clinical trial'} 	 {'head': 'LDK378', 'type': 'Downregulator', 'tail': 'anaplastic lymphoma kinase'} 
{'head': 'diazepam', 'type': 'subject has role', 'tail': 'anticonvulsant'} 	 {'head': 'BDZ', 'type': 'Not', 'tail': 'BDZ receptors'} 
{'head': 'fluoxymesterone', 'type': 'subclass of', 'tail': 'androgen'} 	 {'head': 'DHT', 'type': 'Regulator', 'tail': 'androgen receptor'} 
{'head': 'terfenadine', 'type': 'medical condition treated', 'tail': 'asthma'} 	 {'head': 'terfenadine', 'type': 'Antagonist', 'tail': 'histamine-H1 receptor'} 
{'head': 'Ibrutinib', 'type': 'medical condition treated', 'tail': 'mantle cell lymphoma'} 	 {'head': 'Ibrutinib', 'type': 'Downregulator', 'tail': 'B-cell antigen receptor'} 
{'head': 'propranolol', 'type': 'subject has role', 'tail': 'beta-adrenoceptor antagonist'} 	 {'head': 'propranolol', 'type': 'Antagonist', 'tail': 'beta-adrenoceptor'} 
{'head': 'A23187', 'type': 'subject has role', 'tail': 'calcium ionophore'} 	 {'head': 'arachidonic acid', 'type': 'Substrate', 'tail': '5-lipoxygenase'} 
{'head': 'Bevantolol', 'type': 'medical condition treated', 'tail': 'hypertension'} 	 {'head': 'Bevantolol', 'type': 'Antagonist', 'tail': 'beta-1 adrenoceptor'} 
{'head': 'Triazolobenzodiazepine', 'type': 'subject has role', 'tail': 'anxiolytic'} 	 {'head': 'triazolobenzodiazepines', 'type': 'Regulator', 'tail': 'Benzodiazepine receptor'} 
{'head': 'alpha 1-', 'type': 'subclass of', 'tail': 'adrenoceptor'} 	 {'head': 'phenothiazine', 'type': 'Regulator', 'tail': 'histamine H1 receptor'} 
{'head': 'retinyl acetate', 'type': 'subclass of', 'tail': 'vitamin A'} 	 {'head': 'retinoids', 'type': 'Not', 'tail': 'prothrombin'} 
{'head': 'tritiated diprenorphine', 'type': 'subject has role', 'tail': 'opiate'} 	 {'head': 'Na+', 'type': 'Regulator', 'tail': 'opiate receptor'} 
{'head': 'piriprost', 'type': 'subject has role', 'tail': '5-lipoxygenase inhibitor'} 	 {'head': 'diethylcarbamazine', 'type': 'Downregulator', 'tail': 'leukotriene C synthetase'} 
{'head': 'lactose', 'type': 'part of', 'tail': 'lactose hydrolysis'} 	 {'head': 'lactose', 'type': 'Substrate', 'tail': 'lactase'} 
{'head': 'pimozide', 'type': 'subject has role', 'tail': 'antipsychotic'} 	 {'head': 'phenoxybenzamine', 'type': 'Not', 'tail': 'S-100 protein'} 
{'head': 'testosterone', 'type': 'subclass of', 'tail': 'androgen'} 	 {'head': 'Anandron', 'type': 'Regulator', 'tail': 'prostatic androgen receptor'} 
{'head': 'cardiac depression', 'type': 'subclass of', 'tail': 'blood pressure'} 	 {'head': 'Adenosine', 'type': 'Regulator', 'tail': 'A1 receptors'} 
{'head': 'alpha-ketobutyrate', 'type': 'instance of', 'tail': 'coenzyme'} 	 {'head': 'gossypol', 'type': 'Not', 'tail': 'human and hamster LDH-X'} 
{'head': 'Phenylbutazone', 'type': 'subject has role', 'tail': 'nonsteroidal anti-inflammatory drug'} 	 {'head': 'phenylbutazone', 'type': 'Downregulator', 'tail': 'prostaglandin H synthase'} 
{'head': 'Phenoxybenzamine', 'type': 'subject has role', 'tail': 'alpha-adrenergic antagonist'} 	 {'head': 'phenoxybenzamine', 'type': 'Regulator', 'tail': 'calmodulins'} 
{'head': 'monoamine oxidase A', 'type': 'subclass of', 'tail': 'Amine oxidase'} 	 {'head': 'semicarbazide', 'type': 'Regulator', 'tail': 'Amine oxidase'} 
{'head': 'Penicillin-binding proteins', 'type': 'subclass of', 'tail': 'protein'} 	 {'head': 'amdinocillin', 'type': 'Regulator', 'tail': 'Penicillin-binding proteins'} 
{'head': 'trifluoperazine', 'type': 'subclass of', 'tail': 'phenothiazine'} 	 {'head': 'phenothiazines', 'type': 'Regulator', 'tail': 'epidermal growth factor'} 
{'head': 'alpha-methyl-para-tyrosine', 'type': 'subject has role', 'tail': 'dopamine'} 	 {'head': 'p-HPAA', 'type': 'Regulator', 'tail': 'tyrosine hydroxylase'} 
{'head': 'diphenhydramine', 'type': 'subject has role', 'tail': 'histamine receptor antagonist'} 	 {'head': 'diphenhydramine', 'type': 'Downregulator', 'tail': 'FHA'} 
{'head': 'peroxisomal', 'type': 'part of', 'tail': 'mitochondria'} 	 {'head': 'glyoxylate', 'type': 'Substrate', 'tail': 'Alanine:glyoxylate aminotransferase'} 
{'head': 'Triclosan', 'type': 'subject has role', 'tail': 'antibacterial'} 	 {'head': 'Triclosan', 'type': 'Downregulator', 'tail': 'cyclooxygenase 1'} 
{'head': 'hydroxocobalamin', 'type': 'instance of', 'tail': 'cobalamin'} 	 {'head': '[57Co]cyanocobalamin', 'type': 'Regulator', 'tail': 'transcobalamin II'} 
{'head': 'dopamine', 'type': 'subclass of', 'tail': 'dopamine receptor'} 	 {'head': 'Ergovaline', 'type': 'Regulator', 'tail': 'D2 dopamine receptor'} 
{'head': 'risperidone', 'type': 'subject has role', 'tail': 'antipsychotic'} 	 {'head': 'risperidone', 'type': 'Regulator', 'tail': 'alpha 1B-adrenoceptors'} 
{'head': 'chloroethylclonidine', 'type': 'subject has role', 'tail': 'irreversible'} 	 {'head': 'noradrenaline', 'type': 'Regulator', 'tail': 'alpha 1-adrenoceptor'} 
{'head': 'metoprolol tartrate', 'type': 'subject has role', 'tail': 'beta-adrenoceptor antagonist'} 	 {'head': 'desipramine', 'type': 'Not', 'tail': 'beta 1-adrenoceptors'} 
{'head': 'WB 4101', 'type': 'subject has role', 'tail': 'alpha 1A-adrenoceptor antagonist'} 	 {'head': 'WB 4101', 'type': 'Antagonist', 'tail': 'alpha 1A-adrenoceptor'} 
{'head': 'insulinoma', 'type': 'instance of', 'tail': 'cell lines'} 	 {'head': 'glucose', 'type': 'Substrate', 'tail': 'GLUT2'} 
{'head': 'thrombocytopenia', 'type': 'subclass of', 'tail': 'coagulopathies'} 	 {'head': 'lysine', 'type': 'Downregulator', 'tail': 't-PA'} 
{'head': 'histamine', 'type': 'subject has role', 'tail': 'neuromodulatory'} 	 {'head': 'Histamine', 'type': 'Upregulator', 'tail': 'H1-receptor'} 
{'head': 'tretinoin', 'type': 'medical condition treated', 'tail': 'acne'} 	 {'head': 'adapalene', 'type': 'Not', 'tail': 'retinoic acid binding protein'} 
{'head': 'renin-angiotensin system', 'type': 'has effect', 'tail': 'arterial pressure'} 	 {'head': 'remikiren', 'type': 'Downregulator', 'tail': 'renin'} 
{'head': 'IL-3', 'type': 'subclass of', 'tail': 'cytokine'} 	 {'head': 'nedocromil sodium', 'type': 'Downregulator', 'tail': 'cytokine'} 
{'head': 'leptomeninges', 'type': 'part of', 'tail': 'central nervous system'} 	 {'head': 'Glutathione', 'type': 'Not', 'tail': 'prostaglandin-H2 D-isomerase'} 
{'head': 'cDNA', 'type': 'has part', 'tail': 'nucleotide'} 	 {'head': 'nucleotide', 'type': 'Part_of', 'tail': 'EAA3a'} 
{'head': 'diethylcarbamazine', 'type': 'subject has role', 'tail': '5-lipoxygenase'} 	 {'head': 'diethylcarbamazine', 'type': 'Downregulator', 'tail': '5-lipoxygenase'} 
{'head': 'Tamsulosin', 'type': 'subject has role', 'tail': 'prostate-selective alpha 1A-adrenoceptor antagonist'} 	 {'head': 'Tamsulosin', 'type': 'Antagonist', 'tail': 'alpha 1A-adrenoceptor'} 
{'head': 'PC3', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'COOH', 'type': 'Part_of', 'tail': 'proinsulin'} 
{'head': 'desipramine', 'type': 'subject has role', 'tail': 'tricyclic antidepressant'} 	 {'head': 'Desipramine', 'type': 'Regulator', 'tail': '5-HT2A'} 
{'head': 'alpha1-acid glycoprotein', 'type': 'subclass of', 'tail': 'proteins'} 	 {'head': 'thalidomide', 'type': 'Regulator', 'tail': 'human AGP'} 
{'head': 'AMPA receptor', 'type': 'subclass of', 'tail': 'receptor'} 	 {'head': 'cyclothiazide', 'type': 'Regulator', 'tail': 'GluR-A'} 
{'head': 'striatum', 'type': 'has part', 'tail': 'caudate head'} 	 {'head': '[3H]WIN 35,428', 'type': 'Regulator', 'tail': 'DAT'} 
{'head': 'N-terminal', 'type': 'part of', 'tail': 'protein'} 	 {'head': 'disulfide', 'type': 'Part_of', 'tail': 'PHBP'} 
{'head': 'tolazoline therapy', 'type': 'medical condition treated', 'tail': 'gastric bleeding'} 	 {'head': 'cimetidine', 'type': 'Downregulator', 'tail': 'histamine H2 receptor'} 
{'head': 'GYKI 52466', 'type': 'instance of', 'tail': '2,3-benzodiazepines'} 	 {'head': '2,3-benzodiazepines', 'type': 'Regulator', 'tail': 'AMPA receptors'} 
{'head': 'I1-imidazoline receptor', 'type': 'subclass of', 'tail': 'adrenoceptor'} 	 {'head': '[125I]p-iodoclonidine', 'type': 'Regulator', 'tail': 'human platelet I1-imidazoline binding sites'} 
{'head': 'indomethacin', 'type': 'subclass of', 'tail': 'nonsteroidal anti-inflammatory drug'} 	 {'head': 'minoxidil', 'type': 'Upregulator', 'tail': 'prostaglandin synthase-1'} 
{'head': 'domains', 'type': 'part of', 'tail': 'protein'} 	 {'head': 'amino', 'type': 'Part_of', 'tail': 'glutamyl-prolyl-tRNA synthetase'} 
{'head': 'tretinoin', 'type': 'medical condition treated', 'tail': 'acne'} 	 {'head': 'adapalene', 'type': 'Regulator', 'tail': 'nuclear transcription factors'} 
{'head': '5-hydroxytryptamine', 'type': 'subject has role', 'tail': 'prokinetic'} 	 {'head': 'cinitapride', 'type': 'Agonist', 'tail': '5-HT4'} 
{'head': 'SH2 domain', 'type': 'part of', 'tail': 'protein'} 	 {'head': 'purine', 'type': 'Substrate', 'tail': 'adenosine deaminase'} 
{'head': 'Alendronate', 'type': 'medical condition treated', 'tail': 'osteoporosis'} 	 {'head': 'Alendronate', 'type': 'Not', 'tail': 'PTP epsilon'} 
{'head': 'prostaglandin E receptor', 'type': 'subclass of', 'tail': 'prostanoid receptor'} 	 {'head': 'PGD2', 'type': 'Regulator', 'tail': 'DP'} 
{'head': 'ester', 'type': 'has part', 'tail': 'base'} 	 {'head': 'N', 'type': 'Part_of', 'tail': 'TK'} 
{'head': 'cisapride', 'type': 'subject has role', 'tail': 'gastrointestinal prokinetic agent'} 	 {'head': 'cisapride', 'type': 'Regulator', 'tail': 'human ether-a-go-go-related gene'} 
{'head': 'receptor', 'type': 'has part', 'tail': 'ligand'} 	 {'head': '[3H]MK-801', 'type': 'Regulator', 'tail': 'NMDA receptors'} 
{'head': 'cocaine', 'type': 'subject has role', 'tail': 'dopamine receptor antagonist'} 	 {'head': 'cocaine', 'type': 'Regulator', 'tail': 'Monoamine transporter'} 
{'head': 'neurotensin', 'type': 'subclass of', 'tail': 'receptor'} 	 {'head': '[3H]SR 142948A', 'type': 'Regulator', 'tail': 'neurotensin NT1'} 
{'head': 'naphthoic acid', 'type': 'subject has role', 'tail': 'anti-inflammatory'} 	 {'head': 'retinoid', 'type': 'Regulator', 'tail': 'RAR beta'} 
{'head': 'alpha1C', 'type': 'followed by', 'tail': 'alpha2'} 	 {'head': 'dihydropyridines', 'type': 'Downregulator', 'tail': 'L-type calcium channels'} 
{'head': 'hydroxocobalamin', 'type': 'subclass of', 'tail': 'cobalamin'} 	 {'head': 'methyltetrahydrofolate', 'type': 'Substrate', 'tail': 'Methylenetetrahydrofolate reductase'} 
{'head': 'gene', 'type': 'encodes', 'tail': 'protein'} 	 {'head': 'amino acid', 'type': 'Substrate', 'tail': 'System y+'} 
{'head': 'lintitript', 'type': 'subject has role', 'tail': 'CCK-A receptor antagonist'} 	 {'head': 'lintitript', 'type': 'Antagonist', 'tail': 'CCK-A receptor'} 
{'head': 'isoproterenol', 'type': 'medical condition treated', 'tail': 'asthma'} 	 {'head': 'isoproterenol', 'type': 'Regulator', 'tail': 'Concanavalin A'} 
{'head': 'oxytocin', 'type': 'part of', 'tail': 'myometrial oxytocin receptor'} 	 {'head': 'carbetocin', 'type': 'Regulator', 'tail': 'vasopressin V2 receptor'} 
{'head': 'dimeric', 'type': 'subclass of', 'tail': 'crystal structure'} 	 {'head': 'catechol', 'type': 'Downregulator', 'tail': 'human phenylalanine hydroxylase catalytic domain'} 
{'head': 'glucocorticoid', 'type': 'subclass of', 'tail': 'steroid hormone'} 	 {'head': 'RU486', 'type': 'Regulator', 'tail': 'GR'} 
{'head': 'SUR1', 'type': 'subclass of', 'tail': 'nucleotide-binding folds'} 	 {'head': 'ATP', 'type': 'Regulator', 'tail': 'nucleotide-binding folds'} 
{'head': 'Salmeterol', 'type': 'medical condition treated', 'tail': 'asthma'} 	 {'head': 'salmeterol', 'type': 'Regulator', 'tail': 'beta 2-adrenergic receptor'} 
{'head': 'Apomorphine', 'type': 'subject has role', 'tail': 'dopamine agonist'} 	 {'head': 'Apomorphine', 'type': 'Regulator', 'tail': 'TRPA1'} 
{'head': 'Vitamin C', 'type': 'subject has role', 'tail': 'antioxidant'} 	 {'head': 'Vitamin C', 'type': 'Downregulator', 'tail': 'NF-κB'} 
{'head': 'cognitive decline', 'type': 'has cause', 'tail': "Alzheimer's disease"} 	 {'head': 'choline', 'type': 'Substrate', 'tail': 'choline acetyltransferase'} 
{'head': '1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine', 'type': 'subject has role', 'tail': 'neurotoxicant'} 	 {'head': 'MPTP', 'type': 'Upregulator', 'tail': 'parkin'} 
{'head': 'Norepinephrine transporter', 'type': 'instance of', 'tail': 'gene'} 	 {'head': 'norepinephrine', 'type': 'Substrate', 'tail': 'Norepinephrine transporter'} 
{'head': 'macrophage', 'type': 'has part', 'tail': 'Macrophage'} 	 {'head': 'glutathione disulfide', 'type': 'Upregulator', 'tail': 'NF-kappaB'} 
{'head': 'triflusal', 'type': 'product or material produced', 'tail': 'nitric oxide'} 	 {'head': 'triflusal', 'type': 'Upregulator', 'tail': 'endothelial nitric oxide synthase'} 
{'head': 'dentate gyrus', 'type': 'part of', 'tail': 'hippocampus'} 	 {'head': 'Methamphetamine', 'type': 'Upregulator', 'tail': 'alpha(2A)-adrenergic receptor'} 
{'head': 'methimazole', 'type': 'subclass of', 'tail': 'thioureylene'} 	 {'head': 'iodide', 'type': 'Regulator', 'tail': 'thyroid peroxidase'} 
{'head': 'incretin', 'type': 'medical condition treated', 'tail': 'diabetes'} 	 {'head': 'glucose', 'type': 'Upregulator', 'tail': 'insulin'} 
{'head': 'opioid', 'type': 'has part', 'tail': 'mu opioid receptor'} 	 {'head': 'dezocine', 'type': 'Regulator', 'tail': 'mu opioid receptor'} 
{'head': 'DNMT1', 'type': 'instance of', 'tail': 'epigenetic'} 	 {'head': 'Ibandronate', 'type': 'Upregulator', 'tail': 'FAS'} 
{'head': 'schizophrenia', 'type': 'subclass of', 'tail': 'neuropsychiatric disorders'} 	 {'head': 'CP55940', 'type': 'Upregulator', 'tail': 'β-Arrestin 2'} 
{'head': 'Arsenic trioxide', 'type': 'medical condition treated', 'tail': 'acute promyelocytic leukemia'} 	 {'head': 'Arsenic trioxide', 'type': 'Downregulator', 'tail': 'hERG'} 
{'head': 'dimethocaine', 'type': 'subject has role', 'tail': 'local anesthetic'} 	 {'head': 'SCH 39166', 'type': 'Antagonist', 'tail': 'dopamine D1 receptor'} 
{'head': 'cisapride', 'type': 'medical condition treated', 'tail': 'long QT syndrome'} 	 {'head': 'K+', 'type': 'Regulator', 'tail': 'HERG'} 
{'head': 'acetazolamide', 'type': 'subject has role', 'tail': 'anticonvulsant'} 	 {'head': 'aromatic and heterocyclic sulfonamides', 'type': 'Downregulator', 'tail': 'Carbonic anhydrase'} 
{'head': "2,2',4,4',5-pentaBDE", 'type': 'instance of', 'tail': 'polybrominated diphenyl ethers'} 	 {'head': 'BDE-99', 'type': 'Downregulator', 'tail': 'BDNF'} 
{'head': 'Castrate-resistant prostate cancer', 'type': 'subclass of', 'tail': 'prostate cancer'} 	 {'head': 'indomethacin', 'type': 'Downregulator', 'tail': 'AKR1C3'} 
{'head': 'papillary thyroid cancer', 'type': 'subclass of', 'tail': 'thyroid cancer'} 	 {'head': 'fluoropyrimidine carbamate', 'type': 'Substrate', 'tail': 'thymidine phosphorylase'} 
{'head': 'oestrogen receptor', 'type': 'subclass of', 'tail': 'receptor'} 	 {'head': 'progestagens', 'type': 'Regulator', 'tail': 'progesterone receptors'} 
{'head': 'metformin', 'type': 'subject has role', 'tail': 'inhibitor'} 	 {'head': 'compound C', 'type': 'Regulator', 'tail': 'AMP-activated protein kinase'} 
{'head': 'ventral horn', 'type': 'part of', 'tail': 'spinal cord'} 	 {'head': 'methylated arginine', 'type': 'Substrate', 'tail': 'Dimethylarginine dimethylaminohydrolase 1'} 
{'head': 'HMG-CoA reductase inhibitor', 'type': 'subclass of', 'tail': 'statin'} 	 {'head': 'ezetimibe', 'type': 'Downregulator', 'tail': 'LDL'} 
{'head': 'SB225002', 'type': 'subject has role', 'tail': 'anti-inflammatory'} 	 {'head': 'SB225002', 'type': 'Antagonist', 'tail': 'IL-8 receptor B'} 
{'head': 'eptastigmine', 'type': 'subclass of', 'tail': 'organophosphorus'} 	 {'head': 'organophosphorus', 'type': 'Downregulator', 'tail': 'acetylcholinesterase'} 
{'head': 'steroid hormone', 'type': 'part of', 'tail': 'endocrine'} 	 {'head': 'polychlorinated biphenyls', 'type': 'Downregulator', 'tail': 'aromatase'} 
{'head': 'Panax ginseng', 'type': 'instance of', 'tail': 'traditional Chinese medicine'} 	 {'head': 'Rg1', 'type': 'Downregulator', 'tail': 'Aβ25-35'} 
{'head': 'clozapine', 'type': 'medical condition treated', 'tail': 'schizophrenia'} 	 {'head': 'clozapine', 'type': 'Regulator', 'tail': '5HT-2A'} 
{'head': 'kidney', 'type': 'part of', 'tail': 'liver'} 	 {'head': 'arsenic', 'type': 'Regulator', 'tail': 'cytochrome P450'} 
{'head': 'testosterone', 'type': 'instance of', 'tail': 'carcinogen'} 	 {'head': 'MNU', 'type': 'Downregulator', 'tail': 'E-cadherin'} 
